Characterisation of the centrosome protein Cep63 by Brown, N.J.
Characterisation of the centrosome protein Cep63 
 
 
Nicola J. Brown 
 
 
University College London 
and 
Cancer Research UK London Research Institute 
PhD Supervisor: Dr Vincenzo Costanzo 
 
A thesis submitted for the degree of 
Doctor of Philosophy 
University College London 
September 2011 
2 
Declaration 
I Nicola Brown confirm that the work presented in this thesis is my own.  Where 
information has been derived from other sources, I confirm that this has been indicated 
in the thesis. 
3 
Abstract 
In dividing cells, centrosomes act as the primary microtubule organising centre to 
orchestrate mitotic spindle assembly. Bipolar spindle assembly is responsible for 
accurate segregation of sister chromatids, such that each daughter cell receives an 
identical copy of the genome. Changes in centrosome number can lead to a lack of 
mitotic fidelity and genome instability. Chromosomes are replicated in a controlled and 
timely fashion and the same is true for centrosomes so that cells enter mitosis with two 
centrosomes. Further to their role in spindle assembly, centrosomes are also important 
in cell cycle regulation and DNA damage checkpoint signalling. Centrosomes are 
particularly important in the regulation of neuroepithelial cell division in the developing 
brain: all known incidences of primary microcephaly are caused by mutations in 
centrosome or spindle pole proteins. 
 
Xenopus laevis Cep63 is a target of DNA damage kinase, ATM, and it’s important for 
the formation of bipolar mitotic spindles (Smith et al., 2009). Therefore, Cep63 is an 
exciting candidate for maintenance of genome stability. Human Cep63 has been 
identified as a centrosome protein (Andersen et al., 2003), but its function was 
uncharacterised. In this thesis Cep63 was shown to be a constitutive centrosome protein, 
which plays a role in the regulation of centriole duplication. Cep152 was identified as a 
Cep63 interacting protein; and Cep63 and Cep152 are dependent on each other for their 
centrosomal localisation. Cep152 is required for centriole duplication via recruitment of 
essential duplication factors, Plk4 and CPAP, to the centrosome (Dzhindzhev et al., 
2010b, Cizmecioglu et al., 2010, Hatch et al., 2010b). Furthermore, mouse embryonic 
fibroblasts in which the Cep63 gene is disrupted show decreased centriole numbers and 
signs of genome instability. Intriguingly, preliminary analysis of mouse embryos points 
to a potential link between Cep63 deficiency and microcephaly. We propose that Cep63 
and Cep152 function together to ensure correct centrosomal levels of the essential 
centriole duplication factors Plk4 and CPAP. 
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Chapter 1. Introduction 
1.1 The eukaryotic cell cycle 
Cell division is the process by which a mother cell duplicates its content and divides in 
two, forming two daughter cells. In single celled organisms, each cell division produces 
a whole new organism, whereas in large multicellular organisms such as mammals, cell 
division is required during development to produce the many different cell types that 
make up the body from one fertilised egg cell. Cell division is also required in fully 
developed mammals for the generation of new tissues: there is a high turnover of the 
body’s cells throughout life for tissue maintenance and repair after injury. 
 
The entire process of duplication of the genetic information through to division into two 
new cells is called “the cell cycle”. Each cell contains the genetic information required 
for all cell types in the entire organism and in order for the genetic information to be 
maintained “word for word” throughout all of the trillions of cell divisions from 
fertilisation of a vertebrate egg to development of a fully formed organism, and through 
life the cell cycle has to be strictly controlled. Each cell can only divide when it has 
faithfully copied the genetic information so that an identical copy can be passed to each 
daughter cell. Genetic information is stored as deoxyribonucleic acid (DNA), which is 
packaged by cellular proteins into chromosomes. During cell division DNA is first 
duplicated in S phase (Synthesis) then segregated equally into two daughter cells in 
mitosis (M) by the action of the mitotic spindle (figure 1). 
Chapter 1. Introduction 
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Figure 1 The cell cycle 
DNA is replicated during S (synthesis) phase and duplicated chromosomes are then 
segregated equally into two daughter cells during mitosis. Chromosomes are aligned 
and attached to the mitotic spindle (red lines) such that sister chromatids are attached to 
spindle microtubules emanating from opposite spindle poles. When all chromatids are 
attached in a bipolar fashion the spindle assembly checkpoint is satisfied and anaphase 
occurs (mitosis, right).  Cell cycle checkpoints regulate cell cycle progression at the 
stages indicated by dashed lines. The G1/S, intra-S and G2/M checkpoints are activated 
in response to DNA damage and halt cell cycle progression by inhibition of the 
appropriate Cdk-Cyclin pair. The spindle assembly checkpoint is activated by 
chromatids that are not properly attached to the mitotic spindle and halts mitosis by 
inhibiting the onset of anaphase. Gap phases separate S phase and mitosis in vertebrate 
somatic cell cycles to allow growth and the opportunity for cell cycle regulation by 
internal or external stimuli. 
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The equal segregation of chromosomes during cell division in human cells was first 
visualised by Walther Flemming in 1879 (figure 2, reproduced from (Paweletz, 2001)). 
Upon entry into mitosis, during prophase, replicated chromosomes (pairs of sister 
chromatids) condense, and duplicated centrosomes nucleate microtubules. Mitotic 
spindle formation begins between the two centrosomes. In prometaphase nuclear 
envelope breakdown occurs and spindle microtubules begin to attach to kinetochores on 
chromosomes, which is a highly dynamic process. In metaphase, chromosomes are 
aligned at the equator by the action of spindle microtubules and associated motor 
proteins, such that sister chromatids are attached to microtubules from opposite spindle 
poles (equatorial plate, figure 2). When all chromosomes are attached to the mitotic 
spindle in a bipolar fashion, the synchronous separation of sister chromosomes occurs 
(anaphase). In telophase, chromosomes at spindle poles start to de-condense; the 
nuclear envelope starts to reform; and the contractile ring assembles in the middle of the 
cell. The cytoplasm is divided in two by the contractile ring, made from actin and 
myosin filaments, in cytokinesis. Chromosomes continue to de-condense and nuclear 
envelope formation is completed (reconstruction phase, figure 2). 
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Figure 2 Walter Flemming’s drawings of cell division stages 
Diagram from Walther Flemming, Zellsubstanz, Kern und Zellteilung (1882) “Cell 
substance, nucleus and cell division”. Taken from (Paweletz, 2001). These detailed 
drawing of the stages of cell division illustrate the condensation of duplicated 
chromosomes, their alignment at metaphase and their equal segregation into two 
daughter cells.  
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It is of extreme importance that DNA replication, the duplication of chromosomes, is 
carried out with precision to ensure that copies are identical. As follows, it is important 
that chromosomes are segregated equally during mitosis when the cell divides in two. 
Errors in DNA replication or unequal segregation of chromosomes lead to genetic 
instability and cancer (Negrini et al., 2010).  
 
Theodor Boveri first documented these ideas in the 1880s: Boveri postulated that 
abnormal cell divisions led to tumour formation and that different chromosomes carried 
different genetic traits, so chromosomes had to be inherited equally by the two daughter 
cells during cell division. Boveri also put forward the idea that the cell cycle contains 
“checkpoints”, which control the cell cycle and prevent amplification of cells with 
genetic errors, as documented by Bignold et al.(Bignold et al., 2006). These theories 
were based on earlier work carried out by Hansemann in the late 1800s, who 
documented the presence of abnormal asymmetric mitoses in carcinomas (Bignold et 
al., 2006).  
 
The importance of accurate duplication and segregation of chromosomes during cell 
division has been documented and discussed for over a hundred years, and nowadays 
we know that the control of the cell cycle by regulatory proteins ensures fidelity. First 
of all, DNA replication is highly regulated to ensure that it takes place once and only 
once per cell cycle, and secondly, the duplicated chromosomes are equally segregated 
between the two daughter cells. Cells can only enter mitosis once the genome has been 
fully replicated and separation of the sister chromatids can only occur once all sister 
chromatids are attached to opposite spindle poles. In mammalian cells, S phase and M 
phase are separated by gap phases (G1 and G2), which allow for cell growth and the 
regulation of cell cycle progression by internal or external signals (figure 1). Accurate 
cell cycle control is crucial for the maintenance of genome stability.  
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1.1.1 Cell cycle control 
Progression of the cell cycle is driven by protein kinases that phosphorylate a range of 
substrate proteins required for each stage of the cell cycle. These kinases that control 
cell cycle progression are thus called cyclin-dependent kinases (Cdks). Oscillations of 
the activity of Cdks are regulated, in part, by the periodic translation and proteolytic 
degradation of their cyclin partner, on which they rely for full activation. The first 
indication that the cell cycle could be regulated by protein degradation came from work 
carried out in the 1980s, which identified cyclin as a protein that was degraded 
periodically at a specific point in the cell cycle in fertilised sea urchin eggs (Evans et al., 
1983). Further work showed that the addition of Cyclin B protein to Xenopus laevis egg 
extracts satisfied the requirement for protein synthesis for entry and progression through 
mitosis (Murray and Kirschner, 1989, Murray et al., 1989). 
 
From biochemical studies of fertilised eggs and from genetic studies in yeast, it is now 
known that the cell cycle is controlled by different Cdk-cyclin pairs and that the 
periodic activation and inhibition of these kinases drives cell cycle progression (figure 
3). Internal and external signalling pathways regulate cell cycle progression by 
controlling the activity of Cdk-cyclin complexes (Morgan, 2007). The cell cycle 
progresses in one direction only, due to Cdk-cyclins activating the Cdk-cyclin pair 
required for the next stage in the cycle. Timing of Cdk-cyclin activation depends on 
cyclin protein levels in the cell, removal of inhibitory phosphorylation on the kinase 
moiety and changes in levels of Cdk inhibitor proteins (figure 3). 
 
S-phase and M-phase Cdks are held inactive during G1 by the specific degradation of 
their cyclin partners, suppression of cyclin gene expression, and the presence of specific 
Cdk inhibitors. G1 Cdks activate the S-phase Cdks and promote their own destruction 
ensuring directionality of the cell cycle. S-phase cyclins then activate proteins required 
for DNA replication. Cyclin B levels rise at the end of S-phase, which is required for 
activation of the M-phase Cdk, Cdk1. Full activation of Cdk1-cyclin B requires the 
removal of inhibitory phosphorylation on Cdk1 by Cdc25 phosphatase. Active Cdk1-
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Cyclin B promotes its own activation, which provides a switch-like entry into mitosis 
(figure 4, bottom panel). Inhibitory phosphorylation is maintained by Wee1 kinase 
(Russell and Nurse, 1987), but when Cdk1-cyclin B is activated it inactivates its 
inhibitor, Wee1, and activates its activator, Cdc25 (Norbury et al., 1991). However, 
Cdk1-cylin B also activates the APC/C and therefore brings about its own degradation. 
APC/C activity is responsible for two key activities to allow mitotic exit: firstly, it 
degrades the protein that holds sister chromatids together so that they can be separated 
to opposite sides of the cell; secondly, it degrades cyclin B and consequently inactivates 
Cdk1.  
 
Cdk1-cyclin B is the main regulator of mitotic events, but Cdk2-Cyclin A is also active 
during mitosis. Cdk2-cyclin A is required for mitosis up until mid-prophase (Furuno et 
al., 1999). Cdk2-cyclin A increases Cdk1-cylin B activity by activating Cdc25B and by 
stabilising cyclin B protein levels (Mitra and Enders, 2004, Lukas et al., 1999). 
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Figure 3 Cell cycle control by Cdk-cyclin complexes 
Figure taken from The Cell Cycle: Principles of Control by David O Morgan (New 
Press Ltd. 2007).  Cyclin dependent kinase (Cdk) activity is regulated by binding of 
cyclin partners, inhibitory phosphorylation and Cdk inhibitors. Cdks are only active as a 
Cdk-cyclin complex. Cyclin levels are regulated by selective degradation during the cell 
cycle.  Active G1/S Cdk-cyclin complexes commits a cell to enter a new cell cycle at 
the start checkpoint in late G1. G1/S Cdk-cyclins then activate S phase cyclins, which 
are required for initiation of DNA replication, and promote their own degradation.  The 
M-phase Cdk-cyclin complex is activated after completion of S phase, which causes 
entry into mitosis. M phase Cdk-cyclin activates the APC/C (Anaphase Promoting 
Complex/Cyclosome), which causes anaphase and leads to degradation of M phase 
cyclin. APC/C activity remains high until late G1 and thus keeps the Cdk activity low. 
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1.1.2  DNA damage checkpoints 
When DNA damage occurs, the cell surveillance mechanisms, checkpoints, are 
activated. The purpose of checkpoints is to halt cell cycle progression, allowing time for 
DNA repair to occur, and to activate DNA repair mechanisms. DNA damage 
checkpoints are crucial in maintaining the integrity of the genome (Jackson and Bartek, 
2009). Mutation of checkpoint genes causes DNA lesions to go undetected and 
therefore promotes the accumulation of mutations. Multiple mutations are required for a 
cell to become cancerous, thus oncogenesis is promoted if checkpoints are less efficient 
at recognising or repairing damaged DNA (Hanahan and Weinberg, 2011). 
 
DNA damage checkpoints consist of DNA damage sensor and mediator proteins that 
recognise DNA lesions and activate the signal transducer proteins, and effector proteins 
that halt the cell cycle (figure 4). DNA damage checkpoints at different stages of the 
cell cycle have different effector proteins, but the same sensor, mediator and transducer 
proteins are used throughout the cell cycle. ATM (ataxia telangiectasia mutated) and 
ATR (ATM and Rad3 related) are two important DNA damage activated kinases. It is 
important to know that ATM and ATR do not carry out their function in isolation: there 
are many different mediator proteins that help to amplify the signal and aid recognition 
of damaged DNA, reviewed in (Sancar et al., 2004), (Zhou and Elledge, 2000) and 
(Stucki and Jackson, 2006).  
 
ATM and ATR are both members of the phosphoinositide 3-kinase-like family and they 
phosphorylate a range of protein substrates. ATM is the main sensor of ?-irradiation 
induced DNA damage, which primarily causes double strand breaks whereupon ATM 
phosphorylates and activates the checkpoint kinase Chk2. ATR is the primary sensor of 
UV induced DNA damage in the cell, and signals via Chk1. However, the pathways do 
overlap: ATR can activate ATM in response to UV (Stiff et al., 2006) and ATM can 
activate ATR by mediating DNA double strand break resection to expose single strand 
DNA (Jazayeri et al., 2006).  
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At the G1/S phase transition, DNA damage causes inactivation of Cdk2-Cyclin E/A and 
thus prevents replication initiation. A long-term response is mediated via p53, which 
results in the prevention of S-phase gene transcription (Sancar et al., 2004). When DNA 
damage is encountered during S phase, the intra-S phase checkpoint is activated and the 
cell cycle is arrested in S phase by the inhibition Cdk-Cyclins required for replication 
origin firing. Thus late origin firing is prevented and replication cannot be completed 
until the damage has been repaired. During replication the ATR-Chk1-Cdc25 
checkpoint pathway is active, which targets Cdc25 phosphatase for degradation. Cdc25 
phosphatase is required for removal of the inhibitory phosphorylation from Cdk1 and 
therefore its degradation inhibits Cdk1 activation and the onset of mitosis. 
 
The G2/M checkpoint prevents entry into mitosis in the presence of DNA damage 
(figure 4). DNA damage is recognised by ATM or ATR, which phosphorylate and 
activate Chk2 and Chk1 respectively. Chk1 and Chk2 inhibit Cdc25A phosphatase and 
activate Wee1 kinase. Upon phosphorylation by Chk1 or Chk2, Cdc25A binds to 14-3-3 
proteins, which causes Cdc25A to be sequestered in the cytoplasm and degraded via 
ubiquitin-mediated proteasome degradation. Wee1 is phosphorylated by Chk1, which 
activates its kinase activity and results in the maintenance of inhibitory Cdk1 
phosphorylation (O'Connell et al., 1997). Thus, in the presence of DNA damage Cdk1 is 
held inactive by inhibition of its activator, Cdc25, and activation of its inhibitor, Wee1, 
which prevents entry into mitosis.  
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Figure 4 The G2/M DNA damage checkpoint inhibits activation of Cdk1 
This figure is adapted from Sancar et al. (Sancar et al., 2004). DNA damage in G2 
activates DNA damage sensor kinases ATM and ATR, which phosphorylate and 
activate Chk2 and Chk1 kinases respectively. Rad17-RFC (replication factor C) and the 
heterotrimeric 9-1-1 complex, which consists of Rad9-Rad1-Hus1, are also recruited to 
sites of DNA damage where they promote checkpoint activation. The checkpoint 
kinases Chk1 and Chk2 phosphorylate and activate Wee1 kinase and inactivate Cdc25A 
phosphatase, leading to prevention of mitotic entry. Checkpoint signalling is amplified 
by mediator of DNA damage checkpoint 1 (MDC1), p53 binding protein 1 (53BP1), 
and breast cancer type 1 susceptibility protein (BRCA1). The grey box indicates the 
roles of Cdc25A and Wee1 in the activation and inhibition of Cdk1, respectively. Green 
‘P’ indicates activatory phosphorylation. Red ‘P’ indicates inhibitory phosphorylation
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DNA repair pathways 
 
The purpose of cell cycle stalling in response to DNA damage is to allow time for repair 
of DNA lesions. Many different proteins are involved in DNA repair and exactly which 
proteins are involved depends on the type of DNA lesion. In response to abasic sites, 
base excision repair (BER) proteins carry out the process of removing the abasic site 
using an endonuclease to cut the sugar-phosphate DNA backbone, polymerase to fill in 
the gap, and ligase to join the resulting nicked DNA stand, reviewed in Sancar et al. 
(Sancar et al., 2004). Nucleotide excision repair (NER) is required for moving bulky 
DNA lesions; first dual incisions are made surrounding the lesion by a nuclease then the 
resulting single strand DNA fragment (ranging from 24 to 32 nucleotides in mammals) 
is removed. The gap is filled by DNA synthesis and the single strand nicks are then 
ligated (Sancar et al., 2004). 
 
The repair of DNA double strand breaks (DSBs) can occur by two different pathways: 
non-homologous end joining (NHEJ) or homologous recombination (HR) (Sancar et al., 
2004). NHEJ is an error-prone pathway that results in loss of genetic information since 
the DNA ends at the break are cut back then ligated together. First of all, Ku70, Ku80, 
and DNAPKcs recognise DNA DSB ends and the Mre11/Rad50/Nbs1 complex (MRN) 
carries out resection of the DNA ends. The two double strand DNA ends are then 
ligated by the Ligase4/XRCC4 heterodimer.  
 
HR provides a mechanism for conserving genetic information providing that there is a 
homologous chromosome from which to copy. For HR to occur, the double strand DNA 
ends must first be resected to produce single strand 3’ overhangs, which then form base 
pair interactions with the complementary strand in the homologous chromosome in a 
process called strand invasion. This process results in a DNA structure containing two 
4-way junctions (Holliday junctions). The MRN complex carries out resection of DNA 
ends and the resulting 3’ overhang single strand DNA is coated by Rad51 polymer, 
which is required for strand invasion into the homologous duplex DNA. Double 
Holliday junctions are structures in which the to DNA double helices are topologically 
Chapter 1. Introduction 
25 
linked and they can be resolved by GEN1, which cleaves the two Holliday junctions, 
resulting in either cross-over or non-crossover products. Double Holliday junction 
dissolution can occur by the action of BLM helicase (Bloom syndrome helicase) along 
with its interacting partners TopoIII?, RMI1, and RMI2, which exclusively results in 
non-crossover products, reviewed by Mimmitou et al. (Mimitou and Symington, 2009). 
BRCA1 and BRCA2 are also important for HR repair (Boulton, 2006). Since NHEJ is 
error-prone, homologous recombination is the predominant pathway used by cells in S-
phase or G2, when a homologous chromosome is present. 
 
1.1.3 The Spindle Assembly Checkpoint 
 
In order to ensure equal segregation, replicated “sister” chromatids are attached to 
opposite poles of the mitotic spindle and progression to anaphase is prevented until all 
pairs of sister chromatids are properly attached to spindle microtubules. Important 
factors for the equal segregation of sister chromatids are the cohesion between sister 
chromatids and the attachment of spindle microtubules from opposite spindle poles to 
sister chromatids via the kinetochore, which is a large multi-layered protein complex 
that forms at centromeres (Cheeseman and Desai, 2008). Surveillance of kinetochore to 
spindle microtubule interaction is carried out by the spindle assembly checkpoint 
(SAC). The SAC holds cells at metaphase by inhibition of the APC/C. When the SAC is 
satisfied, the APC/C becomes active and causes degradation of cyclin B and cleavage of 
cohesin, the protein responsible for sister chromatid cohesion (figure 5).  
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Figure 5 The spindle assembly checkpoint  (SAC) 
(A) The SAC is activated when sister chromatids are not attached to the mitotic spindle 
in a bipolar fashion. Spindle checkpoint proteins are recruited to unattached 
kinetochores, which leads to the formation of a soluble mitotic checkpoint complex 
(MCC), which binds and inactivates Cdc20 and thus inhibits APC/C activity (left). 
Kinetochores that are occupied, but not under tension, also result in formation of the 
MCC to inhibit APC/C (middle). When sister chromatids are bound by microtubules 
from opposite spindle poles, the kinetochores occupied and under tension and the SAC 
is satisfied (right). (B) When the SAC is satisfied the E3 ubiquitin ligase APC/C-Cdc20 
becomes active and targets its mitotic substrates for degradation by the 26S proteasome. 
Substrates include Cyclin B, required for the activity of the mitotic Cdk (Cdk1), and 
securin (SEC), which holds the enzyme separase inactive. Activated separase cleaves 
cohesin, a protein responsible for sister chromatid cohesion. 
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SAC Activation 
The spindle assembly checkpoint monitors the binding of spindle microtubules to 
kinetochores in two ways: detection of unattached kinetochores and kinetochores that 
are not under tension (Musacchio and Salmon, 2007). If all sister chromatids are 
attached to microtubules from opposite spindle poles, all kinetochores are occupied and 
under tension from the force of spindle microtubules moving towards spindle poles, and 
the SAC is satisfied. Detection of kinetochores that are not under tension is important in 
the case of syntelic attachment of chromosomes to the spindle, where both sister 
chromatids are attached to the same spindle pole. 
 
Activation of the SAC prevents anaphase and allows time for all kinetochores to 
become attached to microtubules. Therefore the SAC is active during every 
prometaphase/metaphase. Furthermore, the SAC promotes destabilisation of 
kinetochore-microtubule attachments that do not generate tension, allowing the 
formation of correct, bipolar attachment.  
 
Evidence that the inhibitory signal that prevents anaphase onset is generated by 
unattached kinetochores comes from work following anaphase onset after laser ablation 
of unattached kinetochores (Rieder et al., 1995). Importantly, the presence of one 
unattached kinetochore is sufficient to activate the SAC and arrest cells in metaphase. 
Furthermore, when the unattached kinetochore on the last mono-oriented chromosome 
in a cell is destroyed, anaphase onset occurs in the presence of the mono-oriented 
chromosome. These experiments show that SAC inhibition is dependent on the presence 
of unattached kinetochores. Also, the presence of one mono-oriented chromosome, i.e. 
lack of tension across one kinetochore, was not sufficient to maintain SAC activity. 
However, a study of micromanipulation of chromatids in spermatocytes shows that 
tension across kinetochores is important for inactivation of the SAC (Li and Nicklas, 
1995). Furthermore, the SAC is activated in HeLa cells that have all chromosomes bi-
oriented and all kinetochores occupied, but lack of tension in spindle microtubules 
(Skoufias et al., 2001). 
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 SAC components 
There are many components required for the precise regulation of the SAC, but here I 
will describe only the key players. SAC components are comprehensively reviewed in 
Musacchio et al. (Musacchio and Salmon, 2007). 
 
In response to unattached kinetochores, spindle checkpoint proteins Mad1 and Mad2 are 
recruited to the outer kinetochore. These proteins remain at the kinetochore and catalyse 
the conformational change of a highly dynamic pool of Mad2. This model for the 
conformational change and consequent activation of Mad2 is called the Mad2 template 
model, which provides an explanation of how the signal can be amplified from the 
kinetochore such that only one unattached kinetochore is sufficient for preventing 
anaphase onset (Musacchio and Salmon, 2007). Inhibition of the APC/C is carried out 
by the mitotic checkpoint complex (MCC), which consists of the spindle checkpoint 
proteins Mad2, Bub3 and BubRI, and the co-activator of APC/C, Cdc20. The MCC 
renders the APC/C inactive by preventing interaction with its cofactor Cdc20, which is 
required for the mitotic activity of APC/C. The precise mechanism of MCC inhibition 
of the APC/C is unclear: either the MCC binds and sequesters Cdc20 or the MCC acts 
as a pseudo-substrate for the APC/C and acts as a competitive inhibitor (Musacchio and 
Salmon, 2007). 
 
SAC kinases MPS1, Bub1, BubR1, Plk1, NEK2, MAPK and Aurora B are also 
important for SAC signalling. Aurora B is important for sensing kinetochore tension. It 
is responsible for destabilising kinetochore-microtubule interactions that do not 
generate tension, which promotes new binding events and therefore promotes 
chromosome bi-orientation (Musacchio and Salmon, 2007). The current model proposes 
that stretching of the kinetochore moves Aurora B substrates in the outer kinetochore 
out of reach of Aurora B kinase, which is tethered to the centromere (the region of 
chromatin upon which the kinetochore forms). Thus, lack of tension results in the close 
proximity of Aurora B and its substrates, but upon the formation of intra-kinetochore 
tension, its substrates are moved out of reach of the kinase and the SAC is satisfied 
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(Maresca and Salmon, 2009, Uchida et al., 2009). Aurora B kinase activity either 
activates the SAC directly or Aurora B-dependent destabilisation of the kinetochore-
microtubule interaction causes activation of the SAC via the resulting unattached 
kinetochore (Maresca and Salmon, 2010). 
 
Interestingly, the checkpoint kinase, Chk1, is also required for SAC function (Zachos et 
al., 2009). Chk1 deficient DT40 chicken lymphoblast cells are not able to maintain 
mitotic arrest when incubated in the microtubule-stabilising drug, taxol, due to their 
inability to recruit BubR1 to kinetochores. However, both BubRI recruitment and 
mitotic arrest were efficient when cells were treated with the microtubule 
depolymerising drug, nocodazole, which indicates the importance of Chk1 in the 
detection of kinetochores that are not under tension. Interestingly, Chk1 kinase activity 
is required for its function in the SAC and BubR1 is a target of Chk1 kinase. 
 
1.1.4 The mitotic spindle 
Microtubules 
Mitotic spindles are made up from three main groups of microtubules: k-fibres, 
interpolar microtubules, and astral microtubules, all of which have the minus ends held 
at the spindle pole (figure 6). In higher eukaryotes, each kinetochore binds to multiple 
spindle microtubules, which together form k-fibres. K-fibres are responsible for moving 
and aligning mitotic chromosomes. Interpolar microtubules overlap with microtubules 
from the opposite spindle pole and are required for pushing the poles apart. Astral 
microtubules migrate in all directions from the centrosomes to the cell cortex and are 
involved in spindle positioning within the cell. 
 
Microtubules are large polymers of ?- and ?-tublin heterodimers. GTP-bound subunits 
are incorporated into the plus (+) end of microtubules. GTP hydrolysis is stimulated by 
microtubule binding, so the majority of a microtubule consists of GDP-bound tubulin 
monomers. The plus end is the most dynamic end of the microtubule: addition of GTP-
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tubulin to the plus end results in microtubule growth. However, if the rate of GTP 
hydrolysis is faster than new tubulin subunit addition, the microtubule shrinks. 
Microtubules in vitro and in vivo change rapidly and unpredictably between growth and 
shrinkage. This property of microtubules is called dynamic instability, which is 
regulated by many proteins during mitotic spindle assembly in the cell (Kline-Smith and 
Walczak, 2004).  
 
Spindle Assembly 
Although mitotic spindles are formed in a centrosome dependent manner in most cell 
types, spindle assembly can occur in the absence of centrosomes. A series of studies 
using Xenopus laevis mitotic egg extracts showed that bipolar spindles form around 
DNA coated beads by the nucleation of microtubules around the DNA (Heald et al., 
1996). In this system, centrosomes are not present, yet spindle poles are able to form 
due the activity of a minus end-directed microtubule motor protein, dynein (Heald et al., 
1997). Importantly, dynein inhibition inhibits pole formation, but does not affect the 
bipolar array of microtubules around chromatin, which indicates that it is the polarity of 
the microtubules themselves and activity of other microtubule motor proteins that are 
responsible for bipolarity. During acentrosomal spindle assembly, microtubules 
nucleate around chromatin due to the presence the GTP-bound form of a small GTPase, 
Ran (Carazo-Salas et al., 1999). In fact, addition of constitutively active Ran-GTP, 
which is unable to hydrolyse GTP, causes microtubule nucleation in Xenopus mitotic 
egg extracts, whereas mutant Ran with low affinity for GTP or GDP cannot. The high 
local concentration of Ran-GTP at chromatin is due to the chromatin localisation of its 
GEF (guanine nucleotide exchange factor), RCC1. 
 
The most striking evidence for the lack of requirement for centrosomes in mitotic 
spindle assembly and cell division is the fact that DSas-4 null flies, which lack 
centrioles, and therefore centrosomes, grow to adulthood as long as there is a maternal 
complement of DSas-4 (and centrosomes) for the initial embryonic divisions (Basto et 
al., 2006). In these flies spindle assembly occurs normally, although at a slower rate. 
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About 30% of asymmetric cell divisions, important in brain development, are abnormal 
(see section 1.2.4). Centrosomes are, however, essential for embryonic cell divisions, as 
shown in Xenopus laevis (Klotz et al., 1990). 
 
Although centrosomes are not required for mitotic spindle assembly, they are dominant 
over chromatin-dependent microtubule nucleation such that presence of a single 
centrosome causes the formation of a monopolar spindle (Heald et al., 1997). Indeed, 
centrosomes provide a nucleation site for microtubules, which increases efficiency of 
nucleation: purified centrosomes incubated with purified tubulin can nucleate 
microtubules at much lower tubulin concentrations than spontaneous microtubule 
formation (Mitchison and Kirschner, 1984). Microtubules nucleated by centrosomes 
form a radial array, which is called an aster, consequently, microtubules that radiate 
from the centrosome to the cell cortex are called astral microtubules (figure 6). 
Microtubule nucleation by the centrosome is described further in 1.2.2. Nucleation of 
microtubules in the vicinity of chromatin, where Ran-GTP levels are high, also 
contributes to spindle assembly in centrosome-containing cells (Tulu et al., 2006). 
Chromatin microtubule nucleation is dependent on the Ran-dependent spindle assembly 
factor TPX2 (Tulu et al., 2006). Preformed k-fibres are incorporated into the spindle by 
recruitment of their minus ends to centrosomes by the action of minus end directed 
motor proteins, such as dynein (Khodjakov et al., 2003, Tulu et al., 2006).  
 
There are four main groups of motor proteins that are important for spindle assembly 
and spindle pole focussing: Kinesin-5, Dynein, Chromokinesins, and Kinesin-14 (figure 
6) (Kline-Smith and Walczak, 2004). Kinesin-5 is a bipolar motor protein, which is plus 
end directed and is important for microtubule cross-linking required for spindle pole 
separation. Dynein has a motor domain at one end of the molecule, which is minus end 
directed; the other end of the molecule can bind microtubules or other proteins. Dynein 
is important for microtubule minus end clustering at spindle poles and attachment of 
astral microtubules to the cell cortex. Chromokinesins, kinesin-4 and -10, contain a plus 
end directed motor domain and a DNA binding domain. These proteins bind mitotic 
chromosomes and promote their attachment to the plus ends of microtubules. Kinesin-
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14 contains a motor domain at one end of the molecule, which is minus end directed; 
the other end of the molecule can bind microtubules. Kinesin-14 is important for 
microtubule cross-linking and minus end clustering at spindle poles (Tanenbaum and 
Medema, 2010, Gatlin and Bloom, 2010). 
 
 
 
 
Figure 6 Spindle assembly: the role of motor-proteins 
(A) Adapted from Kline-Smith et al. (Kline-Smith and Walczak, 2004) and Morgan, 
2007. The spindle is composed of three types of microtubule. Microtubule minus ends 
(-) are anchored at spindle poles, to centrosomes. K-fibres (kinetochore fibres) consist 
of multiple microtubules that connect the centrosome to the kinetochore ; interpolar 
microtubules come from opposite poles and overlap; and astral microtubules attach the 
centrosome to the cell cortex. Motor proteins are required for organisation for 
microtubules into a biopolar array around chromosomes: kinesin-5 associates with inter-
polar microtubules and causes them to move apart, kinesins-4 and 10 connect 
microtubules to chromatin. Dynein and kinesin-14 are involved in spindle pole 
clustering. Dynein also plays an important role in attaching astral microtubules to the 
cell cortex via binding to proteins located at the cortex. (B) Adapted from Tulu et al. 
(Tulu et al., 2006). The contribution of chromatin-nucleated microtubules (blue) to 
spindle assembly in the presence of centrosomes.  
Chapter 1. Introduction 
33 
1.2 The centrosome 
Centrosomes consist of a pair of centrioles surrounded by pericentriolar material 
(PCM). Centrosomes are the primary microtubule organising centre (MTOC) in somatic 
cells: in dividing and post-mitotic cells. However, microtubule nucleation can occur at 
non-centrosomal sites and centrosome nucleated microtubules can also be released and 
maintained elsewhere in differentiated cells (Keating and Borisy, 1999, Abal et al., 
2002). The centrosome has many different functions in different cell types, such as cell 
motility, adhesion, cell polarity, and spatial organisation as well as organisation of 
mitotic spindle poles (Nigg and Raff, 2009). Furthermore, centrosomes have non-
microtubule associated functions in cell cycle regulation (1.2.2.2). In addition to their 
role in the formation of centrosomes, centrioles can also form cilia, which have 
functions in cell signalling in dividing cells, and sensory signalling and movement in 
differentiated cells. Here I will introduce centrioles with respect to their role as part of 
the centrosome.  
 
1.2.1 Centrosome structure 
Centrioles are cylindrical arrays of triplet microtubules with 9-fold symmetry (figure 7) 
(Paintrand et al., 1992). Centrioles are not symmetrical along their length. Serial 
sectioning electron microscopy studies show that there are 9 sets of triplet microtubules 
(A to C, figure 7) at the proximal end of the centriole, but 9 sets of doublet microtubules 
at the distal end. Nine-fold symmetry is established at the beginning of centriole 
biogenesis by the organisation of the centriolar Sas-6 protein, which is recruited early in 
centriole biogenesis and oligomerises to forms a cartwheel shaped structure with 9-fold 
symmetry (Kitagawa et al., 2011). Centrioles within a centrosome are linked by a long 
bundle of thin filaments, which are visible by electron microscopy (EM) (Paintrand et 
al., 1992). This structural link is maintained during centriole duplication in interphase 
and is abolished upon entry into mitosis (1.2.3). The centrioles within a centrosome are 
not equal: their structure is determined by their age. The mother centriole has two sets 
of 9 appendages: distal and sub-distal (figure 7a and b), which are involved in 
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anchoring microtubules and docking of centrioles at the plasma membrane for 
ciliogenesis (Bettencourt-Dias and Glover, 2007).  
 
In a G1 cell, there is one centrosome, which contains two disengaged centrioles, a 
mother and a daughter. Formation of new centrioles occurs at the proximal end of 
existing centrioles. New centrioles are formed perpendicular to the existing parent 
centriole and are tightly linked (engaged). During mitosis, the mother centriole acquires 
appendages and daughter centrioles acquire the ability to organise PCM and act as an 
MTOC, although they cannot act as an MTOC until they are disengaged from their 
mother centriole. The steps of centriole duplication and the regulation of centriole 
duplication are discussed further in 1.2.3 (reviewed in (Nigg, 2007)). Importantly, 
centrioles are required for PCM organisation and centrosome duplication. Upon 
disruption of centriole structure, centriole and centrosome (PCM) markers disappear 
(Bobinnec et al., 1998).  
 
PCM is responsible for the nucleation of microtubules: it is composed of a matrix of 
proteins that allows recruitment of ?-tubulin, which exists as part of the ?-tubulin ring 
complex (?-TuRC), required for microtubule nucleation (Bettencourt-Dias and Glover, 
2007) (1.2.2). Two predominant members of the PCM are coiled coil domain containing 
proteins AKAP450 and pericentrin, which form a lattice that allows docking of 
components required for microtubule nucleation. AKAP450 and pericentrin are 
recruited to the centrosome themselves via a non-coiled coil region of around 90 amino 
acids that is conserved between the two (Gillingham and Munro, 2000). Fusion of this 
domain to other proteins causes their localisation to the PCM. PCM surrounds the 
mother centriole in interphase and mitotic cells. Furthermore, it has been shown that 
only centrioles that have acquired mitosis-specific modifications can organise the PCM 
(Wang et al., 2011) (1.2.3). 
 
There is a distinct compartment of the PCM, the PCM tube, which is closely associated 
with the centriole, possibly due to association of microtubule binding proteins that bind 
the polyglutamylated tubulin of the centriole walls as well as tubulin minus end binding 
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proteins that bind the proximal end of the centriole (Bornens, 2002). The PCM tube is 
visible by immunofluorescence with autoimmune serum that recognises multiple 
different PCM components (Ou and Rattner, 2000). Correlative electron microscopy 
and immunofluorescence of the same cell shows that the PCM tube surrounds the 
centriole wall (Ou et al., 2003). PCM components pericentrin, ninein and ?-tubulin 
localise to different regions within the PCM tube (Ou et al., 2003) (figure 8). 
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Figure 7 Centrosome structure 
(A) Adapted from Sluder (Sluder, 2005). A G1 centrosome: mother and daughter 
centrioles are disengaged, but still linked together by fibres. Diagrammatic 
representation of longitudinal sections: triplet microtubules are represented in blue and 
the central tube in green. The mother centriole has distal and subdistal appendages and 
is surrounded by pericentriolar material (PCM), which contains the necessary 
components for nucleation of microtubules (red). (B) Three averaged EM sections from 
a mother centriole taken from Paintrand et al. (Paintrand et al., 1992). Scale bars are 0.2 
μm. The 9 triplet microtubules can be seen at the proximal end (tubules labelled A, B, 
and C, red arrows) and 9 doublet microtubules (A, B, red arrows) are seen in a more 
distal section. Distal appendages are marked with an open arrow (top panel). Subdistal 
appendages are indicated by a short arrow (middle panel). (C) Electron micrograph of 
the longitudinal section through a mother centriole taken from (Paintrand et al., 1992). 
The distal (open arrows) and subdistal appendages (black arrows) can be seen. (D) 
Electron micrograph of an in situ prophase centrosome taken from (Vorobjev and 
Chentsov Yu, 1982). The mother centriole (M) is seen in cross section and the daughter 
(D) in longitudinal section. The electron dense PCM can be seen surrounding the 
mother centriole (black arrow) and microtubules (red arrowheads) can be seen 
emanating from the PCM.  
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Figure 8 The PCM tube 
(A) Diagram adapted from Ou et al. (Ou et al., 2003). The PCM tube (red) surrounds 
centriole walls and proximal ends. A cross section and longitudinal representation of the 
PCM tube with respect to centriole triplet microtubules (blue) are shown. (B) Diagram 
showing the localisation of PCM proteins pericentrin (blue), ninein (green), CEP110 
(pink), and ?-tubulin (orange) relative to the PCM tube, as visualised by 
immunofluorescence by Ou et al. (Ou and Rattner, 2000, Ou et al., 2003). All four of 
these proteins localise to different regions of the PCM tube and ?-tubulin can also be 
observed in the lumen of the PCM tube as it is a component of the centriole at the 
proximal end where it caps centriole microtubule minus ends. 
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1.2.2 Centrosome-dependent microtubule organisation 
The microtubule nucleation capacity of the centrosome changes with progression 
through the cell cycle. At the G2/M transition many proteins required for microtubule 
nucleation are recruited to the centrosome, including ?-tubulin containing complexes, so 
the PCM becomes larger and the microtubule nucleating capacity of the centrosome 
increases dramatically (Wiese and Zheng, 2006). This process is called centrosome 
maturation. Centrosome maturation is dependent on the polo-like kinase, Plk1 (Lane 
and Nigg, 1996). Plk1 modifies centrioles during mitosis, such that both mother and 
daughter centrioles in the subsequent G1 phase are able to recruit PCM components and 
act as MTOCs (Wang et al., 2011). Without this mitotic Plk1-dependent modification, 
daughter centrioles inherited by the resulting G1 cells are unable to recruit ?-tubulin or 
act as MTOCs whether the daughter centrioles are engaged or disengaged from the 
mother centriole. This mitosis-dependent modification means that duplicated centrioles 
contain only one centriole (the mother) that is MTOC competent. Plk1 is also required 
for the recruitment of ?-tubulin complexes to the PCM of MTOC-competent centrioles 
(Haren et al., 2009b).  
 
Microtubule nucleation at the centrosome occurs via the ?-tubulin containing ?-tubulin 
ring complex (?-TuRC) and via ?-TuRC independent pathways (Wiese and Zheng, 
2006) (figure 9).  
 
?-TuRC dependent microtubule nucleation 
The ?-TuRC consists of ?-tubulin and cap subunits GCP2-6 and GCP-WD (also called 
NEDD1) (Raynaud-Messina and Merdes, 2007). The ?-TuRC forms a template for 
tubulin ?/? dimer binding and therefore provides a kinetic advantage for the nucleation 
of microtubules. Although a ?-tubulin protofilament model was first put forward as the 
mechanism for nucleation of microtubules by ?-tubulin (Erickson et al., 1996), more 
recent evidence from analysis of ?-TuRC immuno-staining by EM favours the ?-TuRC 
template model where ?-TuRC forms a template that caps the minus ends of 
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microtubules (Keating and Borisy, 2000). Plk1 activity is required for ?-TuRC 
recruitment to centrosomes, and so CDK11p58 kinase also plays an important role by 
facilitating recruitment of Plk1 and Aurora A to centrosomes in mitosis (Petretti et al., 
2006). GCP-WD is essential for the recruitment of the ?-TuRC to centrosomes and it’s 
recruitment is dependent on Plk1, which phosphorylates GCP-WD in mitosis (Luders et 
al., 2006). Plk1-dependent recruitment of GCP-WD to the centrosome may be direct, in 
part, but it is also mediated via recruitment of centrosome proteins Cep192, 
CDK5RAP2/Cep215, Kizuna and pericentrin (Haren et al., 2009b){Oshimori, 2006 
#505}. Indeed, pericentrin is also required for ?-TuRC subunits GCP2 and GCP3 
(Zimmerman et al., 2004).  
 
Constitutive centrosomal proteins PCM-1 and Nudel are important for the centrosomal 
localisation of pericentrin, and consequently they are important for ?-TuRC  as well 
(Dammermann and Merdes, 2002, Guo et al., 2006). Pericentrin recruits the ?-TuRC to 
the centrosome via dynein-dependent transport along microtubules, mediated by 
pericentrin-dynein interaction (Young et al., 2000). Thus, inactivation of dynein or its 
adaptor protein, dynactin, results in reduced levels of pericentrin and ?-tubulin at the 
centrosome and spindle disruption. Although microtubule depolymerisation has been 
shown to decrease pericentrin and ?-tubulin levels at mitotic centrosomes (Young et al., 
2000), there is also evidence that ?-tubulin is recruited to the same extent in the 
presence and absence of microtubules (Khodjakov and Rieder, 1999). Therefore, 
parallel pathways exist for the recruitment of pericentrin and ?-TuRC to the centrosome 
in mitosis, as discussed by Young et al. (Young et al., 2000). 
 
In addition to pericentrin, the PCM protein AKAP450 is also required for efficient 
localisation of ?-tubulin to the centrosome and microtubule nucleation from the 
centrosome via centrosome proteins Cep72 and Kizuna (Oshimori et al., 2009).  
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Microtubule organisation independent of ?-tubulin complexes 
In addition to the proteins described above, there are proteins required for proper 
mitotic spindle assembly that function independently of ?-tubulin. In fact, depletion of 
?-tubulin doesn’t completely inhibit microtubule nucleation (Wiese and Zheng, 2006). 
Transforming acid coiled coil proteins (TACCs) and tumor overexpressed genes 
(TOGs) promote microtubule aster formation at the centrosome independently of ?-
tubulin recruitment (Wiese and Zheng, 2006).  
 
Proteins that function to stabilise microtubules and anchor the minus ends of 
microtubules at the centrosome include NuMA, AKAP450, CDK5RAP2, CAP350, 
FOP, EB1, and Cep135. Firstly, NuMA (Nuclear Mitotic Apparatus) is a nuclear protein 
during interphase, but localises to spindle poles during mitosis (Haren et al., 2009a). 
Experiments in which the mitotic localisation of NuMA is disrupted, but the interphase 
functions remain unaffected, show that NuMA is essential for anchoring the spindle 
pole to the centrosome and focussing spindle poles, but not for initial microtubule 
nucleation (Silk et al., 2009). NuMA functions by recruiting dynein-dynactin to spindle 
poles (Merdes et al., 2000). Furthermore, cohesin, which is required for linking 
replicated sister chromatids, also has a distinct function in spindle assembly, which is 
mediated by interaction with NuMA (Kong et al., 2009). NuMA also interacts with poly 
(ADPribose) (pADPr), which localises to centrosome asters and Ran-induced asters in 
Xenopus laevis egg extracts where it is required for proper spindle assembly (Chang et 
al., 2009). Interestingly, translocations between NuMA and the retinoic acid receptor 
alpha (RAR?) genes are found in a small percentage of acute promyelocytic leukaemia 
(APL), where aberrant functions of RAR? and aberrant functions of NuMA may play a 
role in the disease (Piazza et al., 2001). Translocations between RAR? and 
nucleophosmin (NPM, described in section 1.3.2) are also found in certain cases of 
APL. 
  
CDK5RAP2 interacts with AKAP450 and targets it to the centrosome and AKAP450, 
in turn, interacts with the dynactin subunit p150glued (Barr et al., 2010). AKAP450 also 
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interacts with the small GTPase, Ran, which is required for nucleation of microtubules 
around chromatin (section 1.1.6) (Keryer et al., 2003). When the AKAP450-Ran 
interaction is disrupted ?-tubulin still localises to the centrosome, yet asters do not form 
efficiently in microtubule re-growth assays indicating that ?-tubulin independent 
pathways are important for microtubule nucleation from centrosomes (Keryer et al., 
2003).  
 
The centrosomal protein complex consisting of CAP350, FOP, and EB1 is also required 
for maintenance and stabilisation of microtubule minus ends at the centrosome via the 
interaction between EB1 and dynactin p150glued (Yan et al., 2006). Another 
constitutive centrosome protein, Cep135, contributes to the recruitment of the dynactin 
complex to centrosomes, via interaction with the p50 subunit, dynamitin (Ohta et al., 
2002, Uetake et al., 2004). 
 
In addition to the proteins described above with characterised functions, there are other 
proteins that have been shown to be involved in microtubule organisation, but their 
molecular functions have yet to be characterised. Drosophila melanogaster abnormal 
spindle protein Asp is required for spindle pole focussing and organisation of spindle 
structure (Wakefield et al., 2001). Asp has a human homologue, ASPM, which also 
localises to spindle poles, but its function has not yet been specified. Additionally, 
cAMP dependent protein kinase (PKA) might be involved in spindle assembly as it 
binds and localises to the centrosome with pericentrin (Diviani et al., 2000).   
 
Aurora A in microtubule organisation 
Aurora A kinase is a key player in centrosome maturation and spindle assembly (Brittle 
and Ohkura, 2005). It is important for the chromatin-dependent microtubule nucleation 
pathway via TPX2; the accumulation of PCM proteins required for microtubule 
nucleation in mitosis; and centrosome-dependent microtubule stabilisation via TACC 
proteins. Aurora A kinase is required for the recruitment of Drosophila melanogaster 
centrosomin (Cnn) to the centrosome, which is required for efficient ?-tubulin complex 
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recruitment (Ducat and Zheng, 2004). The Cnn homologue in humans is 
CDK5RAP2/Cep215 (mentioned above) and paralogue, myomegalin (Gomez-Ferreria 
and Pelletier, 2010). Aurora A also promotes full recruitment of C. elegans and D. 
melanogaster SPD-2, which in turn recruits the ?-TuRC and C. elegans Zyg-9 (a TOG 
protein) (Ducat and Zheng, 2004). The human SPD-2 homologue, Cep192, is required 
for recruitment of PCM components ?-tubulin, GCP-WD, and pericentrin during 
centrosome maturation (Zhu et al., 2008). Furthermore X. laevis Cep192 is essential for 
activation of Aurora A kinase specifically at the centrosome by promoting Aurora A 
dimerisation, which leads to strong activation of the kinase and microtubule assembly 
(Joukov et al., 2010). CDK11p58 kinase is also required for localisation of Aurora A to 
the centrosome (Petretti et al., 2006). Aurora A inactivation leads to decreased 
accumulation of PCM components during centrosome maturation, a lower density and 
reduced length of centrosome-derived microtubules, and a failure to maintain 
centrosome separation (Ducat and Zheng, 2004). 
 
In summary, there are redundant pathways for microtubule nucleation and spindle pole 
maintenance, some of which are centrosome-dependent; others are centrosome 
independent. Centrosome-derived microtubule nucleation and maintenance involves 
many different proteins that function in redundant pathways, which indicates the 
importance of the fidelity of chromosome and centrosome segregation in mitosis for 
genome stability. The roles of proteins involved in centrosome-dependent microtubule 
nucleation discussed here are summarised in figure 9. 
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Figure 9 Centrosome dependent microtubule organisation 
Proteins involved in centrosome dependent microtubule (MT) organisation are 
categorised by function. Proteins that are involved in multiple MT organisation 
functions are present in the overlapping regions of the appropriate function areas. 
Proteins that are involved in centrosome dependent MT organisation, but have no 
defined function are also shown. Proteins are coloured with respect to their molecular 
function, if known.  
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1.2.3 The centrosome in cell cycle regulation 
The structure and function of the centrosome changes during the cell cycle (section 1.3), 
but the centrosome also influences cell cycle phase transitions by acting as a docking 
site for cell cycle regulatory proteins (Doxsey et al., 2005).  
 
Activation of the key mitotic regulator, Cdk1-cylin B initially occurs at the centrosome 
before it moves to the nucleus (Jackman et al., 2003). In fact, proteins that regulate the 
activation of Cdk1-cyclin B have been shown to localise to the centrosome by 
immunofluorescence or Western blot of purified centrosomes (Doxsey et al., 2005). 
Cdk1 requires the action of phosphatase Cdc25 for full activation of its kinase activity. 
Cdc25 removes inhibitory phosphorylation at Tyrosine 15 (Y15) of Cdk1. Antibodies 
that specifically detect phospho-Cdk1 Y15 stain the centrosome and cytoplasm in G2 
and levels reduce as cells progress to metaphase (Lindqvist et al., 2005). Interestingly, 
RNAi depletion of Cdc25A or B resulted in high levels of Cdk1 Y15 phosphorylation 
and cell cycle arrest pre-mitosis, whereas depletion of Cdc25C did not affect the ability 
of cells to enter mitosis (Lindqvist et al., 2005). However, Cdc25C has also been shown 
to localise to centrosomes during mitosis and its overexpression causes an increased 
percentage of cells that enter mitosis at a specific time after release of cells from 
synchronisation (Bonnet et al., 2008). Conversely, expression of a Cdc25C phosphatase 
mutant caused a decrease in cells entering mitosis, which shows that Cdc25C also has a 
role in Cdk1-cyclin B activation at the centrosome.  
 
As Cdk1-cyclin B and its activator Cdc25 phosphatase localise to the centrosome during 
G2, so do the regulators of Cdc25 phosphatase activity. Aurora A phosphorylates 
Cdc25B, which contributes to Cdc25 activation and subsequent G2 to M transition, and 
both active Aurora A (phospho-T288) and Aurora A phosphorylated Cdc25B (phospho-
S353) localise to the centrosome (Dutertre et al., 2004, Cazales et al., 2005). 
Furthermore, Aurora A contributes to the accumulation of cyclin B to the centrosome 
(Hirota et al., 2003). There is also evidence for positive regulation of cyclin B by Polo-
like kinase, Plk1, at centrosomes (Petronczki et al., 2008). 
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Chk1 is a well-characterised DNA damage checkpoint kinase that is known to prevent 
mitotic entry by preventing activation of Cdk1-cyclin B by phosphorylating and 
inhibiting Cdc25 (Sancar et al., 2004). Chk1 is also present at centrosomes during an 
unperturbed cell cycle where it phosphorylates Cdc25B on S280, which results in 
Cdc25B inactivation (Schmitt et al., 2006). The Cdc25B phospho-S280 epitope is 
present at centrosomes in G2, prophase and early prometaphase, but disappears during 
prometaphase indicating activation of Cdc25B. Mutation of S280 to inhibit Chk1 
phosphorylation of Cdc25B causes premature mitotic entry (Cazales et al., 2005). 
Furthermore, Chk1 activity at the centrosome leads to the presence of inactive Cdk1 
phospho-Y15 at the centrosome (Löffler et al., 2007). Centrosome proteins 
microcephalin (MCPH1), pericentrin, and CDK5RAP2 are important for centrosomal 
localisation of Chk1 (Tibelius et al., 2009, Barr et al., 2010). These findings are 
summarised in figure 10. 
 
Further to the presence of Chk1 DNA damage kinase at the centrosome, other DNA 
damage kinases including ATM, ATR, DNA-PK, ATRIP and Chk2 have also been 
visualised at the centrosome (Zhang et al., 2007). Chk2 localises to the centrosome in 
the absence and presence of DNA damage (Tsvetkov, 2003, Golan et al., 2010), 
although its function at the centrosome has not been confirmed. 
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Figure 10 Activation of Cdk1-cyclin B at the centrosome 
(A) Diagram of cell cycle regulatory proteins that localise to the centrosome and their 
activities that have been shown at the centrosome. PCM proteins microcephalin 
(MCPH1), pericentrin and CDK5RAP2 recruit Chk1 to the centrosome. Chk1 holds 
Cdc25 phosphatase inactive, preventing mitotic entry. Upon entry into mitosis, Cdc25B 
is dephosphorylated. Aurora A further activates Cdc25B and promotes Cyclin B 
recruitment to the centrosome. Plk1 further activates Cdc25C that has already been 
phosphorylated by Cdk1-cyclin B. (B) Summary of the different immunofluorescence 
signals detected at the centrosome during the cell cycle.  
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The influence of centrosomes on the G2 to M cell cycle transition can be seen in 
Xenopus laevis eggs: injection of centrosomes activates MPF (maturation promoting 
factor, or Cdk1-cyclin B) and advances mitotic entry relative to eggs without 
centrosomes (Perez-Mongiovi et al., 2000). However, eggs without centrosomes are 
able to enter mitosis, with a delay. This phenomenon has also been observed in human 
tissue culture cells: centrosomes promote, but are not required for, mitotic entry 
(Doxsey et al., 2005). Perhaps this is due to redundancy, so centrosomes have a 
dominant effect on the G2/M transition, but the transition can occur by activation of 
Cdk1-cyclin B away from the centrosome. Alternatively, centrosomes per se might not 
be required, but in the absence of a centrosome, PCM components might associate and 
recruit cell cycle regulatory proteins with no requirement for the presence of centrioles. 
 
1.2.4 Centrosomes and microcephaly 
Microcephaly (small brain) is a common feature of genetic diseases MCPH (autosomal 
recessive primary microcephaly); MOPD II (Majewski osteodysplastic primordial 
dwarfism type II); and Seckel syndrome. MCPH patients have a head circumference at 
least 4 standard deviations below average, but have normal stature (Woods et al., 2005). 
MOPD II and Seckel syndrome patients have microcephaly in combination with growth 
retardation and their clinical features can be hard to distinguish (Piane et al., 2009). 
Microcephaly is defined by head circumference, which is a measure of brain size. In 
microcephaly, the overall structure of the brain is normal, but the cerebral cortex is 
smaller due to reduced numbers of neurons produced during development (Woods et al., 
2005).  
 
All known cases of primary microcephaly, MCPH, have been mapped to 7 regions of 
the genome, designated MCPH1-7. All MCPH mutations have now been mapped to 
genes within these regions, all of which are involved with centrosome or mitotic spindle 
pole function (table 1) (Megraw et al., 2011).  
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MCPH gene Gene name Centrosome (C) or 
spindle pole (SP) 
DNA damage 
response 
MCPH1 Microcephalin C Yes 
MCPH2 WDR62 SP ND 
MCPH3 CDK5RAP2, Cep215 C Yes 
MCPH4 Cep152 C ND* 
MCPH5 ASPM SP Yes 
MCPH6 CPAP, CENPJ, Sas-4 C ND 
MCPH7 STIL, Sas-5 SP ND 
Table 1 MCPH genes 
Table adapted from Megraw et al. (Megraw et al., 2011). If there is evidence for a gene 
in the DNA damage response at any stage, it is indicated “Yes”. If there is no evidence, 
the gene is marked “ND” (not determined). * Kalay et al. concluded that DNA damage 
signalling was altered in cells from Cep152 MCPH4 patients, but the evidence 
presented does not support the conclusion; see text (Kalay et al., 2011). 
 
Due to the heterogeneity of MCPH, different mutations in different genes, the resulting 
cellular phenotypes are varied. Consequently, a common biological cause for MCPH 
has not yet been defined. It is clear that MCPH is a disease caused by centrosome 
abnormalities, but which centrosome function is crucial for properly regulated 
neurogenesis and full cerebral cortex growth? Is it due to the role of the centrosome in 
mitotic spindle assembly and spindle positioning; or the role of the centrosome in DNA 
damage signalling; or the role of centrosome asymmetry in asymmetric cell divisions; 
or perhaps it is the role of primary cilia in cell signalling pathways? There is evidence 
for each of these explanations, which is reviewed in Megraw et al. (Megraw et al., 
2011) and summarised below. 
 
It is important to note that MCPH genes are expressed in the developing cerebral cortex 
at the stage of development when neurogenesis occurs, as determined by in situ 
hybridisation of mouse or human embryo brain sections or cDNA analysis (Jackson et 
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al., 2002) (Bilguvar et al., 2010, Yu et al., 2010, Bond et al., 2005, Guernsey et al., 
2010, Bond et al., 2002, Kumar et al., 2009). 
 
MCPH1 microcephalin 
MCPH1 deficient cells show similarities to cells from ATR-Seckel patients, which have 
defective ATR-dependent DNA damage signalling pathways. MCPH1 patient cells have 
been well characterised alongside ATR-Seckel patient cells: they share common 
phenotypes of nuclear fragmentation, supernumerary mitotic centrosomes and defective 
G2/M checkpoint in response to UV (Alderton et al., 2006). The G2/M checkpoint is 
defective due to inefficient Chk1 signalling via Cdc25A: after UV irradiation, phospho-
Chk1 (active) levels are the same as control cells, but Cdc25A is not degraded and thus 
Cdk1-cyclin B is still activated, which could be explained by the finding that 
microcephalin and pericentrin are required for Chk1 localisation to the centrosome 
(Tibelius et al., 2009). For the same reason, Cdk1-cyclinB is activated prematurely in an 
unperturbed cell cycle in MCPH1 patient cells, causing premature chromatin 
condensation (PCC). However, mitotic entry and progression occurs with the same 
kinetics as wild type cells. MCPH1 null mice have a reduced birth rate and slow 
growth; brain size was not examined. In addition MCPH1 mice are hypersensitive to ?-
irradiation and show male infertility due to arrest and apoptosis of spermatocytes during 
meiosis (Liang et al., 2010). 
 
MCPH2 WDR62 
The WDR62 protein localises to the nucleus in interphase, to spindle poles from 
prophase to telophase and to the central spindle in anaphase (Bhat et al., 2011, Nicholas 
et al., 2010) but its molecular function is yet to be characterised. 
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MCPH3 CDK5RAP2 
CDK5RAP2 localises to the centrosome throughout the cell cycle, but it is enriched on 
the centrosome during prophase to metaphase and levels decrease again during 
anaphase and telophase (Bond et al., 2005). Mice with homozygous deletions of the 
conserved first centrosomin domain (CNN1) have microcephaly as well as infertility, 
aneuploidy, radiation sensitivity, anaemia and cancer predisposition (Lizarraga et al., 
2010). Examination of the developing cortex shows that, in the absence of CDK5RAP2 
function, there is misalignment of mitotic spindles in neural precursors and a loss of 
neural progenitors. Neural progenitor loss is coincident with premature cell cycle exit 
and elevated apoptosis (Buchman et al., 2010). In utero RNAi of CDK5RAP2 leads to 
premature cell cycle exit, loss of apical progenitors and an increase in basal progenitors 
and differentiated neurons during the three-day experiment (Buchman et al., 2010). 
These studies show evidence for the lack of control of mitotic spindle positioning as a 
potential cause of microcephaly and the loss of neural progenitors due to inefficient cell 
cycle regulation. 
 
At the cellular level, CDK5RAP2 localisation to centrosomes is required for 
maintaining the link between centrosomes and mitotic spindle poles (Barr et al., 2010). 
CDK5RAP2 interacts with AKAP450 and is required for the localisation of AKAP450 
and the dynactin subunit p150glued to the centrosome. Additionally, CDKRAP5 and 
AKAP450 are required for centriole cohesion during interphase: to prevent mother and 
daughter centrioles disengaging before mitosis. CDK5RAP2 is also required for 
efficient G2/M checkpoint activation in response to ?-IR, which is likely due to 
recruitment of Chk1 to the centrosome (Barr et al., 2010). 
 
MCPH4 Cep152 
Cep152 mutations have been identified in MCPH4 patients and in Seckel patients 
(Guernsey et al., 2010, Kalay et al., 2011). Cells from MCPH4 patients have not yet 
been analysed, but a cell line from one Cep152-Seckel patient shows multiple different 
sized nuclei and centrosomes, micronuclei, misaligned chromosomes in mitosis as well 
Chapter 1. Introduction 
51 
as monopolar spindles and multipolar spindles (Kalay et al., 2011). The authors of this 
study also conclude that there is enhanced Chk2 phosphorylation and increased ?-
H2AX foci formation in response to hydroxyurea (HU) induced replication stress in 
Cep152 Seckel cells relative to wild type. However, the data presented in the paper do 
not support these conclusions. Thus, whether Cep152 is involved in DNA damage 
signalling remains to be shown. 
 
Cep152 has been characterised by RNAi studies in human cell lines: it is required for 
centriole duplication (section 1.3), but there is no evidence of impaired centrosome 
maturation or microtubule nucleation (Blachon et al., 2008, Dzhindzhev et al., 2010b, 
Cizmecioglu et al., 2010, Hatch et al., 2010b).  
 
MCPH5 ASPM 
ASPM mutations are the most common MCPH mutations, with a variety of different 
truncation mutations (Nicholas et al., 2009). Even a small C-terminal truncation of 120 
amino acids (from 3477 amino acids) causes microcephaly (Bond et al., 2003). ASPM 
contains an N-terminal putative microtubule binding domain followed by multiple 
calmodulin binding IQ domains. Interestingly, the number of IQ repeats increases with 
brain complexity in evolution: the C. elegans protein has 2 IQ domains; Drosophila 
have 24; mouse has 61 and humans have 74. Deletion of the C-terminus and only 6 IQ 
domains is sufficient to cause microcephaly (Bond et al., 2002). The function of the IQ 
domain is not known. 
 
Murine Aspm is required for maintaining symmetric cell divisions during early 
neurogenesis (Fish et al., 2006). In the developing cerebral cortex, early divisions of 
neuroepithelial cells are symmetric such that each of the daughter cells maintains 
contact with the apical membrane and both daughters maintain proliferative potential 
(figure 11). During this stage of development, Aspm is found at the mitotic spindle 
poles of all cells, whereas Aspm levels at spindle poles decrease at later developmental 
stages where asymmetric cell divisions are more common (Fish et al., 2006). 
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Asymmetric divisions result in one daughter cell that maintains contact with the apical 
membrane and retains its proliferative potential and one daughter cell that loses apical 
basal polarity and becomes a terminally differentiated neuron. RNAi of Aspm in the 
developing cerebral cortex results in an increased proportion of asymmetric cell 
divisions, due to spindle rotation, at a developmental stage where symmetric cell 
divisions are predominant. Thus, depletion of Aspm causes an increase in the 
production of neurons at an early stage of brain development, which reduces the 
neurogenic capacity at later developmental stages. The Drosophila orthologue, Asp, is 
required for spindle pole focussing and functions by cross-linking microtubule minus 
ends (do Carmo Avides and Glover, 1999, Wakefield et al., 2001). 
 
MCPH6 CPAP 
CPAP (also called CENPJ) localises to the centrosome during interphase and to spindle 
poles during mitosis and CPAP antibody disrupts centrosome induced microtubule 
nucleation in vitro (Bond et al., 2005, Hung et al., 2000). CPAP RNAi results in 
multipolar mitoses in human cell lines, which is likely due to centrosome splitting since 
interphase cells do not contain multiple centrosomes (Cho et al., 2006). Furthermore, 
CPAP regulates centriole length (Kohlmaier et al., 2009, Schmidt et al., 2009, Tang et 
al., 2009), see section 1.3. Interestingly, CPAP and Cep152 interact and Cep152 is 
required for recruitment of CPAP to the centrosome (Cizmecioglu et al., 2010).  
 
MCPH7 STIL 
STIL localises to spindle poles in mitosis and it is required for proper bipolar spindle 
assembly in human cells and in zebrafish (Pfaff et al., 2007). Sil (mouse orthologue of 
STIL) null mice die after embryonic day 10.5 and show arrest of neural tube closure 
(Izraeli et al., 1999). There are fewer cells in the neural fold due to apoptosis rather than 
a defect in proliferation. 
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STIL (SIL) null mouse embryonic fibroblasts (MEFs) show slow growth, low mitotic 
index and have no detectable centrosomes (Castiel et al., 2011). STIL null cells have 
high levels of E3 ubiquitin ligase Chfr, which negatively regulates entry into mitosis by 
targeting Plk1 for degradation, resulting in a delay in Cdk1-cyclin B activation. 
 
In summary, there is no consensus for the molecular cause of microcephaly, although 
there are common themes of deregulation of centrosome MTOC function, mitotic 
spindle assembly and DNA damage checkpoint signalling. Seckel patients have 
defective ATR-dependent DNA damage checkpoint signalling and also have 
microcephaly. Interestingly, some instances of Seckel syndrome are caused by 
mutations in pericentrin (PCNT), which results in defective Chk1 phosphorylation in 
response to ATR-dependent DNA damage signalling (Griffith et al., 2008). Thus, 
pericentrin-Seckel, MCPH1 (microcephalin) and MCPH3 (CDK5RAP2) patient cells 
share a common phenotype of defects in the ATR-dependent G2/M checkpoint, but all 
have a range of other non-overlapping phenotypes. Pericentrin and microcephalin 
interact at the centrosome where they are required for centrosomal localisation of Chk1 
(Tibelius et al., 2009). Furthermore, CDK5RAP2 also interacts with pericentrin 
(Buchman et al., 2010).  
 
Figure 11 shows the effect of symmetric versus asymmetric neuroepithelial cell 
division. Changes in the control of symmetric versus asymmetric are controlled by the 
precise spindle orientation, which can be affected by centrosome amplification, loss of 
spindle pole to centrosome association, or loss of astral microtubule nucleation. All of 
these are phenotypes observed in subsets of microcephaly cells, but there are other 
possible explanations for reduced number of neuroepithelial cells in microcephaly 
models. Some models of microcephaly show loss of neuroepithelial cells due to 
inappropriate exit from the cell cycle and/or apoptosis (MCPH1 and CDK5RAP2). 
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Figure 11 Symmetric and asymmetric neuroepithelial cell divisions 
Adapted from Thornton et al. (Thornton and Woods, 2009). Neuroepithelial cells span 
from the basal lamina to the ventricle, but only undergo mitosis at the ventricular 
(apical) surface. Before the onset of neurogenesis, the mitotic spindle aligns 
perpendicular to the ventrical surface and symmetric cell divisions result in two 
daughters, both with apical determinants and both with self-renewing capacity. During 
neurogenesis, or when the spindle is rotated, asymmetric cell divisions give rise to one 
daughter with apical determinants and self-renewing capacity and one daughter that 
becomes a non-polarised basal progenitor or fully differentiated neuron. If spindle 
orientation is not tightly controlled, spindle rotation can cause asymmetric cell divisions 
before the onset of neurogenesis, which can lead to a depleted pool of neural 
progenitors for subsequent neurogenesis. 
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1.3 The centrosome cycle 
G1 cells contain one centrosome with two centrioles: a mother and a daughter, which 
are disengaged and licensed to duplicate, but still attached to each other via a flexible 
linker between their proximal ends. During S phase, a new daughter procentriole is 
formed at right angles to the mother centriole at the proximal end of the mother. Mother 
and daughter centrioles are tightly engaged during S, G2 and mitosis. During G2, new 
centrioles elongate and the younger mother centriole (a daughter in the previous cell 
cycle) fully matures and acquires appendages. At the G2 to M transition, the flexible 
linker between the two centrosomes is broken and centrosomes separate to allow mitotic 
spindle assembly, see figure 12 and (Nigg, 2007). 
 
During S and G2 phases there are three different generations of centrioles present: the 
grandmother and mother centrioles (mother and daughter from G1) and their new 
daughter centrioles. In order to reach full maturity, a daughter centriole has to pass 
though mitosis to acquire MTOC capacity and the ability to form a new centriole 
(licensing) then in the following G2 phase it becomes fully mature and acquires 
appendages at its distal end.  
 
Chapter 1. Introduction 
56 
 
 
Figure 12 The centrosome duplication cycle 
Centrioles are disengaged and licensed for duplication upon exit from mitosis (blue). 
During G1 and S centrioles are attached to each other by flexible fibres (orange). Upon 
passage through mitosis, daughter centrioles become competent to organise PCM 
(yellow) and duplicate. New procentrioles are formed during S phase and remain tightly 
attached “engaged” to mother centrioles until exit from mitosis. Procentrioles elongate 
in G2 then the younger mother centriole acquires appendages and the fibrous link 
between mother centrioles is severed. Upon entry into mitosis, centrosomes segregate 
and localise to the spindle poles. Centrioles disengage during mitotic exit or early G1 to 
allow another round of centriole duplication. 
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1.3.1 Centriole formation 
Polo like kinase Plk4 is required for the recruitment of core centriole components hSas-
6, Cep135, CPAP, and CP110 to the newly forming daughter centriole (Kleylein-Sohn 
et al., 2007) (figure 13). The first component observed at the site of procentriole 
formation is hSas-6, which forms the cartwheel structure with 9-fold symmetry onto 
which centriole microtubules assemble (Leidel et al., 2005, Kitagawa et al., 2011). 
HSas-6, CPAP, Cep135 and ?-tubulin are all dependent on each other for localisation to 
the centrosome (Kleylein-Sohn et al., 2007). CPAP is concentrated in the proximal 
lumen of the procentriole and is required for centriole formation and elongation (Cho et 
al., 2006, Tang et al., 2009). The C. elegans CPAP orthologue, SAS-4, is required for 
attachment of the first and innermost centriole microtubule (the A tubule, figure7). 
CPAP and ?-tubulin interact, indicating that CPAP might play the same role in human 
cells (Hung et al., 2000). The A tubule nucleates from a ?-TuRC cap at its minus end 
and the subsequent formation of the B and C tubules appear to form from the side of the 
A tubule, and B tubule respectively, in a bidirectional manner with no minus end cap 
(Azimzadeh and Marshall, 2010). Recruitment of the ?-TuRC is essential for centriole 
duplication (Haren et al., 2006) (Kleylein-Sohn et al., 2007). Cep135 is also essential 
for centriole formation, but its role in centriole formation is not well characterised. The 
Chlamydomonas Cep135 orthologue, Bld10p, regulates the length of the radial spokes 
of the cartwheel structure and consequently, centriole diameter (Azimzadeh and 
Marshall, 2010). CP110 lies downstream of CPAP, Cep135, and ?-tubulin, and forms a 
cap at the distal end of the procentriole, under which ?/?-tubulin dimers polymerise to 
elongate the centriole (Kleylein-Sohn et al., 2007).  
 
Cep192 is also required for centriole duplication but it remains to be determined if 
Cep192 carries out a similar function to its C. elegans orthologue SPD-2, which is 
required for Plk4 localisation to the centrosome (Zhu et al., 2008, Carvalho-Santos et 
al., 2010). Cep152 lies upstream of the proteins described above: it is required for 
centriole duplication due to its role in recruitment of Plk4 and CPAP to the centrosome 
(Blachon et al., 2008, Dzhindzhev et al., 2010a, Cizmecioglu et al., 2010, Hatch et al., 
2010b). Although depletion of Cep152 does not lead to complete depletion of Plk4 from 
Chapter 1. Introduction 
58 
the centrosome, Cep152 depletion results in reduced recruitment of Plk4 to the 
centrosome and centriole duplication failure (Cizmecioglu et al., 2010). Additionally, 
Centrosome proteins SPICE and Cep120 are both required for centriole duplication and 
Cep120 functions downstream of hSas-6 recruitment to the procentriole (Archinti et al., 
2010, Mahjoub et al., 2010).  
 
Centrins are conserved proteins that are present in the distal lumen of centrioles, 
although their localisation is not restricted to the centrosome (Paoletti et al., 1996). 
Centrin is required for spindle pole body duplication in yeast, but the requirement for 
centrins in higher eukaryotes remains controversial (Azimzadeh and Marshall, 2010). 
Studies in Xenopus embryos show a requirement for centrins 2 and 3 in centrosome 
duplication and successful embryo cleavage (Paoletti et al., 1996, Middendorp et al., 
2000). Centrin 2 is has also been shown to be required for centriole duplication in HeLa 
cells (Salisbury et al., 2002). However, several studies show that centriole duplication 
occurs in the absence of centrins (Dantas et al., 2011, Yang et al., 2010).
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Figure 13 Centriole formation 
Adapted from Kleylein et al. and Azimzadeh et al. (Kleylein-Sohn et al., 2007, 
Azimzadeh and Marshall, 2010). Centriole biogenesis is dependent on Plk4 kinase and 
structural components of the centriole: hSas-6, CPAP, Cep135, ?-tubulin and CP110. 
Procentriole formation begins with the recruitment of hSas-6, which forms a cartwheel 
structure with 9-fold symmetry that determines the position of centriole microtubules. 
CPAP, Cep135 and ?-tubulin are then recruited to the central tube and ?/?-tubulin 
dimers are then recruited and polymerised to form the centriole triplet tubules. CP110 
forms a cap at the distal end of the centrioles and defines the centriole length. 
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During G2, centrioles elongate by the extension of centriole microtubules. CPAP and 
CP110 act antagonistically to regulate centriole length, with CPAP promoting centriole 
elongation and CP110 restricting elongation (Schmidt et al., 2009, Kohlmaier et al., 
2009). The daughter centriole protein, centrobin, is also important for centriole 
elongation. Centrobin is recruited to the daughter centriole in a hSas-6 dependent 
fashion and its interaction with tubulin is required for the stabilisation of centriole 
microtubules (Gudi et al., 2011). Along with elongation, daughter centrioles acquire 
markers of maturation including hPOC5 at their distal end beginning in G2 and 
continuing during mitosis (Azimzadeh et al., 2009). HPOC5 and centrin levels increase 
throughout G2 and mitosis and consequently, mother centrioles can be distinguished 
from procentrioles due to increased centrin levels.  
 
At the end of G2, the younger mother centriole (that was a daughter in the previous cell 
cycle) reaches full maturity and acquires distal appendages, which consist of proteins 
Ofd1, Cep164, ninein, Cep170, ?-tubulin, ODF2 and cenexin (Azimzadeh and Marshall, 
2010). At this time the fibrous linker between the two centrosomes is broken, which 
allows centrosomes to separate in mitosis. The linker between the proximal ends of the 
two mother centrioles consists of C-Nap1 and Rootelin, which interact with each other 
and are both essential for linking the two centrosomes in interphase (Mayor et al., 2000,  
Bahe et al., 2005, Yang et al., 2006). The linker is broken at the G2/M transition by 
Nek2 kinase via ?-catenin (Bahe et al., 2005, Bahmanyar et al., 2008). 
 
Centriole duplication is tightly regulated such that only one procentriole can form at 
each mother centriole and the duplication process can only occur once per cell cycle. 
Procentrioles form in tight association with the mother centriole, but de novo centriole 
formation can occur: the presence of a mother centriole “template” is not essential but 
likely acts to concentrate the required factors and thus speed up the kinetics of centriole 
formation in comparison with de novo formation (Khodjakov et al., 2002). The presence 
of one daughter centriole per mother prevents the formation of additional procentrioles: 
removal of the daughter centriole allows formation of another (Loncarek et al., 2008). 
Importantly, it is a centrosome-intrinsic property that prevents reduplication since G2 
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cytoplasm is permissive for duplication of centrioles from G1 cells and centrosomes 
form G2 cells cannot duplicate in the presence of S phase cytoplasm (Wong and 
Stearns, 2003). Furthermore, de novo centriole formation only occurs in the absence of 
any centrioles and during de novo centriole formation there is no restriction on the 
number formed (La Terra et al., 2005).  
 
Centriole duplication is coordinated with the chromosome duplication cycle. In order 
for a centriole to duplicate it must have passed through mitosis and it must be 
disengaged from its partner centriole, which occurs after the metaphase to anaphase 
transition. Since both the mitosis specific modification and disengagement processes are 
not active during S or G2, centriole duplication is restricted to once per cell cycle. 
 
1.3.2 Centriole duplication licensing 
From centriole formation in S phase through to the metaphase-anaphase transition 
mother and daughter centrioles remain tightly held together in orthogonal arrangement 
(engaged). Upon metaphase to anaphase transition the protease separase becomes active 
due to the destruction of its inhibitor, securin, as described previously (figure 5). 
Separase cleaves cohesin, which is involved in holding mother and daughter centrioles 
together, and is therefore essential for centriole disengagement (Tsou and Stearns, 2006, 
Tsou et al., 2009, Schockel et al., 2011) (figure 14). Importantly, disengagement is not 
sufficient for centrioles to be competent for duplication: Plk1 activity during mitosis is 
also required (Tsou et al., 2009, Wang et al., 2011). Plk1 is required for efficient 
cleavage of cohesin by separase, perhaps by modifying cohesin and thus making it a 
better substrate for separase cleavage. However, aside from the role of Plk1 in centriole 
disjunction, it has a role in modifying centrioles during mitosis in an unknown manner, 
which primes them for duplication in the subsequent S-phase. When centrioles are 
pushed through mitosis in the absence of Plk1 activity, the resulting centrioles remain 
engaged due to the role of Plk1 in centriole disjunction. However, if single centrioles, 
formed de novo, are put through the same process they cannot duplicate during the 
subsequent S-phase even though they are not engaged (Wang et al., 2011). Therefore, 
Chapter 1. Introduction 
62 
both centriole disjunction and Plk1-dependent modification of centrioles are required 
for duplication. It is important to note that separase activity is not absolutely required 
for centriole disengagement: without separase, centriole disengagement is delayed, but 
still occurs in a Plk1 dependent fashion (Tsou et al., 2009). 
 
Centriole duplication is temporally separated from disengagement and licensing, as 
DNA replication is separated from replication origin licensing, which prevents multiple 
rounds of licensing and duplication/replication in one cell cycle. Cdk2-cyclin E and 
Plk2 are active in S phase and promote centriole duplication by removal of 
nucleophosmin from the centrosome (Okuda et al., 2000, Krause and Hoffmann, 2010). 
Nucleophosmin is phosphorylated by these two kinases on distinct sites and its 
subsequent removal from the centrosome is required for centriole duplication. 
Nucleophosmin is recruited back on to centrosomes at mitosis and remains there during 
G1 to inhibit centriole duplication when licensing is ongoing. Furthermore, Cdk2-cyclin 
E dependent phosphorylation of Mps1 stabilises Mps1 at the centrosome where its 
kinase activity is required for centriole duplication (Fisk and Winey, 2001, Fisk et al., 
2003). Intriguingly, NPM mutations are found in lymphomas and leukaemia, either as 
translocations with other genes, including the RAR? gene found in APL as mentioned 
previously, or as aberrant NPM proteins, which can result in aberrant localisation of 
NPM and its interacting partners to the cytoplasm (Meani and Alcalay, 2009, Falini et 
al., 2007). 
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Figure 14 Centriole disengagement 
Adapted from Schöckel et al. (Schockel et al., 2011). Plk1 leads to removal of a 
phosphatase-sensitive fraction of cohesin during prophase, but a sugoshin 1 (Sgo1, blue 
oval) protected pool of cohesin remains (orange encased in blue). Furthermore, Plk1 
primes cohesin, probably by direct phosphorylation, for cleavage by separase. When 
separase becomes active at the metaphase to anaphase transition, it cleaves the 
remaining cohesin and centriole engagement is abolished. The centrioles inherited by 
G1 cells are disengaged and both competent for PCM recruitment, microtubule 
organisation, and duplication. Plk1 activity is essential for centriole 
disjunction/disengagement. 
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1.3.3 Control of centriole copy number 
The mechanisms restricting the formation of daughter centrioles to one per mother 
centriole are not fully understood, but Plk4 regulation plays an important role in this 
process. Plk4 is absolutely required for centriole duplication and the precise regulation 
of Plk4 protein levels is essential for controlled centriole duplication: Plk4 
overexpression causes the formation of multiple daughter centrioles per mother 
centriole in a flower-like arrangement (Habedanck et al., 2005). Both its localisation to 
the centrosome and its kinase activity are required for centriole duplication. 
Importantly, Plk4-induced centriole “flower” formation is only observed in S phase or 
G2 cells, suggesting that Plk4-induced centriole formation is subject to cell cycle 
regulation (Kleylein-Sohn et al., 2007).  
 
Proteolysis is essential for restricting centriole copy number to one per mother centriole. 
Inhibition of the proteasome leads to centriole flower formation, which is dependent on 
Plk4 (Duensing et al., 2007). Plk4 is subject to proteasome-mediated degradation 
following Plk4 trans-autophosphorylation, which leads to ubiquitination by the 
SCFSlimb/?-TrCP ubiquitin ligase (Guderian et al., 2010, Holland et al., 2010). Plk4 over-
expression causes centriole flower formation to a lesser extent than proteasome 
inhibition. Cdk2-cyclin E over-expression enhances Plk4-induced centriole flower 
formation to levels seen using the proteasome inhibitor. Although Cdk-cyclin E is not 
required for centriole over-duplication (Duensing et al., 2007), it is a positive regulator 
of duplication and it needs to be regulated in order to prevent the formation of multiple 
daughter centrioles. Along with Plk4, Cdk2-cyclin E levels are regulated by proteolysis 
(Duensing et al., 2007). Furthermore, the Cdk inhibitor p21 is required to prevent the 
formation of more then one daughter centriole per mother (Duensing et al., 2006), and 
Cyclin E is regulated by Orc1 (origin recognition complex subunit), which prevents 
cyclin E dependent centriole reduplication (Hemerly et al., 2009). Depletion of Orc1 
leads to an increase in cyclin E levels and centriole reduplication.  
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Plk4 induced centriole duplication is dependent on factors that are required for 
formation of the centriole structures: hSas-6, CPAP, Cep135, and CP110. Depletion of 
any of these factors does not affect Plk4 centrosomal localisation, but these proteins are 
all structural components of the procentriole (hSas-6, CPAP, Cep135) or the growing 
centriole (CP110) and are therefore necessary for daughter centriole formation 
(Kleylein-Sohn et al., 2007).  
 
HSas-6 recruitment to the centrosome is the essential first step in procentriole formation 
and its levels are tightly regulated by proteolysis. Over-expression of hSas-6 also leads 
to the formation of centriole flowers (Strnad et al., 2007). Localisation of hSas-6 to the 
centrosome is dependent on Plk4 (Strnad et al., 2007), and hSas-6 is targeted for 
degradation by the SCF-FBXW5 ubiquitin ligase at the end of mitosis such that hSas-6 
is absent from the cytoplasm and centrioles of G1 cells, but protein levels begin to 
accumulate at the G1/S transition allowing pro-centriole formation (Puklowski et al., 
2011). FBXW5 itself is cell cycle regulated by the APC/C, which keeps levels of 
FBXW5 low at the end of mitosis and during G1. At the beginning of S phase the 
APC/C becomes inactive and FBXW5 protein levels peak. However, Plk4 
phosphorylates and inactivates FBXW5 allowing hSas-6 levels to rise (Puklowski et al., 
2011). As mentioned above, Plk4 is responsible for its own down-regulation, so as S 
phase proceeds and Plk4 activity decreases, FBXW5 becomes active and targets hSas-6 
for degradation (figure 15).  
 
CP110, is also regulated by proteolysis; it is ubiquitinated by SCF-cyclin F, and 
targeted for degradation (D'Angiolella et al., 2010). Cyclin F levels peak in G2 and 
therefore prevent centriole reduplication by limiting the amount of CP110. CP110 is 
also negatively regulated by Cep76, which interacts with CP110 and specifically 
prevents centrosome reduplication rather than normal duplication (Tsang et al., 2009). 
Cep76 specifically inhibits centriole duplication induced by DNA replication stalling 
agents, but has no effect on the formation of multiple daughter centrioles around one 
mother centriole induced by overexpression of Plk4.  
Chapter 1. Introduction 
66 
As Plk4 kinase is a positive regulator of centriole duplication, the phosphatase Cdc14B 
is an important negative regulator, although its substrates at the centrosome are not yet 
known. Cdc14B activity at the centrosome prevents centriole reduplication caused by 
cell cycle arrest with replication stalling agents, or by proteasome inhibition (Wu et al., 
2008).  Since proteasome inhibition leads to centriole reduplication in a Plk4 dependent 
manner it seems likely that Cdc14B may dephosphorylate Plk4 targets involved in 
centriole duplication. 
 
In summary, multiple mechanisms ensure that centriole numbers are strictly regulated 
so that cells enter mitosis with only 2 centrosomes, each containing a pair of engaged 
centrioles. The mechanisms described above are summarised in figure 15. There is a 
plethora of evidence for the role of centrosome amplification in the formation of 
multipolar spindles, aneuploidy and genome instability (Nigg and Raff, 2009, Acilan 
and Saunders, 2008). As centriole duplication is tightly regulated, so is centriole 
elongation during G2, and maturation and separation of centrosomes at the G2/M 
transition, which is reviewed in (Azimzadeh and Marshall, 2010).  
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Figure 15 Regulation of centriole duplication 
Centrioles are disengaged at the end of mitosis by the combined activities of Plk1 and 
separase. In G1 centrioles are licensed for duplication, but duplication does not take 
place until S phase when the S phase Cdk-cyclin kinase is active. Cdk2-cyclin E, Plk4 
and Plk2 activity promotes daughter centriole formation. Centriole reduplication is 
prevented in G2 by mechanisms that restrict daughter centriole formation to one per 
mother centriole and prevent disengagement and licensing of centrioles before the next 
cell cycle. 
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1.3.4 Centriole reduplication 
The formation of multiple procentrioles per mother centriole in a flower-like 
arrangement described previously, caused by overexpression of Plk4, hSas-6 or 
inhibition of the proteasome is due to abolishment of “copy number” control. However, 
centriole reduplication can also occur when cell cycle regulation of centriole duplication 
is deregulated. Reduplication of centrioles upon treatment of the human osteosarcoma 
cell line, U2OS, with replication stalling agents such as hydroxyurea (HU) or 
aphidicolin (Aph) is well known (Cizmecioglu et al., 2008). This phenomenon is also 
apparent in Chinese hamster ovary cells (CHO) (Balczon et al., 1995, Kuriyama et al., 
2007), but does not occur in other cancer cell types such as HeLa or in non-transformed 
cells. Treatment of U2OS cells with HU or Aphidicolin to arrest them in S phase results 
in centrosome reduplication caused by multiple rounds of duplication and 
disengagement of mother and daughter centrioles as determined by the fact that 
centriole diplosomes and individual centrioles are formed, rather than mother centrioles 
surrounded but daughter centriole flowers (figure 16). Treatment of cells with ?-IR also 
results in centrosome duplication in the same way: uncoupling of the centriole 
duplication cycle from the cell cycle. 
 
Centrosome reduplication after DNA damage is due to a prolonged G2 phase, which is 
dependent on the DNA damage induced G2/M checkpoint (Dodson et al., 2004). 
Centrosome amplification in G2 following DNA damage is due to a centrosome 
intrinsic signal that allows centriole disengagement (Inanç et al., 2010). Inanç and 
colleagues performed cell fusion experiments between human and chicken cells in order 
to distinguish between centrosomes that came from cells that had been irradiated and 
those that had not been irradiated. Only centrosomes from irradiated cells undergo 
amplification in G2. Recent experiments have shown that centrosome reduplication in 
HU-arrested U2OS cells also actually occurs in G2 rather than S phase, as previously 
thought (Loncarek et al., 2010). HeLa cells treated with HU, arrest with duplicated 
centrioles, which are engaged with procentrioles shorter than their mother and lacking 
the maturation marker hPOC5.  However, U2OS cells in the same condition contain 
procentrioles that are as long as their mothers and also have hPOC5 staining at their 
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distal end. These mature procentrioles disengage from their mothers and multiple 
rounds of centriole duplication occur. Importantly, Cdk1 inhibition, which causes both 
HeLa and U2OS cells to arrest in late G2 phase, causes centriole disengagement and 
reduplication in both cell lines. Thus, the previously unknown difference between the 
effect of S phase arrest on centriole duplication in these two cell lines is not due to a 
difference in their centriole duplication mechanisms, rather a difference in the 
stringency of the S phase arrest. Centrosome disengagement, and therefore 
reduplication, during G2 is dependent on active Plk1 at the centrosome (Loncarek et al., 
2010). During an unperturbed S phase, Plk1 activity is low and centriole disengagement 
cannot occur; therefore multiple rounds of centriole duplication cannot occur. During 
G2, Plk1 becomes active at the centrosome; centrioles can disengage and undergo 
another round of duplication if they are held in G2 for long periods of time. In 
accordance with this, centrosome amplification also occurs in CHO and DT40 cells 
upon inhibition of Cdk1, which causes G2 arrest (Steere et al., 2011). 
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Figure 16 Centriole reduplication 
Centriole duplication can occur due to abrogation of centriole copy number control by 
overexpression of Plk4, for example (left) or due to prolonged G2 arrest (right). In late 
G2, Plk1 becomes active at centrosomes, which promotes procentriole maturation and 
disengagement during arrest in G2, therefore licensing them for another round of 
duplication. 
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1.4 Cep63 
Cep63 was identified as a centrosome protein in a mass spectrometry analysis of 
purified centrosomes (Andersen et al., 2003), also verified by (Jakobsen et al., 2011). 
Xenopus laevis Cep63, herein referred to as XCep63, was identified in the laboratory of 
Dr. Costanzo as a novel ATM substrate in Xenopus egg extracts (Smith et al., 2009). 
XCep63 localises to the centrosome in Xenopus tissue culture cells and to the 
centrosomes associated with sperm nuclei when incubated in Xenopus egg extracts. 
Depletion of XCep63 from Xenopus CSF (cytostatic factor arrested) extracts results in 
defective spindle assembly induced by the addition of purified sperm nuclei (and their 
associated centrosomes). Interestingly, XCep63 depletion does not affect the formation 
of chromatin-induced spindles upon the addition of DNA coated beads to CSF extract, 
which indicates that XCep63 plays a role specifically in centrosome-dependent spindle 
assembly (Smith et al., 2009).  
 
In the presence of DNA damage in CSF extract, ATM is activated and DNA damage 
signalling leads to disruption of mitotic spindle assembly induced by the addition of 
purified sperm nuclei. XCep63 is phosphorylated by ATM in response to DNA damage 
on serine 560 and consequently delocalises from centrosomes. Addition of recombinant 
XCep63 mutated in the ATM target sequence, S560A, rescues the defect in spindle 
assembly resulting from DNA damage signalling. Furthermore, XCep63 S560A 
remains localised to the spindle poles in the presence of DNA damage, when the 
endogenous protein delocalises. Additionally, caffeine, an inhibitor of ATM and ATR 
kinases, also rescues spindle formation in the presence of DNA damage (Smith et al., 
2009). 
 
DNA damage in mitosis has been studied, but the effects on mitotic progression are 
varied. Upon DNA damage during mitosis, cells either die after a prolonged mitotic 
arrest or progress to G1 without delay (Nitta et al., 2004, Mikhailov et al., 2002); or 
revert to a G2-like phase without passing through mitosis (Chow et al., 2003). 
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Importantly, many of these studies show a cell line and DNA damage dose-specific 
response (Mikhailov et al., 2002, Nitta et al., 2004, On et al., 2011).  
 
In response to extensive DNA damage, cells arrest in mitosis in a spindle assembly 
checkpoint (SAC) dependent manner due to disruption of kinetochore function 
(Mikhailov et al., 2002, Royou et al., 2005). In this situation, SAC activation is 
independent of ATM/ATR signalling. Smaller amounts of DNA damage that result in 
double strand DNA breaks, but not kinetochore damage, result in mitotic progression 
without delay (Mikhailov et al., 2002) or mitotic delay due to Chk1 dependent 
signalling (Royou et al., 2005). The extent of mitotic catastrophe in response to mitotic 
DNA damage is affected by the extent of SAC signalling and mitotic delay (On et al., 
2011). Abrogation of SAC signalling prevents mitotic delay and mitotic catastrophe 
after DNA damage (Mikhailov et al., 2002, Nitta et al., 2004, On et al., 2011).  
 
In conclusion, the effects of DNA damage signalling on mitotic cells is varied, 
depending on the cell type, efficiency of the SAC, dose and type of DNA damage. It is 
clear that the SAC is required for the mitotic delay in many different cell types, but the 
extent to which DNA damage signalling kinases are required varies. In Xenopus laevis 
egg extracts, XCep63 function in spindle assembly is inhibited by ATM dependent 
phosphorylation in response to DNA damage, which leads to disruption of spindle 
structure and, likely, activation of the SAC and mitotic delay (Brown and Costanzo, 
2009). 
 
1.4.1 Aims 
Study of XCep63 indicates that it is an extremely interesting candidate for involvement 
in the maintenance of genome stability. The reasons for this are twofold: XCep63 is a 
target of DNA damage signalling kinases and it is involved in formation of bipolar 
mitotic spindles. Due to the potential for Cep63 to promote genome stability, future 
study of this protein may have important implications for cancer research.  
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The aim of my thesis is to characterise the function of human Cep63, which at the 
beginning of this project was unknown. Two approaches are taken to identify the role of 
Cep63 in human cell lines. Firstly, pull down of Cep63 and identification of binding 
partners will indicate pathways or processes in which Cep63 may play a role. Secondly, 
RNA interference (RNAi) to deplete Cep63 protein levels in cells will allow detection 
of any abnormalities in cell cycle progression or spindle assembly. Since Cep63 is a 
centrosome protein and an ATM target, there is potential for Cep63 to be involved in 
the regulation of cell cycle phase transitions. Furthermore, if the ATM-dependent 
phosphorylation of Cep63 is conserved between Xenopus and human, study of Cep63 
may lead to a better understanding of mitotic DNA damage signalling. Perhaps Cep63 
and potential associated partners might be the link between DNA damage checkpoint 
activation and activation of the spindle assembly checkpoint. As XCep63 is required for 
bipolar spindle assembly and maintenance, it will be interesting to see if this 
centrosomal function is conserved in humans. Perhaps Cep63 plays a role in 
maintaining microtubule minus ends at the centrosome, or mediating the link between 
spindle poles and the centrosome. As a centrosome protein, Cep63 has potential to be 
involved in many different pathways that regulate the duplication of the centrosome 
itself; the transition from one cell cycle phase to the next; and spindle assembly and 
mitotic progression. 
 
Outline of aims 
• Study the cellular localisation of Cep63. 
• Produce and validate an antibody to allow study of human endogenous Cep63. 
• Validate Cep63 siRNAs. 
• Identify Cep63 interacting proteins. 
• Investigate the function of Cep63 in human cell lines using RNAi. 
• Ascertain if human Cep63 is phosphorylated by ATM, as XCep63 is. 
• Set up a Cep63 gene-trap mouse model to allow study of Cep63 at the level of 
the whole organism and cell based studies. 
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Chapter 2. Materials and Methods 
2.1 Chemicals and solutions 
2.1.1 Suppliers of reagents  
Unless stated, all chemicals were obtained from Sigma-Aldrich, BDH Laboratory 
Supplies (UK) or Fisher Scientific (UK). All restriction enzymes were purchased from 
New England Biolabs (NEB). 
 
Standard solutions of 0.5 M EDTA, pH 8.0; 1M Tris-EDTA (TE), pH8.0; 1M Tris-HCl, 
pH7.5; 1M MgCl2; 5M NaCl; Phosphate Buffered Saline (PBS); and Tris Borate EDTA 
(TBE) were prepared by Cancer Research UK London Research Institute (LRI) Central 
Services. All other stock solutions were made according to standard methods 
(Sambrook et al.).  
 
Ultrapure agarose was obtained from Invitrogen; ammonium persulfate (APS), 
N,N,N,N’-tetra-methyl-ethylenediamine (TEMED), Tween 20, formaldehyde 36.5%, 
Igepal, Triton X-100 and bovine serum albumin (BSA) were obtained from SIGMA. 
Ethidium bromide, 40% Acrylamide/Bis 37.5:1, 1.5 M Tris HCl pH8.8, 0.5 M Tris HCl 
pH 6.8 and Laemmli sample buffer were obtained from Biorad. Sodium dodecyl sulfate 
(SDS), DMSO and ?-mercaptoethanol were obtained from Fisher Scientific. Ultra Pure 
30 % Acrylamide and Ultra Pure 2% Bisacrylamide were obtained from National 
Diagnostics (UK). Complete protease inhibitor cocktail tablets were obtained from 
Roche (UK). All primers were produced by Sigma-Genosys (UK).  
  
2.1.2 Medium for bacteria 
Luria-Bertani Broth (LB): 1% w/v bacto-tryptone (DIFCO), 0.5% w/v yeast extract 
(DIFCO), 0.1 M NaCl. pH adjusted to 7. 
LB agar: LB broth + 2 % (w/v) Bacto agar  
Chapter 2. Materials and Methods 
75 
SOC: 2% w/v bacto-tryptone, 0.5% w/v yeast extract, 10mM NaCl , 2.5mM KCl, 
10mM MgCl2, 10mM MgSO4, 20mM glucose. pH adjusted to 7. 
  
2.1.3 Solutions 
PBS (Phosphate Buffered Saline) and PBS-Tw: 0.13 M NaCl, 7 mM Na2HPO4 , 3 mM 
NaH2PO4 , pH adjusted to 7.5 with HCl. Routinely, a 10x stock solution was prepared 
and diluted in water before use. 0.1% Tween-20 was added for PBS-Tw 
 
TBS (Tris Buffered Saline) and TBS-Tw: 10mM Tris-base, 150mM NaCl, pH adjusted 
to 7.5 with HCl. Routinely, a 10x stock solution was prepared and diluted in water 
before use. 0.1% Tween-20 was added for TBS-Tw 
 
TE (Tris-EDTA): 1mM Tris-Cl pH 7.5, 0.1mM EDTA, pH 8.0. Routinely, a 10x stock 
solution was prepared and diluted in sterile water before use.  
 
10 x Tris-Glycine: Trizima base 30.3 g/l, Glycine 144 g/l. 
 
2.1.4 Bacterial strains  
From Invitrogen  
MAX Efficiency DH5? Competent Cells  
One shot TOP10 Chemically competent cells 
One shot BL21(DE3) pLysS  
From Stratagene  
BL21 Codon Plus (DE3-RIL)  
XL1-Blue Supercompetent Cells  
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2.1.5 Bacterial storage  
E. coli strains were stored at 4°C on solid medium containing the appropriate antibiotic 
for up to 1 week. For long term storage, glycerol stocks were made by mixing an 
overnight culture with 30% sterile glycerol and freezing in a dry ice/ethanol bath before 
storing at -80°C.  
 
2.2 Molecular biology techniques  
2.2.1 Plasmid preparation  
For plasmid preparation a QIAGEN Miniprep or Maxiprep kit was used according to 
the manufacturer’s instructions.  
  
2.2.2 Restriction digests and ligation reactions  
DNA was digested in a final volume of 20 ?l at 37°C for 1 h. All restriction enzymes 
were from New England Biolabs (NEB), and digestions were performed in the 
appropriate NEB buffer. All digestions were analysed by agarose gel electrophoresis.  
   
Ligation reactions were performed using Quick T4 DNA ligase (New England Biolabs) 
as recommended by the manufacturer:  
10 ?l 2X Quick Ligation Buffer  
50 ng vector DNA   
3X molar excess of insert DNA  
1?l of Quick T4 DNA Ligase  
Double distilled (dd) H2O to 20 ?l  
Ligation was carried out for 5 minutes at room temperature (approximately 23 ˚C).   
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2.2.3 Agarose gel electrophoresis  
Horizontal agarose gels were routinely used for the separation of DNA fragments. All 
agarose gels were 1% w/v agarose in 1xTBE, except for fragments being separated for 
band excision and extraction of the DNA, for which 0.6% agarose gels were used. 
Samples were loaded in 1x loading dye (6x stock: 0.25% bromophenol blue; 0.25 
xylene cyanol FF; 30% v/v glycerol). Gels also contained 1?g/ml ethidium bromide to 
allow visualisation of DNA under UV light. Gels were run at ~6V/cm of the distance 
between the two electrodes. 1Kb ladder (New England Biolabs) was used for 
determination of fragment size. Visualisation of DNA fragments by UV light was 
carried out with a Geldoc trans-illuminator (Biorad). 
  
2.2.4 Purification of DNA from agarose gels  
Following agarose gel electrophoresis, DNA gel slices were excised using UV light to 
visualise the position of the fragment. DNA was extracted from the agarose gel using a 
Qiagen gel extraction kit as directed by the manufacturer’s protocol.  
  
2.2.5 DNA sequencing  
Sequencing reactions were carried out using the BigDye Terminator v.3.1 Cycle 
Sequencing Kit (Applied Biosystems) according to the manufacturer’s instructions. The 
Cancer Research UK Sequencing Service was used for analysis of the reactions. 
Sequences were analysed using Sequencher v4.5 software (Genecodes).  
 
2.2.6 Transformation of E. coli with plasmid DNA  
Plasmid transformation of E. coli: 
50 ?l of chemically competent cells (TOP10, Invitrogen) were mixed with DNA and 
incubated on ice for 30min. The cells were then subjected to heat shock at 42°C for 30 
sec, and cooled on ice for 2 minutes. 0.25 ml of SOC was then added and the tubes were 
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incubated at 37°C with shaking for 1 hour. Cells were then plated on LB agar plates 
with the appropriate antibiotic.  
 
2.2.7 Conventional Cloning  
Conventional cloning was carried out by polymerase chain reaction (PCR) using 
appropriate primers that incorporated convenient restriction enzyme sites for the 
expression vector to be used.  
 
Pfu Ultra polymerase (Stratagene) was used as follows:  
5 ?l 10x Pfu buffer  
5 ?l DMSO 
0.4 mM of each dNTP  
125 ng forward primer  
125 ng reverse primer  
1 ?l Pfu turbo Polymerase   
50 ng DNA template   
dH2O to 50 ?l  
  
For the amplification of Cep63 cDNA, PCR reactions were usually performed with the 
following cycling parameters:  
1 cycle:  5 min at 95°C  
30 cycles: 30 sec at 95°C  
30 sec at the primer annealing temperature (50 – 60 ˚C) 
2 min at 72°C (or 1 min per kb of DNA to amplify)  
1 cycle:  10 min at 72°C  
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Blunt end PCR products were then checked by agarose gel electrophoresis to visualise 
the size of the fragment and to detect the presence of potential off-target products. PCR 
reactions generating only one product were used in a Topo cloning reaction to insert the 
fragment into the pCR-BluntII TOPO vector (Invitrogen) using the kit as per 
manufacturer’s instructions. Topo vectors were amplified in TOP10 E. coli and DNA 
was prepared by miniprep (Qiagen). Topo vectors were checked by restriction digest to 
select clones containing the correct fragment size, and then positive clones were 
sequenced. Vectors containing the correct inserts were digested with the appropriate 
restriction enzymes and DNA fragments were purified by agarose gel electrophoresis 
and gel extraction. Expression vectors were digested and purified in the same way. Cut 
fragment and vector were ligated as described above and then amplified in TOP10 E. 
coli (Invitrogen). 
 
For cloning into the pMAL-c4x expression vector, Cep63 was amplified by PCR using 
a forward primer with a BamHI restriction site and a reverse primer with the SalI site. 
These restriction sites were also included in the primers used for the generation of 
Cep63 fragments. The same procedure, using the same restriction enzyme sites, was 
also carried out with the Xenopus Cep63 sequence. 
 
For cloning into the pIRES puro 3 GFP-Flag mammalian expression vector, Cep63 was 
amplified with primers containing AgeI and NotI restriction sites. The same restriction 
sites were used for the cloning of Cep152 N and C terminal halves. I was unable to 
generate TOPO clones with the full-length human Cep152 sequence. 
 
For cloning Xenopus laevis Cep152 (XCep152) proteins (full length, N-terminal half 
and C-terminal half) into pcDNA3, forward primers contained BamHI restriction sites 
and reverse primers contained NotI sites. 
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2.2.8 Gateway cloning 
Gateway cloning was carried out as described by the Gateway manual (Invitrogen). 
PCR primers were designed to include attB sites and the IMAGE clones listed below 
were used as templates. PCR reactions were checked by agarose gel electrophoresis to 
ensure that only one product was made and the PCR reaction was then used directly in 
the BP reaction with pDONR221. E. coli were then transformed with the BP reaction 
and amplified pDONR plasmids were checked by restriction digest and sequencing. 
Correct pDONR plasmids were used for LR reactions to produce Destination vectors 
with the desired insert. 
 
LR reactions were performed with the following destination vectors: 
pcDNA5 Dest FRT/TO Flag  
pcDNA5 Dest FRT/TO YFP 
both kind gifts from Zuzanna Horejsi. 
 
2.2.9 Colony PCR 
Colony PCR was used to screen large numbers of colonies for the presence of inserts 
during conventional and Gateway cloning protocols for Cep152 (human) cDNA. 
Preparation of colonies 
Single colonies were picked and resuspended in 100 μl ddH2O, vortexed, then incubated 
for 10 minutes at 100 °C followed by centrifugation at 16,000 x g for 5 minutes. The 
resulting DNA suspension was used in the PCR reaction. 
PCR reaction 
5  μl DNA suspension 
5 μl 10 x buffer 
5 μl DMSO 
4 μl 25 mM MgCl2  
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0.4 μl 25 mM dNTP mix 
2 μl of primer mixture (100 pmol/μl stocks; each diluted 1:10) 
0. 25 μl Simple Red Taq polymerase (Thermo Scientific) 
For reactions with primers spanning the full length Cep152 an extension time of 5 
minutes was used. For reactions containing primers for the C-terminal half of Cep152 
and extension time of 2 minutes was used. Annealing temperature was 50 – 55 °C. 
 
2.2.10 Cep63 and Cep152 templates  
XCep63: XCEP63 BC088974 Xenopus laevis hypothetical LOC496369. Coding 
sequence 1947 bp. 
Cep63: CEP63 transcript variant 2 Homo sapiens centrosomal protein 63kDa 
IMAGE:5951988 complete cds. Coding sequence 1626 bp. 
XCep152: Xenopus laevis hypothetical protein LOC446951 IMAGE:5084879. Coding 
sequence 4992 bp. 
Cep152: Hs CEP 152kDa, mRNA IMAGE:40125733 complete cds. Coding sequence 
4965 bp. 
 
2.2.11 Cep63 cloning 
The human Cep63 protein sequence was divided as follows to produce truncated forms 
of the protein. These truncated sequences were cloned into the pMAL-c4x vector for 
expression of MBP-tagged proteins in E. coli. Gateway cloning, as described above, 
was used to clone the same truncation sequences into vectors for expression in 
mammalian cells.  
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 Sequence 5’ – 3’ (pMAL-c4x) Sequence 5’ – 3’ (Gateway) 
a GGATCCGAGGCTTTGTTAGAAGGAATAC GGGGACAAGTTTGTACAAAAAAGCAGGCTTCGAGGCT
TTGTTAGAAGGAATAC 
b GGATCCTCTGAAATTGAGAGGTTAACTGC GGGGACAAGTTTGTACAAAAAAGCAGGCTTCTCTGAA
ATTGAGAGGTTAACTGC 
c GGATCCTTACATCAGCGAGATATCACTATT
G 
GGGGACAAGTTTGTACAAAAAAGCAGGCTTCTTACAT
CAGCGAGATATCACTATTG 
d GTCGACCTACTTTAAGGCTGTGAATTGTCT
C 
GGGGACCACTTTGTACAAGAAAGCTGGGTCCTACTTT
AAGGCTGTGAATTGTCTC 
e GTCGACCTATAACTCCTGAGTTAGATGGGA
G 
GGGGACCACTTTGTACAAGAAAGCTGGGTCCTATAAC
TCCTGAGTTAGATGGGAG 
f GTCGACCTACCGATCTTCCCTGTGATTTTT
G 
GGGGACCACTTTGTACAAGAAAGCTGGGTCCTACCGA
TCTTCCCTGTGATTTTTG 
 
Bold letters indicate the attB recombination site required in the first step of Gateway 
cloning. Red letters highlight the stop codon. 
 
No. Domain Start-end 
nt 
primers Size bp Start-end 
aa 
Size kDa Size 
+MBP 
1 N-term 1-408 a/f 408 1-135 16 60 
2 SMC-like 409-1272 b/e 864 136-424 33 77 
3 C-term 1273-1626 c/d 357 425-841 14 58 
4 N-SMC 1-1272 a/e 1272 1-424 49 93 
5 SMC-C 409-1626 b/d 1218 136-841 47 91 
6 Full  1-1626 a/d 1626 1-841 63 107 
Table 2 Human Cep63 truncation proteins 
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Cep63 full length was also cloned into pIRESpuro3GFP-Flag (a kind gift from Tohru 
Takaki), for mammalian expression and generation of stable cell lines, using AgeI and 
NotI restriction sites and primers as follows: 
Cep63 Forward AgeI 
ACCGGTGAGGCTTTGTTAGAAGGAATAC 
Cep63 Reverse NotI 
GCGGCCGCCTACTTTAAGGCTGTGAATTGTC 
 
2.2.12 Cep152 cloning 
Xenopus Cep152 full length sequence was cloned into the pMAL-c4x vector for 
expression in E. Coli using BamHI and SalI restriction sites. Primer sequences are as 
follows: 
Forward BamHI 
5’ GGATCCTCTATCGACTTTGATAGTG 3’ 
Reverse SalI 
5’ GTCGACTTAGTTGAAGTTATTTAAG 3’ 
 
Human Cep152 was cloned using the Gateway system to generate vectors for 
mammalian cell expression using the following primers: 
Forward 
5’ GGGGACAAGTTTGTACAAAAAAGCAGGCTTCTCATTAGACTTTGGCAGTG 3’ 
Reverse 
5’ GGGGACCACTTTGTACAAGAAAGCTGGGTCTTAGTCTAGATTAACAAATG 3’ 
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Bold letters indicate the attB recombination site required in the first step of Gateway 
cloning. 
 
Human Cep152 N- and C-terminal halves were cloned into a pIRESpuro3GFP-Flag 
vector also for mammalian expression using AgeI and NotI restriction sites and primers 
as follows: 
 Forward primer AgeI Reverse primer NotI 
N ACCGGTTCATTAGACTTTGGCAGTGTGGCAC GCGGCCGCTTAAACATCACTGGTGGTTACTTGGT 
C ACCGGTATTTCCAAGAAAGAGATGGCA GCGGCCGCTTAGTCTAGATTAACAAATGGGC 
 
Table 3 Human Cep152 truncation proteins 
 
During cloning of all Cep152 constructs, many colonies were screened at each step by 
colony PCR due to low efficiency of Cep152 cloning. This was the case for 
conventional and Gateway cloning. 
 
2.2.13 Expression vector gifts 
pEGFP-Cep152 was a kind gift from Ingrid Hoffmann (German Cancer Research 
Center, DKFZ, Heidelberg). Flag-Plk2 and Myc-Plk4 constructs were also gifts from 
Ingrid Hoffmann’s lab. 
pIRESpuro3 vector modified with an N-terminal GFP-Flag tag was generated by Tohru 
Takaki (Petronczki lab, Clare Hall). pcDNA5Dest FRT/TO-Flag and YFP vectors were 
generated by Zuzanna Horejsi (Boulton lab, Clare Hall). 
 
C152 truncation Start-end nt bp Start-end aa Size kDa 
N-terminal half 1-2409 2409 1-803 93 
C-terminal half 2410-4965 2556 804-1654 96 
full length 1-4965 4965 1-1654 189 
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2.2.14 Site directed mutagenesis (SDM) 
Point mutations in the Cep63 and Cep152 ORFs were introduced by using the 
QuikChange site-directed mutagenesis kit (Qiagen), Pfu Turbo DNA polymerase and a 
temperature cycler following manufacture’s instructions. Presence of the point 
mutation(s) was then confirmed by DNA sequencing.  
 
pIRES puro3 GFP-Flag-Cep63 was used as a template for SDM to mutate the site 
targeted by siRNA 63-2. The SDM reaction was carried out with the following primers:  
Wobble 2 F  GAGGAATTCCGTCAAAAGAGCTTAGATTGGGAGAAGCAACGCTTG 
Wobble 2 R  CAAGCGTTGCTTCTCCCAATCTAAGCTCTTTTGACGGAATTCCTC 
Table 4 Cep63 mutagenesis primers 
 
For SDM of pEGFP-Cep152, the following primers were used: 
Q265P F AAAGTTAAATGAAAGTGAACGTCCAATTCGATATCTGAATCACCAGC 
Q265P R GCTGGTGATTCAGATATCGAATTGGACGTTCACTTTCATTTAACTTT 
R987X F ACCGGCAATTTTTAGATGATCACTGAAATAAAATTAATGAGGTGCTT 
R987X R AAGCACCTCATTAATTTTATTTCAGTGATCATCTAAAAATTGCCGGT 
 Table 5 Cep152 mutagenesis primers 
 
2.2.15 Reverse transcription-PCR (RT-PCR) 
RNA extraction was carried out using the RNeasy kit (Qiagen). RT-PCR reactions were 
carried out using a one-step RT-PCR kit (Qiagen) with the primers shown on the next 
page. 2 μg RNA was used per 50 μl reaction.  
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Name Sequence product length, bp (Cep63 variant) 
2F GTTGCCAAAACAAAGGGGATTTGGTG 
2R CTCATGTAAACCCAATTCCAATTTC 
1493 bp (1&2); 1355 bp (3&4) 
4F AAACCAACACACAGCAGAAC 
4R CTTTAAGGCTGTGAATTGTC 
483 bp (variant 1) 
5F AGTTGGATGTGACACATAAG 
5R CTGCTGCTCCTGTAGGACAG 
548 bp (all variants) 
6F CATACATGAGGCCAGAATAC 
6R GTTCTTTCAACTTCTTAATC 
347 bp (1&2); 209 bp (3&4) 
G1F CTGCACCACCAACTGCTTAG 
G1R ACAGTCTTCTGGGTGGCAGT 
GAPDH 111 bp control 
G2F TTCACCACCATGGAGAAGG 
G2R TTCACACCCATGACGAACAT 
GAPDH 104 bp control 
Table 6 Cep63 RT-PCR primers 
 
2.3 Protein Expression 
2.3.1 Expression of recombinant proteins  
MBP tagged recombinant proteins  
MBP tagged Cep63, XCep63 and XCep152 proteins and truncations were expressed in 
BL21 Codon Plus (DE3-RIL) cells (Stratagene) and purified on amylose resin and 
eluted with maltose according to manufacturer’s protocol (MBP purification protocol, 
NEB). E. coli were grown at 37 °C until an optical density (OD) at 600 nm of 0.5 was 
reached, then cultures were shifted to 16 °C and induced with 0.3 mM IPTG for 2-4 
hours. Cells were collected by centrifugation at 4,000 x g for 20 minutes at 4 °C and 
pellets were resuspended in column buffer (20 mM Tris HCl pH 7.5, 200 mM NaCl, 1 
mM EDTA, 1 mM DTT) plus Complete protease inhibitors. Cells were passing through 
a cell disruptor twice then incubated with amylose resin for 2 hours at 4 °C. Washes and 
elution were carried out in a glass column with diameter 2.5 cm. Resin was washed with 
12 column volumes of column buffer and bound protein was eluted in column buffer 
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containing 10 mM maltose. Fraction size was 1/5 of the column volume; 20 fractions 
were collected. Proteins were dialysed to remove maltose before use in experiments. 
 
2.3.2 In vitro transcription-translation 
35S-methionine (Promix, Amersham) labelled recombinant proteins were generated 
using a SP6 or T7 quick-coupled transcription- translation reticulocyte lysate (TNT, 
Promega). XCep63 was under the control of an SP6 promoter. Reactions were set up as 
follows: 
TNT SP6 master mix, 40 μl 
DNA, 400 ng 
Promix 35S-Methionine, 3 μl 
ddH2O to 50 μl 
Reactions were incubated for 90 minutes at 30 °C. 
 
2.3.3 Quantification of proteins  
Protein concentrations were determined using the Bradford method (Bradford, 1976).  
Protein samples were mixed with Bradford’s reagent (Biorad) and the absorbance at 595 
nm was measured on a spectrophotometer. Protein absorbance measurements were 
converted to concentration using standard curve readings from a range of known bovine 
serum albumin (BSA) concentrations.  
 
2.4 Protein Techniques 
2.4.1 SDS Poly Acrylamide Gel Electrophoresis (SDS-PAGE) 
SDS-PAGE gels were poured using the Biorad Protean mini-gel apparatus unless 
otherwise stated. Stacking gels were made using 40% Acrylamide/Bisacrylamide 37.5:1 
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(Biorad) and resolving gels were made using Ultra Pure 30 % Acrylamide and Ultra 
Pure 2% Bisacrylamide (National Diagnostics UK). SDS-PAGE gels were run at 100 V, 
constant voltage. Biorad Precision Plus dual colour protein markers were used as 
molecular weight standards. 
SDS-PAGE running buffer: 1 x Tris-glycine, 0.1% SDS 
 
Resolving gel 7.5% 10% 15% Stacking gel  4%  
30% Acrylamide 2.5 3.34 5 
2% Bisacrylamide 0.97 0.65 0.43 
40% Acryl/Bis 1 
1.5 M Tris-HCl, pH 8.8 2.5 2.5 2.5 0.5 M Tris-HCl pH 6.8 2.5 
10% SDS 0.1 0.1 0.1 10% SDS 0.1 
ddH2O 3.8 3.3 1.9 ddH2O 6.3 
APS 0.1 0.1 0.1 APS 0.1 
TEMED 0.01 0.01 0.01 TEMED 0.01 
Total volume (ml) 10 10 10 Total volume (ml) 10 
Table 7 SDS-PAGE gel recipes 
 
Phos-tagTM  SDS-PAGE gels were prepared with Phos-tagTM AAL-107 (NARD Institute 
Ltd., Japan) and 40% Acrylamide and 2% Bisacrylamide from Biorad. Phos-tag gels 
were cast using the Biorad Protean mini-gel apparatus and run for 20 mA, constant mA, 
per gel. Before transfer to nitrocellulose membrane, Phos-tag gels were washed twice 
for 15 minutes in transfer buffer containing 10 mM EDTA, then once in transfer buffer 
alone. 
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 Phos-Tag 20 ?M 
40% Acril 1.88 ml 
2% BisAcril 0.49 ml 
1.5 M Tris-Cl, pH 8.8 2.5 ml 
5 mM Phos-Tag  40 ?l 
10 mM MnCl2 40 ?l 
10% SDS 100 ?l 
10% APS 100 ?l 
TEMED 10 ?l 
ddH2O 4.80 ml 
Total volume (ml) 10 
Table 8 Phos-tag acrylamide gel recipe 
 
Other SDS-PAGE gels used include Nupage Novex Bis-Tris 4-12% or tris-acetate 7% 
mini gels (Invitrogen). These gels were run using MOPS or MES buffer (Invitrogen) at 
100 V. 7% Tris-acetate gels were used when carrying out a Western blot for ATM 
phospho-Serine 1981 since ATM is a large protein, which migrates slower that 250 
kDa. 
 
Coomassie blue staining: After separation of loaded protein samples, polyacrylamide 
gels were incubated in Coomassie blue stain (0.5% Coomassie blue, 45% methanol, 
10% acetic acid) for 5 minutes and incubated with destain solution (25% methanol, 7% 
acetic acid) overnight.  
Sypro Ruby staining: as per manufacturer’s instructions (Invitrogen). 
  
2.4.2 Western blotting   
Transfer buffer: 1 x Tris-Glycine (TG), 0.01% SDS, 20% methanol 
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Proteins were transferred from SDS-PAGE gels to Protran nitrocellulose membrane 
(Whatman) for 2 hours to overnight at 100 mA using Biorad wet transfer apparatus for 
mini-gels. Transfer buffer with 2 x TG was used when detection of large proteins was 
required; routinely used for Cep152 and ATM phospho-Serine 1981 Western blots. 
 
Membranes were blocked for 30 minutes in 5% (w/v) non-fat powder milk in PBS-Tw 
(PBS + 0.1% Tween) at room temperature. Antibodies were prepared at dilutions 
indicated in table 9 in 5% milk in PBS-T unless stated otherwise. Membranes were 
incubated overnight at 4°C with primary antibodies, followed by 3 washes in PBS-Tw. 
Primary antibodies were detected using HRP-conjugated secondary antibodies (dilution 
indicated in Table) in 5% milk PBS-Tw. Membranes were washed 3 times and antibody 
complexes detected using ECL substrate (GE Healthcare), and visualised on Hyperfilm 
ECL (GE Healthcare). TBS-Tw (TBS, 0.1% Tween 20) was used for Western blotting 
with antibodies directed specifically against phosphorylated-protein antigens.  
 
Membrane stripping and re-probing:   
For re-probing membranes, bound antibodies were removed by incubation with 
stripping buffer (100mM ß-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl, pH6.7) for 
10 minutes at 55°C. The membranes were washed three times for 10 minutes in PBS-
Tw, followed by blocking and probing as described above.  
 
2.4.3 Preparation of cell lysates for Western blot 
Cells were washed in PBS, collected in 5 ml PBS using a cell lifter (Corning) and 
collected by centrifugation. Cell pellets were resuspended in RIPA buffer plus either 
Complete or LPC protease inhibitors. Cells were incubated on ice for 5 minutes then 
sonicated for 10 seconds, three times. Insoluble material was collected by centrifugation 
at 16,000 x g and the resulting supernatant was retained. For analysis of histone proteins 
(phospho-histone H3 and ?H2AX) by Western blot, cells were lysed directly in 
Laemmli buffer, boiled and sonicated.  
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RIPA buffer: 150 mM NaCl, 1% Igepal, 0.1% SDS, 0.5% sodium deoxycholate in 
MilliQ water. 
 
2.4.4 Pull-down of tagged proteins from cell lysates 
Flag IP buffer: 50 mM Tris HCl, pH 7.4, 150 mM NaCl, 1 mMEDTA, 1% Triton X100 
Flag immuno-precipitations were carried out using anti-Flag M2 affinity gel (SIGMA 
A2220). All experiments were carried out according to the manufacturer’s instructions. 
Small-scale experiments for analysis by Western blot were carried out using one 10 cm 
plate and approximately 1 mg of total protein (whole cell lysates). Proteins were eluted 
by boiling the resin in Laemmli buffer. 
 
For large-scale experiments for analysis of Flag-Cep63 binding proteins by mass 
spectrometry, 20 litres of 293 Flag-Cep63 or Flag-Empty cells were used. This volume 
of cells (grown by cell services in suspension) gave 15 ml cell pellets. Cell pellets were 
resuspended in 50 ml Flag lysis buffer and sonicated 5 times for 1 minute on ice. The 
lysates was centrifuged in a Sorval centrifuge with the SS34 rotor at 16,000 x g for 30 
minutes at 4 °C. A Bradford assay was performed on the cleared cell lysates in order to 
equalise the amount of protein in the control and experimental samples; 1300 mg cell 
lysates was used for each sample. First the lysates was incubated with 500 μl protein A-
agarose beads for 1 hour at 4 °C with agitation. Agarose beads were pre-washed three 
times with 10 ml TBS. Agarose beads were removed by centrifugation at 500 x g and 
the supernatant was passed through a 10 ml column (Biorad) to remove residual beads . 
The resulting lysates was incubated with 500 μl of anti-Flag M2 resin for 4 hours at 4 
°C. Flag resin was washed 3 times with 10 ml TBS before use. Flag resin was then 
washed four times with 15 ml TBS 0.1% Triton X100, then 3 times with 15 ml TBS. 
Bound proteins were eluted in three elution steps, each with 500 μl of 0.5 mg/ml Flag 
peptide solution. For analysis by Western blotting; 5 μl of pre-cleared whole cell lysates 
and each elution fraction was mixed with Laemmli buffer and loaded on a SDS-PAGE 
gel. For mass spectrometry analysis 75 μl of each fraction was separated by SDS-PAGE 
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on a NuPAGE 4-12% Bis-Tris gel. The first elution fraction of each sample (Flag-
Empty and Flag-Cep63) was sent for mass spectrometry analysis. The gel was stained 
using Sypro Ruby (Invitrogen) and visualised with a fluorescence scanner. The resulting 
picture was printed and the gel aligned on a glass plate on top. The entire lane of each 
elution fraction was cut into approximate 1 mm bands and put in a 96-well plate and 
sent to the mass spectrometry facility (Mark Skehel, Protein Analysis & Proteomics, 
London Research Institute Clare Hall Laboratories). 
 
This protocol was repeated with cells incubated in the presence (or absence) of 0.2 
mg/ml Phleomycin for 2 hours before collection.  
 
2.4.5 Cell fractionation 
Solutions 
Sucrose buffer: 10 mM Hepes, pH 7.9, 340 mM sucrose, 3 mM CaCl2, 2 mM 
magnesium acetate, 0.1 mM EDTA. Add Complete protease inhibitors fresh. 
Nuclear Lysis buffer: 20 mM Hepes, pH 7.9, 150 mM KCl, 3 mM EDTA, 1.5 mM 
MgCl2, 10% glycerol. Add Complete protease inhibitors fresh. 
Nuclease Incubation buffer: 150 mM Hepes, pH 7.9, 1.5 mM MgCl2, 10% glycerol. 
All centrifugation steps were carried out in a bench top microcentrifuge at 4 °C. 
 
293 FlpIn cell lines stably expressing Flag-Empty or Flag-Cep63 (one 15 cm plate each) 
were trypsinised, washed in PBS and resuspended in 2 ml sucrose buffer + 0.5% Igepal 
and incubated on ice for 10 minutes. Nuclei were collected by centrifugation at 3,900 x 
g for 20 minutes. The resulting supernatant was removed and kept on ice (this was the 
cytoplasmic fraction). The nuclear pellet was resuspended in sucrose buffer without 
detergent, and then centrifuged at 3,900 x g for 20 minutes. The supernatant was 
discarded and pellets were resuspended in 1 ml nuclear lysis buffer and incubated on a 
rotating wheel at 4 °C for 30 minutes. Centrifugation was then carried out at 16,000 x g 
for 30 minutes and the supernatant was removed and kept as the nucleoplasmic fraction. 
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The insoluble pellet was incubated in 300 μl nuclease incubation buffer with 5 μl 
benzonase (25U/μl stock, Novagen) for 1 hour at room temperature. Insoluble material 
was then sedimented by centrifugation at 16,000 x g for 30 minutes and the supernatant 
was removed and kept as the chromatin fraction. Fractions were analysed by SDS-
PAGE and Western blotting. 
 
2.4.6 Centrosome preparation from cultured cells 
Purification of centrosomes from KE37 human lymphoblast cells was carried out using 
a protocol based on the paper Structural and Chemical Characterization of Isolated 
Centrosomes (Bornens et al., 1987). Centrifugation steps were carried out at 4 °C for 5 
minutes at 1,200 x g for all cell collection and washing steps and all other steps were 
carried out on ice with pre-chilled solutions. 
 
Solutions 
Lysis buffer: 1 mM Tris-HCl pH 8.0, 0.1% ?-mercaptoethanol, 0.5% Igepal, 0.5 mM 
MgCl2. Complete protease inhibitors added fresh. 
DNase incubation buffer: 0.5 M K-PIPES pH 7.2, 1 mM EDTA.  
Sucrose gradient buffer: 10 mM K-PIPES pH 7.2, 1 mM EDTA, 0.1% ?-
mercaptoethanol, 0.1% Triton X-100. 
 
2 x 108 KE37 cells were incubated for 1 hour in 0.2 μM nocodazole then collected by 
centrifugation. Cells were washed twice in 50 ml PBS and once in 8% sucrose in 10 
times diluted PBS. Cells were resuspended gently in 25 ml of lysis buffer by pipetting 
with a 10 ml pipette with a 2 mm hole. The tube was inverted 3 times and incubated for 
5 minutes. Swollen nuclei were sedimented at 1,200 x g for 10 minutes and the 
supernatant was filtered through a 70 μm Nylon cell strainer (BD Falcon). The filtered 
lysates was then incubated for 30 minutes with 600 U of benzonase in 0.5 ml DNase 
incubation buffer. The supernatant was then poured gently on top of a discontinuous 
sucrose gradient in a SW28 centrifuge tube (Beckman, Ultraclear) as follows: 3 ml 70% 
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(w/w) sucrose, 2 ml 50% sucrose and 4 ml 40% sucrose prepared in sucrose gradient 
buffer. Centrifugation was carried out at 26,000 rpm for 1 hour in an SW28 swing rotor 
in a Beckman Ultracentrifuge. The gradient was collected from the bottom using a 19-
gauge needle to pierce the tube and fractions were collected by hand. The first 1.5 ml 
were discarded and 15 x 0.5 ml fractions were collected subsequently. For Western blot 
analysis, 50 μl of each fraction was resuspended in 1 ml 10 mM K-PIPES pH 7.2 then 
centrifuged at 16,000 x g for 15 minutes at 4 °C. Liquid was removed and the remaining 
centrosome pellet (invisible) was resuspended in 20 μl 1 x Laemmli buffer. Samples 
were analysed by SDS-PAGE and Western blotting on a 10% Anderson gel. 
 
For immunofluorescence analysis 20 μl of each fraction was resuspended in 3 ml 10 
mM K-PIPES, pH 7.2 and centrifuged onto a poly-L-Lysine (0.01%, Sigma) coated 
glass coverslip at 20,000 x g for 10 minutes in a HB-6 swing rotor (Sorvall). Glass 
coverslips were positioned on top of a Perspex disc supported by a fixed solid support 
in modified 15 ml glass Corex tubes (homemade). Coverslips were removed and post-
fixed in -20 °C methanol and rehydrated with three 5 minute washes in PBS 0.1% 
Trition X100. Immunofluorescence was carried out as described for 
immunofluorescence of cultured cells. Typically, most centrosomes were found in 
fractions 5 and 6. 
 
Centrosome preparation from 3T3 MEFs was carried out using the solutions and the 
protocol described above, but the starting number of cells was 3 x 107 per sample. 
 
2.4.7 Analytical gel filtration of cell lysates 
Gel filtration was carried out using a Superdex 200 10/300 GL column (GE Healthcare) 
with eluent buffer (50 mM Phosphate buffer pH7.0, 150 mM NaCl). An AKTA FPLC 
(Amersham – now GE Healthcare – model UPC900) was used and set to a flow rate of 
0.5 ml/minute. A sample size of 500 μl was used. 
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Calibration was carried out using 500 μl Blue dextran (2 mg/ml). Elution was at 15 
minutes, which determined the void volume of the column as 7.5 ml. Protein standards 
(Sigma) were dissolved in 500 μl phosphate buffer at the following concentrations: 
Thyroglubulin 0.8 mg/ml and Albumin 1 mg/ml 
?-amylase 0.8 mg/ml and carbonic anhydrase 0.6 mg/ml 
Apoferritin 1 mg/ml and alcohol dehydrogenase 0.5 mg/ml 
Elution volume (Ve) was divided by void volume (V0) and a standard curve was drawn 
using semi-logarithm graph paper. 
 
Three 10 cm plates of 293 cells stably expressing YFP-Cep63 (clone 10) were 
trypsinised and the cytoplasmic fraction was prepared as described above. Before 
loading on the column, the salt concentration of the extract was adjusted to 150 mM 
NaCl. Ten mg was loaded in 500 μl. Fractions 1 to 6 were 1 ml and the subsequent 
fractions were 0.5 ml. Fractions 1 to 12 were analysed by SDS-PAGE; 10 μl of each 
fraction was loaded. Estimations of protein complex size were drawn from the standard 
curve. 
 
2.4.8 Antibodies   
Cep63 
Cep63 antibodies 47 and 49 were produced by Millipore. GST-tagged Cep63 (isoform 
b) was injected into rabbits and serum from the test bleeds and final bleeds were pooled 
and affinity purified using the recombinant protein. I generated the pDONR221-Cep63 
vector, and from here on Millipore carried out the protein expression and purification, 
and the immunisation of rabbits. I tested serum throughout the immunisation process 
and gave feedback to Millipore. Millipore then affinity purified (AP) the antibodies 
using recombinant GST-Cep63. 
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Millipore immunisation protocol 
Date   Procedure  
17-Nov-2009  Pre-Bleed  
17-Nov-2009  Injection  
08-Dec-2009  Injection  
29-Dec-2009  Injection  
19-Jan-2010  Injection  
01-Feb-2010  Bleed  
09-Feb-2010  Injection  
22-Feb-2010  Bleed  
25-Feb-2010  Bleed  
01-Mar-2010  Shipping  
02-Mar-2010  Injection  
09-Mar-2010  Bleed  
30-Mar-2010  Injection  
07-Apr-2010  Bleed  
12-Apr-2010  Bleed  
15-Apr-2010 Exsang  
 
Cep63 47AP and 49AP antibodies were used 1:1000 to 1:5000 for immunofluorescence 
and at the same dilutions for Western blotting. 
 
Cep152 
Cep152 antibody no. 9 was produced by immunisation of rabbits with peptides a and b 
(below) (Pettingill technology Ltd., PTL). Affinity purification was carried out using 5 
mg of a 1:1 mixture of peptides a and b conjugated to a Sulfolink column (Pierce). 10 
ml of final bleed serum was passed through the column. The column was then incubated 
with 5 ml of the serum for 4 hours at 4 °C with agitation, then the other 5 ml was 
incubated with the column overnight. The column was washed with 12 ml coupling 
buffer (Pierce) and antibody was eluted with 0.1 M Glycine-HCl, pH2.5. Eight 1 ml 
fractions were collected and each neutralised with 100 μl Tris-HCl, pH8.0. Cep152 
9AP4 (affinity purified fraction 4) was used at a dilution of 1:100 for Western blotting. 
Cep152 peptide a: CEYDEEDYEREKELQ (N-terminal peptide) 
C added for KLH (Keyhole Limpet Hemocyanin) conjugation. 
Cep152 peptide b: CGHPSRHKADRLKSDFKK (C-terminal peptide) 
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PTL 77 day rabbit immunisation protocol 
Day Date Technique 
0 26-Nov-09  Pre-bleed (10ml) + Immunisation in Complete Freunds 
Adjuvant 
14 10-Dec-09 Boost 1 in Incomplete Freunds Adjuvant 
28 24-Dec-09 Boost 2 in Incomplete Freunds Adjuvant 
35 31-Dec-09 TEST BLEED 1 (10ml) 
42 07-Jan-10 Boost 3 in Incomplete Freunds Adjuvant 
49 14-Jan-10 TEST BLEED 2 (10ml) 
56 21-Jan-10 Boost 4 in Incomplete Freunds Adjuvant 
63 28-Jan-10 TEST BLEED 3 (10ml) 
70 04-Feb-10 Boost 5 in Incomplete Freunds Adjuvant 
77 11-Feb-10 TERMINAL BLEED 
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2.4.9 Commercial Antibodies 
Primary antibody source company catalogue no. IF WB 
ATM PSer1981 rabbit Rockland 200-301-400  1:1000 
?-tubulin mouse SIGMA T6199 1:10,00
0 
1:10,000 
Cdk1 mouse Julian Gannon clone A17 1:500 1:1000 
Centrin 20H5 mouse Millipore 64-1624 1:500  
Centrin 2 rabbit Santa Cruz sc-27793-R 1:500  
Centrin 3 mouse abcam ab54531  1:1000 
Cep152-479 rabbit Bethyl A302-479A 1:1000 1:1000 
Cep152-480 rabbit Bethyl A302-480A   
Cep63 PTG rabbit PTG Lab  16268-1-AP  1:1000 
CPAP rabbit P. Gönczy gift 1:1000 1:1000 
Cyclin B mouse Julian Gannon V152  1:1000 
FLAG M2 AI mouse SIGMA F3165 1:1000 1:5000 
GFP rabbit Julian Gannon  1:1000 1:1000 
GFP mouse Roche 11814460001 1:1000 1:1000 
?-tubulin  mouse SIGMA T5326 1:10,00
0 
1:10,000 
?-tubulin rabbit SIGMA T3559 1:1000  
ninein rabbit Abcam ab4447 1:1000  
pericentrin rabbit Covance PRB-432C 1:1000  
Phospho-Chk1 Ser 345 rabbit Cell Signaling 2341  1:1000 
Phospho Histone H3 mouse Cell Signaling 9706 1:1000 1:1000 
Phospho histone H3 rabbit Upstate  06-570 1:1000 1:1000 
Phospho-p53 Ser15 rabbit Cell Signaling 9286  1:1000 
Phospho-(Ser/Thr) 
ATM/ATR Substrate 
rabbit Cell Signaling 2851  1:1000 
?-H2AX clone JBW301 mouse Millipore 05-636 1:1000 1:1000 
?-H2AX clone  rabbit Upstate 07-164 1:1000 1:1000 
SAS-6 mouse Santa Cruz 81431 1:1000 1:1000 
53BP1 rabbit Sigma  B4436 1:1000 1:1000 
Table 9 Commercial primary antibodies 
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Secondary antibody source  Company catalogue no. IF WB 
Alexa Fluor 488 anti-rabbit (H+L) goat Invitrogen A11008 1:400  
Alexa Fluor 488 anti-mouse IgG1 goat Invitrogen A21121 1:400  
Alexa Fluor 594 anti-rabbit (H+L) goat Invitrogen A11012 1:400  
Alexa Fluor 594 anti-mouse (H+L) goat Invitrogen A11005 1:400  
Alexa Fluor 350 anti-mouse (H+L) goat Invitrogen A21049 1:200  
anti-rabbit-HRP goat Dako P0448  1:10,000 
anti-mouse-HRP goat Dako P0447  1:10,000 
Table 10 Commercial secondary antibodies 
 
2.5 Xenopus laevis egg extract 
Xenopus laevis eggs were laid in MMR (see below) and extract was prepared in the 
absence of calcium ions in order to maintain the cytostatic factor (CSF) mediated arrest 
in metaphase of meiosis II.  
 
2.5.1 Solutions for making CSF extract 
10 x MMR: 1 M NaCl, 20 mM KCl, 10 mM MgCl2, 20 mM CaCl2, 1 mM EDTA, 50 
mM Hepes, pH 7.8. 
10 x XB: 0.1 M HEPES, pH 7.8, 0.5 M sucrose 
20 x salt solution: 2 M KCl, 0.1 M EGTA, 40 mM MgCl2  
10 x XB and 20 x salt solution were filter sterilised, kept at 4 °C and diluted on the day 
of use. 
50 x Energy mix: 375 mM creatine phosphate, 50 mM ATP, 10 mM EGTA, 50 mM 
MgCl2  
LPC Protease inhibitors: 30 mg/ml each of Leupeptin, pepstatin and chymostatin in 
DMSO. 
Cytochalasin B: 10 mg/ml in DMSO 
Energy mix, protease inhibitors and Cytochalasin B were aliquoted and stored at -20 °C. 
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2M sucrose for freezing extract: filtered and stored at 4 °C. 
 
Solutions to be made on the day of use (quantities for 2 lots of eggs): 
2% Cysteine solution: make 1 litre Cysteine in MilliQ water, adjust pH to 7.8 with 
NaOH. 
XB wash buffer: make 1 litre 1 x XB, 1 x salt solution in MilliQ water. Check pH is 7.8. 
Chill on ice before use. 
 
2.5.2 CSF extract preparation 
Eggs were laid and collected in MMR solution. All was steps were carried out at room 
temperature (approximately 22 °C); all centrifugations were carried out at 4 °C and all 
steps after crushing of the eggs were carried out on ice. During all wash steps care was 
taken not to pour solutions onto the eggs directly, but on the side of the beaker. White 
or miscoloured eggs were removed using a 1.5 ml Pasteur pipette during all wash steps 
as and when necessary. 
 
MMR solution was poured off and cysteine solution added to the eggs (approximately 
200 ml at a time). Cysteine washes were repeated 3 times and the total incubation time 
was not longer than 10 minutes, in most cases eggs were completely de-jellied in 5 
minutes. Eggs were then washed 3 times with XB wash buffer. XB wash buffer was 
then poured off and 14 μl of 10 mg/ml Cytochalasin B (in DMSO) and 14 μl of LPC 
protease inhibitors were added and the eggs were poured into a 15 ml polypropylene 
round-bottomed tube (Falcon 2059). Eggs were then packed by centrifuging for 1 
minute at 300 x g in a swing bucket rotor (rotor 4250, Beckman Allegra X-22R). Excess 
liquid on top of the packed eggs was removed and the eggs were crushed by 
centrifugation in a swing rotor at 22,500 x g for 20 minutes (Beckman; rotor JS 13.1 
12,000 rpm). The resulting cytoplasmic extract (middle golden yellow layer) was 
removed by puncturing the side of the tube with a 19-gauge needle and slowly 
removing the cytoplasmic layer with a 2 ml syringe. This extract was placed in a 5 ml 
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polypropylene round-bottomed tube (Falcon 2063). Energy mix was added (1:50 
dilution) and LPC and Cytochalasin B were added (1:1000 dilution). The extract was 
then mixed gently using a 1.5 ml Pasteur pipette and then centrifuged at the same 
conditions for a further 15 minutes. In order to fit the 5 ml tubes in the JS 13.1 rotor, 
they were placed inside a 15 ml Falcon tube with 1 ml water to act as a cushion. The 
resulting extract was also removed by needle and syringe as above, and the extract 
placed in a fresh tube ready for use. Extract was kept on ice until use and was incubated 
at 23 °C during assays.  
 
For long term storage the extract was mixed with 2 M sucrose (10% in the extract) and 
frozen in liquid N2 in 20 μl aliquots, which form small balls when added to the liquid 
N2. 
 
2.5.3 Checking the CSF arrest of egg extracts 
10 μl samples of extract were incubated at 20 °C with 3000 sperm nuclei per μl in the 
presence or absence of 0.4 mM CaCl2. At times 0, 20, 30, 45 and 60 minutes after 
calcium addition; 1 μl of each extract was taken and mixed with 1 μl fixative including 
Hoechst on a glass slide and a coverslip placed on top. Slides were then analysed with a 
fluorescence microscope. The sample without CaCl2 should contain mitotic shaped 
nuclei throughout the incubation, but extract activated with CaCl2 should start forming 
round nuclei with a nuclear membrane between 30 and 60 minutes.  
 
Fixative (1.5 ml): 0.5 ml EB buffer, 150 μl formaldehyde (37%), 3 μl Hoechst (1 
mg/ml), 0.75 ml  glycerol, up to 1.5 ml with ddH20. Stored at -20 °C. 
EB buffer: 100 mM KCl, 2.5 mM MgCl2, 50 mM Hepes pH 7.5.  
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2.5.4 Activation of ATM in CSF extract 
In order to activate ATM and the downstream DNA damage signalling cascade, 
including phosphorylation of XCep63, DNA double strand breaks were added to the 
extract. Poly A and poly T 70 nucleotide oligomers were annealed by denaturing at 95 
°C and gradual cooling of 5 °C every 5 minutes for 18 cycles. These pA/pT double 
stranded annealed oligos were stored at -20 °C and used at a concentration of 5 ng/μl in 
the extract. 
 
2.5.5 MBP-protein pull down assays in Xenopus CSF extract 
MBP-XCep152 pull-down 
Amylose resin was washed 3 times with EB buffer, then 75 μl packed resin was 
incubated with approximately 5 μg MBP or MBP-XCep152 in 500 μl EB on a rotating 
wheel at 4 °C for 2 hours. Resin was then washed 3 times with EB + 0.25% Igepal then 
3 times with EB. Packed resin bound to MBP or MBP-XCep152 (25 μl per sample) was 
then incubated with CSF containing either 35S-labelled XCep63 or 35S Luciferase. For 
each reaction, 150 μl of CSF plus 15 μl TNT reaction mix was used. Another set of 
MBP or MBP-XCep152 bound resin was incubated with 10 μl of the TNT mix without 
extract, diluted to 200 μl in EB buffer. Samples were incubated with gentle agitation for 
1 hour at 4 °C. Resin was then washed 6 times with PBS + 0.25% Igepal. All proteins 
were eluted by boiling the amylose resin in Laemmli buffer for 2 minutes. All 
centrifugation steps were carried out at 100 x g in a bench top microcentrifuge at 4 °C. 
TNT reactions were set up as described previously (2.3.2). Samples were separated by 
SDS-PAGE on a 10% Anderson gel. The gel was then dried and an autoradiography 
film was exposed to the gel overnight to detect 35S-labelled proteins. 
For interaction studies using phosphorylated XCep63, the procedure was carried out as 
outlined above, but extract was first incubated with the TNT mix containing XCep63 
and 5 ng/μl pA/pT for 15 minutes at 22 °C. 
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2.6 Cell culture 
HeLa, HeLa Kyoto, U2OS and 293 FlpIn cells (Invitrogen) were obtained from the 
London Research Institute Cell Services and were grown in DMEM (+ 4.5 g/l glucose + 
Glutamine + Pyruvate, GIBCO) with 10% foetal bovine serum (FBS, PAA Laboratories 
GmbH) heat inactivated by incubation at 56 °C for 30 minutes. A trypsin and versene 
mixture was used to detach cells from cell culture plates. The mixture was obtained 
from LRI cell services and diluted 1 in 5 in PBS before use. Cells were washed in PBS, 
then incubated in 1 x trypsin/versene for 5 to 10 minutes then collected in pre-warmed 
growth medium. Cells were collected by centrifugation for 5 minutes at 300 x g and 
resuspended in medium and diluted appropriately. Cells were counted using an 
improved Neuberger haemocytometer. 
 
5 x Trypsin/Versene (1 litre): Trypsin 2.5 g, NaCl 8.0 g, Na2HPO4 1.15 g, KH2PO4 0.2 
g, Versene (EDTA) 1.0 g, Phenol Red (1%) 1.5 ml, Double distilled water (ddH2O) to 1 
litre. The pH of the solution was then adjusted to 7.2 using NaOH and aliquots were 
stored at -20 °C. 
 
The U2OS GFP-Centrin 1 stable cell line was obtained from Stefan Duensing 
(University of Pittsburgh Cancer Institute) with the permission of Michel Bornens 
(CNRS-Institut Curie). U2OS cells expressing HA-Plk2 under a tetracycline regulated 
(Tet-off) promoter were obtained from Ingrid Hoffmann (DKFZ, Heidelberg). U2OS 
HA-Plk2 cells were grown in DMEM low glucose (1 g/l glucose, Gibco) with 10% heat 
inactivated FBS and 2 μg/ml doxycyline. For induction of HA-Plk2 expression cells 
were trypsinised and resuspended in tetracycline and doxycycline-free medium 
containing 10% certified tetracycline-free FBS (PAA Laboratories GmbH). 
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2.6.1 Freezing cells for storage 
Cells were frozen down for long term storage by trypsinisation of a 70% confluent 10 
cm plate with 1 ml trypsin and resuspension in 4 ml of 10% DMSO in FCS. The 
resulting 5 ml was split between 4 cryo-tubes and the tubes were wrapped in thick 
layered tissue paper and kept at – 80 °C. Cells were kept at – 80 °C for at least 3 days 
before being moved to a liquid nitrogen storage tank. 
 
Cells were thawed in a 37 °C water bath then mixed drop wise with 5 ml pre-warmed 
culture medium. Cells were collected by centrifugation and gently resuspended in 
culture medium and plated in a 10 cm plate. The medium was changed approximately 
12 hours after plating. 
 
2.6.2 Generation of stable cell lines 
HeLa Kyoto cells stably expressing either GFP or GFP-Cep63 were generated by 
transfection with pIRES(puro3)-GFP-Flag (Empty vector) or (Cep63) using Effectene 
transfection reagent (Qiagen). For each 10 cm tissue culture plate transfected, 2 μg 
plasmid DNA and 60 μl Effectene. Transfection complexes were removed the day after 
transfection and selection with puromycin was started 2 days after transfection. Cells 
were maintained in 0.3 μg/ml puromycin for 2 weeks, by which time untransfected 
control cells were dead. Clones were generated by trypsinisation and isolation of 
individual colonies using cloning rings. Cells were maintained in medium containing 
puromycin throughout. 
 
293 FlpIn stable cell lines expressing Flag or YFP tagged proteins were generated by 
transfecting pDestFRT/TO vectors with the pOGG44 recombinase vector. For each 10 
cm tissue culture plate a total of 6 μg of DNA was transfected with 18 μl Fugene 
transfection reagent. A ratio of 3:1 pcDNA5 Dest FRT/TO Flag-Cep63 to pOG44 was 
used (i.e. 4.5 μg Flag-Cep63 and 1.5 μg pOG44 per plate). Cells with integrated Flag-
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Cep63 were selected using 100 μg/ml Hygromycin B (Roche) 3 days after transfection. 
Clones were isolated by diluting cells to a density of 1 cell per 200 μl medium and 
plating 100 μl per well in a 96-well plate. 
 
2.6.3 RNA interference (RNAi) 
Transfection of siRNAs was carried out using Lipofectamine RNAiMax (Invitrogen). 
For RNAi of Cep63 and Cep152 siRNAs were transfected at a concentration of 50 nM 
using 7.5 μl RNAiMax reagent and 0.5 ml Optimem (Invitrogen) per well in a 6-well 
plate (total volume of medium and transfection complexes was 2.5 ml per well). First a 
reverse transfection was carried out, where cells were collected by trypsinisation and 
plated on top of transfection complexes. After 24 hours, a second transfection was 
carried out by adding transfection complexes to the cells on the plate (forwards 
transfection). For RNAi of Cep63 or Cep152, cells were collected 4 days after the first 
transfection unless otherwise stated.  
Target gene Target Sequence Company Name 
Cep63 GAGUUACAUCAGCGAGAUA 63-1 
Cep63 CGUCAGAAAUCGCUGGACU 
Dharmacon  
On-Target plus 
63-2 
Cep63 GGAGUCAGUUGGAUGUGACACAUAA Invitrogen 63-3 
Cep152 GAGCAAGAUUACCGGCAAU 152-1 
Cep152 AAAUGAAAGUGAACGUCAA 152-2 
Cep152 GCAUUGAGGUUGAGACUAA 152-3 
Cep152 GACCAGAGUCGUAGAGAAU 
Dharmacon 
On-Target plus 
152-4 
Control  Medium GC content Invitrogen  Control 
Mad2 HSS106243 Invitrogen  Mad2 
Table 11 siRNA sequences 
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2.6.4 Reduplication assays 
First, U2OS cells were transfected with siRNAs as described above. At the time of the 
second transfection 1.9 μg/ml Aphidicolin was added to the medium and cells were 
collected 3 days later. Reduplication assays carried out using hydroxyurea (HU) were 
carried out as described, but with 2 mM or 4 mM HU in place of Aphidicolin. HU 
powder (Sigma) was dissolved in water to a concentration of 1 M, fresh before each 
use. Aphidicolin powder (Sigma) was dissolved in DMSO to a concentration of 5 
mg/ml and stored in aliquots at -20 °C. 
 
2.6.5 Cell synchronisation 
Double thymidine block for HeLa Kyoto cells was carried out as follows: 
• 2.5 mM thymidine (Sigma) 23 hours 
• Release 8 hours 
• 2.5 mM thymidine 14 hours 
• Release and collect samples at varying time points 
 
Mouse embryonic fibroblasts (MEFs) were incubated with 100 ng/ml nocodazole 
(Sigma) for 7 hours then released in the presence of 10 μM MG132 (proteasome 
inhibitor, Calbiochem) for 1 hour to enrich the percentage of mitotic cells. 
 
All drugs were washed out using one wash with PBS followed by two washes with 
medium. Nocodazole powder was dissolved in DMSO to a stock concentration of 10 
mg/ml and kept at 4 °C. MG132 was purchased in solution (DMSO 1 mg/ml). 
Thymidine powder was dissolved in Optimem medium (Gibco) to a stock concentration 
of 100 mM and stored at -20 °C. 
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2.6.6 DNA damaging agents for cell culture 
Cells were irradiated using a Caesium 137 irradiator with 2Gy or 10 Gy as indicated. 
UV irradiation was carried out using a Stratalinker  (Stratagene): cells were first washed 
with PBS and PBS was removed before irradiation. Phleomycin was used at a final 
concentration of 100 μg/ml in culture medium. Cells were incubated with Phleomycin 
for one hour, then the drug was washed out and cells were collected 1 hour later. 
 
2.7 Fluorescence activated cell sorting (FACS) 
All FACS analyses were carried out by the LRI FACS laboratory (Head of Department: 
Derek Davies). Cells were collected by trypsinisation, resuspended in complete medium 
and centrifuged to collect the cell pellet. Cells were then washed in PBS, collected by 
centrifugation then resuspended by drop wise addition of ice cold 70% ethanol while 
vortexing. The subsequent steps were carried out by cell services: for analysis of DNA 
content, cells were first treated with ribonuclease (100 μg/ml) then stained with 50 
μg/ml propidium iodide (PI).  
 
For quantification of mitotic index, cells were stained with phospho-histone H3 (Serine 
10) antibody (Cell Signaling) and an anti-mouse fluorescent secondary antibody, as 
follows.  After fixation in ethanol cells were washed twice in PBS then permeabilised in 
blocking solution (PBS, 0.1% BSA, 0.2% Tween20) for 15 minutes at room 
temperature. Cells were then collected and resuspended in 50 μl of phospho-H3 
antibody diluted 1:1000 in the above blocking solution. Cells were then washed in 
blocking solution then incubated with a secondary anti-mouse red fluorescent antibody 
for 30 minutes at room temperature. Cells were then washed in PBS, treated with 
ribonuclease and stained with PI, as above. 
 
Samples were analysed using a FACScan or FACSCalibur analytical cytometer (Becton 
Dickinson). 
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2.8 Immunofluorescence 
12 mm diameter glass coverslips were washed in 70% ethanol then PBS then added to 
tissue culture plates and washed with medium before plating cells. Upon collection 
coverslips were washed in 37 °C PBS, 1 mM EGTA then fixed in -20 °C Methanol for 
30 minutes minimum. Cells were then rehydrated by 3 washes with PBS 0.01% Triton 
X100 (TX). Permeabilisation was carried out with a 20 minute incubation in PBS 0.2% 
TX, then coverslips were washed 3 times, each for 5 minutes, with PBS-0.01% TX. 
Blocking was carried out at room temperature for 30 minutes in PBS, 1% BSA, 2% HI 
FCS. All antibody incubations were also carried out with antibodies diluted in this 
blocking solution. Primary antibody incubations were either carried out at room 
temperature for 1 hour or overnight at 4 °C. Coverslips were inverted onto a 100 μl drop 
of primary antibody solution on parafilm and the incubation was carried out in a wet 
chamber. After primary antibody incubation coverslips were rinsed once with PBS-
0.01% TX then washed 3 times for 5 minutes with PBS-0.01% TX. Secondary antibody 
incubations were carried out as for primary incubations, but at room temperature for 30 
minutes. Washes were carried out as above and for samples with DAPI staining, an 
additional 5 minute incubation in 0.1 μg/ml DAPI in PBS 0.01% TX was carried out. 
Coverslips were then rinsed in PBS then ddH2O before mounting on pre-cleaned glass 
slides with Vectashield (Vector Laboratories). Coverslips were sealed with nail varnish. 
GFP and YFP fusion proteins were viewed by direct fluorescence unless indicated 
otherwise. 
 
2.8.1 Co-staining Cep63 and Centrin-2 
For immunofluorescence using both Cep63 and Centrin-2 antibodies (both rabbit) 
coverslips were first incubated with anti-Centrin-2 (1:500 dilution) overnight at 4 °C. 
Coverslips were then washed 3 times for 5 minutes with PBS-0.01% TX and incubated 
with Alexa Fluor (AF) 594 anti-rabbit secondary antibody (1:400) for 30 minutes. 
Coverslips were then washed extensively (minimum 10 washes) in PBS-0.01% TX then 
incubated with anti-Cep63 49AP (1:5000) for 1 hour; if a mouse antibody was also 
used, it was included during this incubation; washed 3 times in PBS-0.01% TX then 
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incubated in AF488 anti-rabbit (1:1000) for 30 minutes. Final wash steps and mounting 
were carried out as above. 
 
2.9 Microscopy 
All microscopy was carried out using a Delta Vision RT inverted fluorescence 
microscope with Softworx software, unless stated otherwise. For all experiments 
requiring the visualisation of centrosomes, an Olympus UPlanSApo 100 x/1.4 oil 
objective was used. A COOLSNAPHQ / ICX285 CCD camera was used. Z-stacks were 
acquired at 0.2 μm intervals and z-stacks were then projected by maximum intensity to 
a flat image. Deconvolution was performed using Softworx with the “enhanced ratio 
(aggressive)” setting and noise filtering set to medium for 10 cycles. Deconvolution was 
not carried out for all pictures and is indicated in the figure legends. 
Fluorescence filters: 
DAPI   Excitation 360 nm Emission 457 nm 
FITC  Excitation 490 nm Emission 528 nm 
RD-TR-PE   Excitation 555 nm Emission 617 nm 
Softworx data inspector was used to measure fluorescence intensities. A circle of 20 x 
20 pixels was used to measure fluorescence intensities at the centrosome. Fluorescence 
intensities were measured as a ratio; relative to the intensity of ?-tubulin staining. Local 
background was subtracted. Measurements were taken from the flattened R3D files 
without deconvolution. 
 
Live cell images in figure 18 (chapter 3) were taken with a Zeiss Axiovert 200M 
microscope with a Zeiss 10 x Ph1 Plan Neo FL objective using an Axiocam MRm 
camera and Axiovision 3.1 software. Pictures were collected for one z position only. 
Pictures in figure 46 (chapter 4) were taken with a Zeiss Axio Imager M2 microscope 
with a Zeiss Plan Apochrome 63 x objective and a Hamamatsu digital camera 
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(C10600), using Volocity software. Images of primary MEFs in figures 66 and 68 
(chapter 5) were taken using a Leica microscope in Dr Travis Stracker’s lab. 
 
Time-lapse microscopy in figure 53 (chapter 4) was carried out using a Zeiss Axio 
Observer Z1 microscope with a Zeiss 10 x objective, Hamamatsu digital camera 
(C8484), a motorised Nanodrive stage and Simple PCI 6 software. Cells were grown in 
a 6-well plastic tissue culture plate in CO2 medium without phenol red and 10% HI 
FCS. Cells were kept at 37 °C throughout imaging. Images were taken in 9 different 
fields: 3 field for each different RNAi treatment and pictures were taken every 5 
minutes at one z position only. 
 
2.10 Mass spectrometry 
Mass spectrometry was carried out on gel slices form Flag-Cep63 pull down elutes (as 
described previously).  Liquid chromatography mass spectrometry was carried out by 
the Protein Analysis & Proteomics laboratory at London Research Institute Clare Hall 
Laboratories, headed by Dr Mark Skehel. 
 
Polyacrylamide gel slices (1-2 mm) containing the purified proteins were prepared for 
mass spectrometric analysis using the Janus liquid handling system (PerkinElmer, UK).   
Briefly, the excised protein gel pieces were placed in a well of a 96-well microtitre plate 
and destained with 50% v/v acetonitrile and 50 mM ammonium bicarbonate, reduced 
with 10 mM DTT, and alkylated with 55 mM iodoacetamide.   After alkylation, proteins 
were digested with 6 ng/?L Trypsin (Promega, UK) overnight at 37 °C.   The resulting 
peptides were extracted in 2% v/v formic acid, 2% v/v acetonitrile.   The digest was 
analysed by nano-scale capillary LC-MS/MS using a nanoAcquity UPLC (Waters, UK) 
to deliver a flow of approximately 300 nL/min.  A C18 Symmetry 5 ?m, 180 ?m x 20 
mm ?-Precolumn (Waters, UK), trapped the peptides prior to separation on a C18 
BEH130 1.7 ?m, 75 ?m x 100 mm analytical UPLC column (Waters, UK). Peptides 
were eluted with a gradient of acetonitrile.  The analytical column outlet was directly 
interfaced via a modified nano-flow electrospray ionisation source, with a hybrid linear 
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quadrupole fourier transform mass spectrometer (LTQ Orbitrap XL/ETD, 
ThermoScientific, San Jose, USA).  Data dependent analysis was carried out, using a 
resolution of 30,000 for the full MS spectrum, followed by eight MS/MS spectra in the 
linear ion trap.  MS spectra were collected with an automatic target gain control of 
5x105 and a maximum injection fill time of 100 ms over a m/z range of 300–2000.  
MS/MS scans were collected using an automatic gain control value of 4x104 and a 
threshold energy of 35 for collision induced dissociation.  LC-MS/MS data were then 
searched against a protein database (UniProt KB) using the Mascot search engine 
programme (Matrix Science, UK) (Perkins et al., 1999).  Database search parameters 
were set with a precursor tolerance of 5 ppm and a fragment ion mass tolerance of 0.8 
Da.  One missed enzyme cleavage was allowed and variable modifications for oxidized 
methionine, carbamidomethyl cysteine, pyroglutamic acid, phosphorylated serine, 
threonine and tyrosine were included.  MS/MS data were validated using the Scaffold 
programme (Proteome Software Inc., USA) (Keller et al., 2002).  All data were 
additionally interrogated manually.  
 
2.11 Mouse Techniques 
2.11.1 Cep63 gene trap targeting construct 
ES cells containing a gene trap between exons 1 and 2 of the Cep63 gene were 
purchased from EUCOMM (European Conditional Mouse Mutagenesis Program; 
Cep63 MGI 2158560; clone ID EUCE0251_H11). This was a clone that has lost its 3’ 
LoxP site and is consequently not conditional. The structure of the gene trap construct is 
outlined below. 
 
 
The 5’ homology arm, or sequence tag, is in the intron following Exon1 and the 3’ 
sequence tag is in the intron before Exon2. 
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5’ sequence tag (5’ to 3’): 
TAGTATGAGAGGTGCGGAAATGTGGCGGGAACCCCTGATGGCAGGGGAATTGCAGATGGCTTCACGCTTT
CAAGTCAAGCATAGGAAACAAGATTGGTGGAGTGAAAGTTTGGAAAGGGGAATTCCACAACAGCGCTTTC
ACGCGGAGACACTTGACAGTGAATGGGCTTTTGTCCTTTACAAAATCGTGGAGTTAGTGCATTCTGATGT
CAGACCTAGTTTTCATTTACAGACTGTAGACTTGTTGCCAAAAGTGCTCCCCATTCTCCCCAACT 
3’ sequence tag (5’ to 3’): 
GCTATGATCTGGAACTTGCAGTGTAGACCAGGCTGGCCTCAAACTCAGAGATGGGCCTACCTATGTCTCC
TAATTAAGGATCCGCGCCACCTCGCCTGGCTTTCTTGAGGCCAATTTAGAGTTTCAAAAATGTATTACTT
TATTATAGCTCTTTGTACAACTCGAATATTTGTATTTTATATTTTGTATGTAAGTCAGAGATCAATGGCT
ATAGTTATCTT 
 
2.11.2 ES cell culture 
E14 Medium:  
500 ml Knockout™ DMEM (Gibco 10829) 
50 ml FBS (PAA Laboratories GmbH)   
5 ml 100X L-Glutamine (Gibco)  
5 ml 100X beta-mercaptoethanol (360 microliters/500 ml PBS; filtered, stored at -20°C)  
Murine LIF (Leukemia inhibitory factor, ESGRO, Millipore ESG1107, dilute 1000 x)   
 
Freezing Medium:  Add dimethylsulphoxide (DMSO) (Sigma # D2650) to E14 medium 
to a final concentration of 10% (v/v)  and filter sterilise.  Make fresh before use.  
PBS: Dulbecco’s phosphate-buffered saline (PBS) without calcium and magnesium 
(Invitrogen # 14190-094)  
Trypsin: 500ml PBS (Gibco), add 0.1g EDTA and 0.5g D-glucose. Filter sterilize (0.22 
?m).  Add 5ml Chicken Serum (Gibco), 10ml 2.5% Trypsin (Gibco), and store in 20 ml 
aliquots at -20°C   
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Tissue culture plates were coated with gelatin before use by adding a 0.1% solution of 
gelatin in sterile water (2% gelatin stock, Sigma) at least 10 minutes then aspirating the 
liquid off before plating cells. ES cells were grown in E14 medium at 37 °C and 5% 
CO2. Initially, cells were brought up in the LRI Transgenics Unit in a mycoplasma-free 
facility and early passage cells were frozen for microinjection and sent to Dr Travis 
Stracker (IRB, Barcelona). 
 
2.11.3 Checking ES cells for gene trap insertion 
Confirmation of gene trap position by PCR 
Genomic DNA from Cep63 gene trap (gt) ES cells or wild type (wt) ES cells was 
extracted using a genomic DNA extraction kit (Qiagen). PCR reactions were carried 
with Simple Red Taq polymerase using 100 ng of genomic DNA as a template and the 
primers listed below. 
Name Sequence product size (bp) 
Ms C63 5'P1 AACCGACCGCATGCCCCAAAGAC 1532 
Ms C63 5'P2 GTAGGACCAGGCCTTAGCGTTAG 1225 
Ms C63 5'P3 CAGGTGCTTCGGCCTGCGGGAG 1314 
B32 CAAGGCGATTAAGTTGGGTAACG reverse primer in gt 
Ms C63 3'P4 TGGTGGCGCACGCCTTTAATC 1931 
Ms C63 3'P5 TGAAACTTCAGCATATACAC 2164 
Ms C63 3'P6 CAATTCATTGCTGTAGTCTG 3433 
GT 2 GGGAGGATTGGGAAGACAAT forwards primer in gt 
Table 12 Mouse Cep63 gene-trap PCR primers 
 
The 5’ Cep63 forward primers were used in combination with the B32 reverse primer 
whose binding sequence is in the ?-galactosidase gene of the gene trap. The 3’ Cep63 
reverse primers were used with the GT2 forwards primer whose binding sequence is in 
the 3’ end of the gene trap. 
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2.11.4 Southern blotting  
Southern blotting was used on genomic DNA digests from wt and gt ES cells in order to 
confirm that the targeting construct was only inserted in one location. 
Solutions 
Alkaline transfer buffer: 0.4 N NaOH, 1.5 M NaCl 
Neutralisation buffer: 0.5 M Tris-HCl pH 7.2, 1 M NaCl 
Pre-hybridisation buffer: 45% formamide, 4 x SSC, 100 mM sodium phosphate, pH 
6.5, 10 x Denhardt’s solution (Sigma), 2% SDS, 0.25 mg/ml Herring sperm DNA 
(Sigma). 
Hybridisation buffer: 45% formamide, 4 x SSC, 100 mM sodium phosphate, pH 6.5, 1 x 
Denhardt’s solution, 0.4% SDS, 0.1 mg/ml Herring sperm DNA, 10% Dextran sulphate 
and 32P ?- dATP labelled probe. 
Wash solution: 0.1 x SSC, 0.1% SDS 
20 x SSC: 175.32 g/l NaCl, 88.25 g/l Tri-sodium Citrate   
 
Genomic DNA was extracted from ES cells and 10 μg was used per reaction; with 5 
U/μl ApaI, DraI or NcoI restriction enzymes. DNA digests were incubated overnight at 
the appropriate reaction conditions in a total of 50 μl. The resulting DNA fragments 
were separated by electrophoresis on a 0.7% agarose gel without ethidium bromide. 
Electrophoresis was carried out at 60 V for 11 hours and the gel was post-stained with 
ethidium bromide to visualise DNA by UV light. The DNA fragments were transferred 
by chromatography overnight to a Hybond N+ membrane (positively charged nylon 
membrane, Amersham – now GE Healthcare) using alkaline buffer. The membrane was 
then incubated in neutralisation buffer for 15 minutes at room temperature, then pre-
hybridisation buffer for 7 hours at 42 °C; all membrane incubations were carried out in 
a sealed glass tube on a rotating rack in a hybridisation oven. Hybridisation was carried 
out at 42 °C overnight in hybridisation buffer containing a radio-labelled DNA probe 
(see below). The membrane was washed at 48 °C using 8 volumes of pre-warmed was 
Chapter 2. Materials and Methods 
115 
solution. The membrane was then wrapped in Saran wrap and exposed to 
autoradiography film (GE Healthcare) at – 80 °C for one week. 
 
2.11.5 Generating a probe for Southern blotting 
Vectors B1 and SK+Tag3 (from Ian Rosewell, LRI Transgenics Unit) were digested 
with BamHI and PstI respectively to isolate a 1 kb (B1) and 780 bp and 200 bp 
fragments (SK+) that code for the Neomycin resistance gene. The digest was carried out 
using 2 μg vector DNA. DNA fragments were separated by agarose gel electrophoresis 
and once separated the bands were visualised a square of agarose gel was removed from 
in front of the band of interest and this hole was filled with 0.5 % low melting point 
agarose (Seaplaque, Lonza). The gel was put back in the electrophoresis chamber and 
run until the band of interest was in the low melting point agarose square. This agarose 
was then cut from the gel and boiled for 5 minutes with 100 μl ddH2O then placed 
immediately on ice; 10 μl of this DNA solution was used per 50 μl Prime-It random 
primer labelling reaction (Stratagene). The reaction was carried out as per 
manufacturer’s instructions using 5 μl ?-32P dATP (Easytides, Perkin Elmer) to label 
the DNA probe. The reaction was carried out at 37 °C for 30 minutes, then 2 μl stop 
mix (Stratagene) was added and DNA was purified by passing through a G25 column 
(GE Healthcare). The probe was then boiled and added directly to the warmed 
hybridisation solution. 
 
2.11.6 Generation of mouse embryo fibroblasts (MEFs) 
MEF media 
DMEM high glucose (Gibco, Invitrogen) 
1X glutamax (Gibco, 100X stock) 
15% Fetal bovine serum (Hyclone) 
Penicillin/Streptomycin (100X stock, Gibco) 
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All breeding and MEF generation was carried out by Dr Travis Stracker (IRB, 
Barcelona). 
Breeding animals were set up and plugs were checked the following morning.  (Before 
10 am is optimal). Plugged females were separated and sacrificed at day E13.1 using 
CO2 asphyxiation in animal facility. Embryo sacs were dissected out in a tissue culture 
hood and transfer to PBS, as follows: 
• Use sterile scissors and tweezers for incision of each skin layer. 
• Tease apart yolk sacs to release the embryos and carefully transfer to fresh 
sterile PBS. 
• Using tweezers, remove the tail and transfer to an eppendorf tube for 
genotyping. 
• Remove all of the red tissue (heart, liver, spleen) delicately with tweezers. 
The embryos were then transferred to 5 ml cold trypsin-EDTA overnight then incubated 
at 37 °C for 20 minutes to digest tissue. Excess trypsin was removed and the tissue was 
homogenised by pipetting with fresh media. Large tissue pieces were left to settle for 3 
minutes and the remainder was plated to three 10 cm cell culture plates. The following 
day, cells were washed twice with PBS to remove non-fibroblast cells and debris. The 
3T3 protocol was carried out by plating 1 million cells to a 10 cm plate. Early passage 
cells were frozen in 10% DMSO, 50% FBS, 40% MEF media. Genotyping of embryos 
was carried out by Travis Stracker. Primary cells and 3T3 cells were split every two to 
three days to 0.5 x 106 cells per 10 cm plate or 1.8 x 105 per 60 mm plate.
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Chapter 3. Cep63 is a constitutive centrosome 
protein that interacts with Cep152 
The aim of this project was to characterise the human Cep63 protein, herein referred to 
as Cep63. Cep63 was originally identified as a centrosome protein in a centrosome 
purification and mass spectrometry screen to identify novel components (Andersen et 
al., 2003). Previous work carried out in the Costanzo lab confirmed that Xenopus laevis 
and chicken Cep63 also localise to the centrosome (Smith et al., 2009).  Although 
extensive work has been carried out on XCep63 in Xenopus laevis cell free extract as 
described in introduction 1.4, the function and characteristics of the human protein were 
unknown. Firstly, localisation of exogenous Cep63 to the centrosome when expressed 
in human cell lines was confirmed. Secondly, in order to determine the function of 
Cep63, a biochemical approach was used to identify Cep63 binding partners by mass 
spectrometry. 
 
3.1 Exogenous Cep63 localises to the centrosome throughout 
the cell cycle 
Human embryonic kidney cell lines (293) were generated stably expressing Flag-tagged 
Cep63 using the FlpIn system from Invitrogen (figure 17). 293 FlpIn cells from 
Invitrogen include only one copy of an FRT recombinase site in the genome. 293 FlpIn 
cells were transfected with Flag-Cep63 or YFP-Cep63 vectors containing the FRT sites, 
along with a vector containing the recombinase enzyme and carried out antibiotic 
selection to isolate positive clones. Flag or YFP vectors with no insert (empty) were 
used as negative controls for all experiments. Both Flag-Cep63 and YFP-Cep63 co-
localised with centrosome components ?-tubulin and pericentrin (figure 17 and 18). 
Flag-Cep63 was visualised using an anti-Flag antibody, which stained centrosomes in 
293 Flag-Cep63 cells, but not in Flag-Empty 293 cells, indicating that centrosomal 
staining with the Flag antibody was due to detection of Flag-Cep63, rather than the Flag 
antibody recognising a centrosome epitope. YFP-Cep63 was observed by direct 
fluorescence in fixed cells (figure 18a and c) and live cells (figure 18d), to confirm that 
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Cep63 localisation was not affected by the fixation process. Positive clones were 
identified by checking for localisation of the tag (Flag or YFP) at the centrosome and 
checking for the presence of tagged-Cep63 at the appropriate size on Western blots of 
whole cell lysates. Examples of positive Flag and YFP clones are shown in figure 17 
and 18 respectively. Flag-Cep63 migrated to approximately 63 kDa and YFP-Cep63 to 
around 90 kDa on SDS-PAGE gels (figures 17b and 18b). Flag-Cep63 293 stable clones 
expressed less Flag-Cep63 than 293 cells collected one day after transfection, which 
was likely due to the stable clones containing only one copy of the expression construct 
per genome (figure 17, loading control not shown but equal loading was confirmed by 
Ponceau staining of the membrane). Cells that were not selected for stable integration of 
the construct were likely to contain multiple expression constructs per cell, which 
would lead to higher expression levels. 
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Figure 17 Flag-Cep63 localises to the centrosome 
(A) 293 FlpIn cells stably expressing Flag-Cep63. Flag-Cep63 293 cells (pool of cells 
after antibiotic selection) fixed and stained with anti-Flag M2 antibody and DAPI. (B) 
Western blot of 293 cell lysates, separated by SDS-PAGE on a 10% gel, with anti-Flag 
M2 antibody. 293 cells transiently expressing Flag or Flag-Cep63 and collected after 24 
hours (first two lanes) were used for comparison with Flag and Flag-Cep63 293 stable 
clones. (C) Flag-Cep63 or Flag-Empty 293 cells (clones) fixed and stained with anti-
Flag M2 (green) and anti-pericentrin (red) antibodies and DAPI (blue). Small panels 
show the boxed region enlarged three times (C). Images are maximum projections of 
deconvolved z-sections. 
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Figure 18 YFP-Cep63 localisation at the centrosome 
(A) 293 FlpIn cells stably expressing YFP-Cep63. YFP-Cep63 cells (pool of cells after 
selection) were fixed and stained with DAPI. (B) Western blot of 293 YFP and YFP-
Cep63 stable cell lysates separated by SDS-PAGE on a 15% gel and blotted with anti-
GFP antibody. (C) YFP-Cep63 293 cells stained with DAPI (blue) and anti-pericentrin 
or anti-?-tubulin (red). Lower panels are enlargements of the boxed areas. Images are 
maximum projections of deconvolved z-sections. (D) Images of YFP-Cep63 293 live 
cells incubated with Hoechst: two images were taken in quick succession with the blue 
filter (to visualise Hoechst) and the green filter (to visualise YFP). YFP-Cep63 localises 
to the centrosome in interphase and mitotic cells. Live cell images show only one focal 
plane without deconvolution. 
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To examine the subcellular localisation of YFP-Cep63, cell fractionation of 293 YFP-
Cep63 cells was performed. Fractionation experiments showed that YFP-Cep63 was 
cytoplasmic, as would be expected for a centrosome protein (figure 19a). Gel filtration 
of 293 YFP-Cep63 cell lysates showed that the elution peak of YFP-Cep63 (fraction 4) 
partially overlapped with the elution peaks of known centrosome components ?-tubulin 
and Centrin-3 (fraction 3, figure 19b). 
 
 
 
 
 
Figure 19 YFP-Cep63 is cytoplasmic 
(A) 293 YFP-Cep63 cells were fractionated and whole cell lysates, cytoplasmic, nuclear 
and chromatin fractions were separated on a 15% SDS-PAGE gel and analysed by 
Western blotting with anti-GFP; anti-?-tubulin to mark the cytoplasm and anti-histone 
H2B to mark the chromatin. (B) 293 YFP-Cep63 cell lysate was separated by gel 
filtration and fractions were analysed by SDS-PAGE on a 15% gel and Western blotting 
with anti-GFP, anti-?-tubulin and anti-Centrin 3. Protein standards are marked in (B). 
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These findings were further confirmed in HeLa Kyoto cells, a human cervical cancer 
cell line. HeLa cells stably expressing GFP-Flag-Cep63 using a bicistronic pIRES 
expression vector with a puromycin resistance gene were generated. It was important to 
generate these additional cell lines because HeLa cells are much more amenable to 
microscopy when compared to 293 cells, which detach easily from the coverslip or plate 
making it more difficult to follow mitotic cells. Furthermore, 293 cells are considerably 
more 3-dimensional and therefore less amenable to live cell imaging in which fewer z-
sections are optimal. Larger, flatter HeLa cells stay attached to the coverslip or plate 
throughout the cell cycle and therefore provide a better system for microscopy based 
studies. 
 
GFP-Flag-Cep63 (hereafter called GFP-Cep63) also localised to the centrosome in 
HeLa cells (figure 20 and 21). GFP-Cep63 was visualised at the centrosome throughout 
the cell cycle and it was not visible at any other cellular location (figure 20b). All 
immunofluorescence analysis was carried out on clonal cell populations due to the 
variation in levels of overexpression between clones. Analysis of GFP-Cep63 HeLa 
cells by immunofluorescence showed that GFP-Cep63 colocalised with pericentriolar 
material (PCM) components ?-tubulin, pericentrin and Cep152. Colocalisation with ?-
tubulin and pericentrin was incomplete, such that GFP-Cep63 resides in a smaller area 
than that covered by these two PCM proteins (figure 21a and b). All of GFP-Cep63 
localised within the PCM, but GFP-Cep63 was only present in part of the area covered 
by ?-tubulin and pericentrin. Colocalisation of GFP-Cep63 with Cep152, on the other 
hand, was complete (figure 21d).  
 
Centrin-3 is a centriole protein and staining with this antibody marks the position of the 
distal end of the centrioles (Strnad et al., 2007). GFP-Cep63 is located between the 
Centrin-3 foci in G2 or mitotic cells (figure 21d) and adjacent to the single centrin focus 
in G1 cells that have separated, but not yet duplicated their centrioles (figure 21e). This 
pattern of localisation suggests that Cep63 localises to the PCM surrounding the 
proximal end of the centriole. 
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Figure 20 GFP-Cep63 localises to the centrosome throughout the cell cycle 
(A) Western blot of HeLa GFP-Empty or GFP-Cep63 clone lysates with anti-GFP 
antibody. Lysates were separated on a 15% SDS-PAGE gel. Lane marked with a tick 
shows the clone that was used for further immunofluorescence experiments. (B) HeLa 
cells stably expressing GFP-Cep63 were fixed and stained with anti-?-tubulin antibody 
(red) and DAPI (blue). GFP-Cep63 localised to the centrosome at all stages of the cell 
cycle: examples shown are G1 cells (top left), S-phase or G2 cell (bottom left), 
prophase and late anaphase (top right) and metaphase (bottom right). Inserts show 3.75 
x enlargements of the boxed areas. Images are maximum projections of deconvolved z-
sections. 
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Figure 21 GFP-Cep63 colocalises with pericentriolar material (PCM) proteins 
HeLa GFP-Cep63 stable cells were fixed and stained with ?-tubulin (A), Pericentrin 
(B), Centrin-3 (C,E) and Cep152 (D) (red) and DAPI (all). GFP-Cep63 was visualised 
by direct fluorescence. Left hand panels show interphase cells with 2 centrosomes and 
right hand panels show mitotic cells (A-D). GFP-Cep63 showed exact colocalisation 
with Cep152 (D) and overlap with ?-tubulin and pericentrin (A and B). GFP-Cep63 
localised between pairs of Centrin-3 foci, and adjacent to single Centrin-3 foci (E). 
Scale bar is 15 μm in A,B,C and E; 10 μm in D. Lower panels are 3x enlargements of 
the boxed areas. Images are maximum projections of deconvolved z-sections. 
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3.2 Cep63 interacts with Cep152 
To investigate the function of Cep63, anti-Flag immunoprecipitation (IP) experiments 
using FLAG-Cep63 were performed. The eluted proteins from immunoprecipitation 
were sent for analysis by mass spectrometry. Identification of Cep63 interacting 
proteins was a starting point for highlighting cellular processes in which Cep63 could 
be involved. Using the Flag-Cep63 and Flag-Empty cell lines described in 3.1, large-
scale Flag IPs were performed using anti-Flag M2 affinity gel (Flag M2 antibody 
immobilised on agarose beads, Sigma). The Flag IP was carried out on equal amounts 
of Flag-Empty or Flag-Cep63 293 whole cell lysates and bound proteins were eluted 
using a peptide with 3 Flag repeats (Sigma). Eluted proteins were separated by SDS-
PAGE on a 4-12% Bis-Tris gel (NuPage, Invitrogen) and stained with Sypro Ruby 
(Invitrogen) to visualise total protein with a blue fluorescent light scanner (figure 22b).  
Flag-Cep63 was visible in the eluate on the Sypro Ruby stained gel (arrow, figure 22b), 
but there were no other visible bands present only in the Flag-Cep63 eluate and not in 
the Flag-Empty control. 
 
A small fraction of each sample was analysed by Flag or Cep63 Western blot in order to 
check that Flag-Cep63 was indeed present in the eluate (figure 22a). Both lanes of the 
Sypro Ruby stained gel were cut into bands and sent for analysis by mass spectrometry. 
The proteins were eluted from the gel, subjected to tryptic digestion and analysed by 
LC-MS as described in materials and methods (2.10). Figure 22c shows the two highest 
scoring proteins, with respect to number of peptides identified, that were present in the 
Flag-Cep63 eluate, but absent from the control. Mass spectrometry analysis confirmed 
that Cep63 was present in the Flag-Cep63 eluate and Cep152 was the most abundant 
interacting protein identified.  
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Figure 22 Identification of Cep152 as a Flag-Cep63 interacting protein 
An anti-Flag IP experiment was performed with cell lysates from 293 cells stably 
expressing Flag-Cep63 or the empty vector. Input (I) and eluate (E) fractions were 
separated by SDS-PAGE on a 4-12% Bis-Tris gel and analysed by Western blotting 
with Flag M2 mouse antibody (A, left) or Cep63 rabbit (A, right). Eluted proteins were 
separated by SDS-PGE on a 4-12% Bis-Tris gel, stained with Sypro Ruby and 
visualised using a fluorescence scanner (B). Both lanes were cut into 1 mm fragments 
and sent for analysis by mass spectrometry (Protein Analysis and Proteomics 
Laboratory, Clare Hall). (C) The two highest scoring proteins identified in the Flag-
Cep63 eluate that were absent in the control: Cep63 and Cep152.  
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Cep152 is a centrosome protein, which was also identified in the centrosome 
purification screen (Andersen et al., 2003). Cep152 has also been identified as a Plk4 
interacting partner and it has been shown to be involved in the regulation of centrosome 
duplication (Cizmecioglu et al., 2010, Hatch et al., 2010b, Dzhindzhev et al., 2010a) as 
described in Introduction 1.3. Mammalian Cep152 was uncharacterised when this result 
was obtained. Literature on the mutants of the Drosophila melanogaster orthologue, 
asterless (Varmark et al., 2007, Blachon et al., 2008) demonstrate that asterless flies 
have severe problems with spermatogenesis due to an inability to form asters, and hence 
proper bipolar spindles, causing unequal segregation of chromatids (Varmark et al., 
2007), which made Cep152 a very interesting candidate to focus my attention on. 
 
Blachon et al. showed that Asl is required for centriole duplication in Drosophila and 
that the vertebrate homologue of Cep152 plays the same role in zebrafish (Blachon et 
al., 2008). Experiments were undertaken to confirm the Cep63-Cep152 interaction via 
several methods prior to investigating a role for Cep63 in this process.  
 
A Xenopus Cep152 orthologue (XCep152) was identified by sequence homology using 
the NCBI BLAST database search tool using the human Cep152 nucleotide sequence as 
reference. Henceforth I will refer to human Cep152 as Cep152 and Xenopus Cep152 as 
XCep152. The sequence identified for XCep152 was hypothetical Xenopus laevis 
protein LOC446951; the complete coding sequence for this and for human Cep152 were 
available as IMAGE clones (IMAGE:5084879 and IMAGE:40125733 respectively) and 
used as a starting point for cloning.  
 
Xenopus cell free egg extract provides a useful in vitro system for biochemical studies 
and as such it was important to validate the Cep63-Cep152 interaction in both Xenopus 
egg extract and human cell systems. A maltose binding protein (MBP) tag was added at 
the N-terminus of a XCep152 expression construct and the MBP fusion protein was 
expressed in E. coli at 16°C since the protein was completely insoluble at higher 
temperatures. Expression and solubility were low, but it was possible to purify 
sufficient MBP-XCep152 for in vitro binding experiments from bacterial cell lysate 
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using an amylose resin column. It was not possible to obtain pure MBP-full length 
protein as the preparation always contained a series of what appeared to be either MBP-
XCep152 degradation products or, perhaps, products of premature translation 
termination (figure 23c). It was not possible to remove these smaller degraded proteins 
either by anion exchange or by gel filtration (not shown). Therefore, pull down assays 
were performed using preparations that contained shorter truncation, or degradation, 
products.  
 
Either 35S-labelled Luciferase or XCep63 was mixed with Xenopus laevis CSF extract 
before incubation with MBP or MBP-XCep152 bound to amylose resin. 35S-XCep63 
and 35S-XCep152 were generated by adding the appropriate expression vectors to a 
rabbit reticulocyte in vitro transcription translation system, supplemented with 35S 
labelled methionine (see 2.3.2 and 2.5.5). XCep63 was present in MBP-XCep152 
eluate, but not in the MBP eluate (figure 23). Luciferase was used as negative control 
and was absent in both eluates, which showed that MBP-XCep152 was not just binding 
all proteins in the reaction.  
 
Importantly, in the reaction without CSF extract, MBP-XCep152 and XCep63 were 
able to interact, which shows that the interaction was likely to be direct. The amount of 
XCep63 in the eluate from the reaction containing XCep152, without extract, was lower 
than the reactions carried out with extract, but this was due to a lower amount of MBP-
XCep152 being bound to the amylose resin (figure 23c). This in vitro experiment was 
carried out using XCep63 that was produced using rabbit reticulocyte lysate, so all 
proteins in the lysate were also present and there is a possibility that they could have 
mediated the interaction. In order to confirm the direct interaction an in vitro 
experiment in the absence of any other proteins would be necessary. Both Cep63 and 
Cep152 recombinant proteins are insoluble. Adding an MBP tag to Cep63 promotes 
solubility, but MBP-Cep152 is still mainly insoluble. In order to carry out this 
validation it will be necessary to generate soluble recombinant Cep152 with a tag other 
than MBP. Another option would be expression of the recombinant proteins together 
using a bicistronic expression vector. I predict that this would promote their solubility 
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due to the recombinant proteins being able to interact upon expression and improve 
solubility in a chaperone-like manner. 
 
 
 
 
 
Figure 23 Xenopus Cep63 and Xenopus Cep152 recombinant proteins interact 
(A) Schematic diagram of the MBP pull down experiment performed. Either 35S-
labelled Luciferase or XCep63 was mixed with Xenopus CSF extract before incubation 
with MBP or MBP-XCep152 bound to amylose resin. (B) Autoradiograph of input 
(CSF extract mixed with 35S labelled protein) and MBP or MBP-XCep152 eluate 
samples. Eluate samples from MBP or MBP-XCep152 and 35S-XCep63 incubated 
without extract are also shown (right hand side). (C) Anti-MBP Western blot showing 
MBP or MBP-Cep152 in the eluate fractions with or without CSF extract as indicated. 
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In order to study the Cep63-Cep152 interaction in human cells, human Cep152 was 
cloned into a Flag destination vector using the Gateway system and 293 stable cell lines 
were subsequently generated using the FlpIn system, as with Flag-Cep63 (figure 24). 
Flag-Cep152 localised to the centrosome in these cell lines, as expected (figure 24a). To 
validate the interaction a Flag IP was carried out after transient transfection of Flag-
Cep152 in YFP-Empty or YFP-Cep63 cell lines (figure 8c). YFP-Cep63, but not YFP, 
was present in the Flag-Cep152 eluate and neither YFP nor YFP-Cep63 were present in 
the Flag-Empty eluate, which confirmed the mass spectrometry result. Exogenously 
expressed Cep63 and Cep152 interacted in human cells. 
 
The reverse experiment was then carried out: to pull down exogenous Cep63 and blot 
for exogenous Cep152. While it was not possible to clone full length Cep152 by 
conventional cloning, the N-terminal half (amino acids 1-803, 93 kDa) and C-terminal 
half (amino acids 804-1654, 96 kDa) were successfully cloned into a pIRES expression 
vector with a N-terminal GFP-Flag tag. While these constructs were useful for other 
experiments, a full length Cep152 in a pEGFP mammalian expression vector was kindly 
provided by Ingrid Hoffmann (DKFZ, Mammalian Cell Cycle Control Mechanisms 
Group), whose group is also working on Cep152. The full length pEGFP-Cep152 was 
used for transient transfection in a 293 Flag-Cep63 stable cell line and Flag IP of Flag-
Cep63 was performed (figure 25). Flag-Cep63 bound GFP-Cep152, but not GFP.  
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Figure 24 Flag-Cep152 localises to the centrosome and interacts with YFP-Cep63 
(A) Flag-Cep152 293 cells stained with anti-Flag and anti-pericentrin antibodies and 
DAPI. Lower panels show 1.75x enlargements of the boxed areas. Scale bar 15 μm. 
This image is a maximum projection of deconvolved z-sections. (B) Western blot of cell 
lysates from Flag-Empty or Flag-Cep152 293 stable cell lines. Left panel shows a 
Western blot with anti-Flag antibody and the right shows that same membrane re-
blotted with anti-Cep152 (479, Bethyl Labs). (C) YFP-Cep63 or empty vector control 
293 cell lines were transfected with Flag-Cep152 (+) or empty vector control (-) and 
anti-Flag immunoprecipitation (IP) was carried out. Input cell lysates and eluted 
proteins (Flag IP) were analysed by SDS-PAGE on a 7.5% gel and Western blotting 
with anti-Flag antibody to visualise Flag-Cep152 and anti-GFP to visualise YFP-Cep63.  
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Figure 25 Flag-Cep63 interacts with GFP-Cep152 
Flag IP with ?-Flag M2 resin from 293 Flag-Cep63 cell lysates. Cells were transfected 
with pEGFP, pEGFP-Cep152, pEGFP-C152 Q265P or pEGFP-C152 R987X then 
collected after 48 hours. For Flag IP, 5 mg of cell lysate was used per sample. Bound 
proteins were eluted and separated on a 10% SDS-PAGE gel, then blotted with anti-
GFP, anti-Cep152 479 (Bethyl Labs), or anti-Cep63 49AP (Millipore) antibodies to 
detect GFP-Cep152 proteins, GFP-Cep152 and endogenous Cep152, and Flag-Cep63. 
100 μg whole cell lysate was analysed (input) samples. 
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Interestingly, work from Guernsey et al. has associated MCPH4 linked primary 
microcephaly in three patients to mutations in Cep152 (Guernsey et al., 2010). In this 
study, two patients were found to be homozygous for a single nucleotide change A to C 
at nucleotide 794 of Cep152. This was a non-conservative mutation causing a glutamine 
to proline change at amino acid 265 (Q265P). The third patient was heterozygous for 
Q265P as was one parent, but the patient was also found to be compound heterozygous 
with another Cep152 mutation from the other parent. This mutation was a single 
nucleotide change 2959 from C to T resulting in a premature stop codon at amino acid 
987, instead of an arginine residue.  
 
With the hypothesis that the Cep152 mutations described in patients with microcephaly 
may disrupt the interaction between Cep63 and Cep152, pEGFP-Cep152 vectors 
harbouring the described patient mutations were generated in order to study their ability 
to interact with Cep63. The pEGFP-Cep152 vector was used as a template for site 
directed mutagenesis, as described in 2.2.14, and the resulting constructs used for 
transient overexpression in Flag-Cep63 293 cells for subsequent Flag IP of Cep63 as 
described above (figure 25). Interestingly, although both of these mutants were 
expressed as efficiently (Q265P) or more efficiently (R987X) than the wild type 
protein, neither of them were as abundant in the Flag-Cep63 IP eluate as the wild type 
protein. This may have been expected to be the case for R987X, which does not localise 
to the centrosome (Guernsey et al., 2010), where both Cep63 and Cep152 normally 
localise. It is interesting to speculate that the pathology associated with mutations in 
Cep152 are a consequence of an inability of Cep152 to interact with Cep63.   
 
The previously described GFP-Flag-Cep152 N and C terminal half constructs were 
employed for binding studies with Cep63. 293 cells were transfected with either of the 
truncation constructs of the pEGFP-Cep152 full length vector. Cell lysates were 
prepared from transfected cells and incubated with either MBP- or MBP-Cep63 bound 
amylose resin. Flag IP could not be used in this case since the Cep152 N and C 
constructs themselves contain a Flag tag. All three GFP-Cep152 proteins were 
expressed and the most efficient binding was seen between full length Cep152 and 
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Cep63. Although both the N and C-terminal halves could bind MBP-Cep63, binding 
was much more efficient with the C-terminal half (figure 26a). Importantly, MBP did 
not bind any of these Cep152 proteins (figure 26a) and, conversely, GFP did not bind 
either MBP or MBP-Cep63 (figure 26b).  
 
Transfected 293 cells expressing either of the Cep152 truncations of full length protein 
were fixed for microscopy and DNA was counterstained with DAPI (figure 26c). Full 
length GFP-Cep152 localised to the centrosome as expected, as did the C-terminal half, 
the N-terminal half however did not. This data supports the finding that amino acid 
residues 1045 to 1290 are required for centrosome localisation of Cep152 (Hatch et al., 
2010b) and that residues 1067 to 1654 (C-terminal end) of Cep152 are able to localise 
to the centrosome (Cizmecioglu et al., 2010).  The C-terminal half truncation used 
covers residues 804 to 1654 and thus includes the residues necessary for centrosome 
localisation, while the N-terminal half does not. Since the interaction with Cep63 was 
stronger with the C-terminal half of Cep152, which includes the region required for 
centrosome localisation, it is interesting to speculate that the interaction with Cep63 
may be required for centrosome localisation of Cep152. On the other hand, it could be 
the case that Cep63 and Cep152 are only able to interact if both are localised to the 
centrosome. However, since this experiment was carried out using MBP-Cep63 
immobilised on amylose resin, it was likely that the interaction could occur without the 
need for both proteins to be located at the centrosome, as seen for the interaction study 
carried out in Xenopus egg extract where there were no centrosomes present (figure 23). 
The hypothesis that Cep63 has a role in localising Cep152 to the centrosome was 
investigated further and the results of these studies are presented in chapter 4.  
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Figure 26 MBP-Cep63 interacts with the C-terminal half of Cep152 
(A) Western blots of whole cell lysates (100 μg, Input) and eluates from amylose MBP 
or MBP-Cep63 pull downs carried out with 1 mg cell lysate from 293 cells transfected 
with GFP-Cep152 full length, N- or C-terminal expression vectors. 7.5% SDS-PAGE 
gel. Ponceau (bottom) stains total protein. Western blotting was carried out with anti-
GFP (mouse) or anti-Cep152 9AP  (rabbit) antibodies. * non-specific bands. (B) 
Western blot of Input (100 μg  whole cell lysate) and eluates from amylose MBP or 
MBP-Cep63 pull downs carried out with 1 mg cell lysate from 293 cells transfected 
with GFP. 15% SDS-PAGE gel. Ponceau shows total protein on the membrane. (C) 293 
cells used in the pull down experiment were fixed and stained with DAPI for 
microscopy. Images are maximum projections of z-sections. 
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3.2.1 Cep63 - Cep152 interaction is maintained in the presence of DNA 
damage 
XCep63 is an ATM target, which is phosphorylated in response to DNA damage in 
Xenopus egg extract (Smith et al., 2009) and 1.4. XCep63 is a centrosome protein that is 
required for correct bipolar spindle assembly in CSF extracts. In the presence of DNA 
damage XCep63 is phosphorylated in an ATM/ATR dependent manner and it is 
subsequently de-localised from the centrosome. As a result, spindle formation and 
maintenance is disrupted. Addition of exogenous mutant XCep63 that cannot be 
phosphorylated by ATM/ATR, rescues spindle formation in the presence of DNA 
damage.  
 
To address whether XCep63 was performing its function in spindle assembly in 
combination with XCep152 and whether the DNA damage dependent phosphorylation 
of XCep63 would have an effect on its interaction with XCep152, interaction studies 
were carried out in the presence of DNA damage. Exogenous XCep63 produced with 
the rabbit reticulocyte lysate in vitro transcription-translation system is completely 
phosphorylated in the presence of DNA damage signalling in Xenopus CSF extract, as 
determined by band shift (figure 27a and (Smith et al., 2009). DNA damage signalling 
in extract is stimulated, in this experiment, by the addition of short double stranded 70-
mer fragments of DNA, created by annealing poly-A and poly-T 70-mer 
oligonucleotides (pA/pT). The experiment described in figure 23 was repeated in the 
presence of DNA damage. MBP or MBP-XCep152 was immobilised on amylose resin 
and CSF extract containing 35S-labelled XCep63 was incubated with or without pA/pT 
double stranded DNA, then added to the amylose resin. Eluates were analysed by SDS-
PAGE and autoradiography (figure 27a). 35S-XCep63 was clearly phosphorylated in 
extract supplemented with pA/pT, as determined by SDS-PAGE band shift, and this 
phosphorylated form of the protein was still able to bind MBP-XCep152 with high 
efficiency.  
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To address the same question in human cells, a Flag IP was performed with Flag-empty 
or Flag-Cep63 cell lines incubated in the absence or presence of Phleomycin (0.2 
mg/ml) for 2 hours prior to collection and lysis. Phleomycin is an antibiotic that causes 
double strand DNA breaks (Povirk, 1996) and thus causes activation of ATM and the 
downstream DNA damage signalling cascade. Activation of the DNA damage 
checkpoint after Phleomycin treatment was confirmed by Western blotting with anti- 
phospho-Serine 1981 ATM and ?H2AX antibodies, which are direct and downstream 
markers of ATM activation, respectively (figure 27b). Flag IP eluates were separated by 
SDS-PAGE and bands were cut and sent to the Protein Analysis & Proteomics 
laboratory for mass spectrometry analysis. Cep152 was still present as the most 
abundant interacting protein in the Flag-Cep63 eluate with Phleomycin treatment; 
although this technique did not generate a quantitative result, it indicated that the 
presence of DNA damage signalling did not affect the stability of the Cep63-Cep152 
interaction. It was unknown if human Cep63 was a target of ATM/ATR kinase activity. 
Cep63 does contain several ATM/ATR consensus sites, but the region of XCep63 that 
is phosphorylated is not conserved in the human protein (figure 55)(Smith et al., 2009)). 
The work presented in section 4.9 addresses the possibility that Cep63 might also be an 
ATM target in human cells.  
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Figure 27 Cep63-Cep152 interaction is not disrupted by DNA damage 
(A) MBP or MBP-XCep152 was immobilised on amylose resin and incubated with 
extract containing 35S-labelled XCep63 in the absence (-) or presence (+) of 70-mer 
double stranded DNA molecules (pA/pT). XCep63 is phosphorylated in the presence of 
pA/pT, which activates ATM and the subsequent DNA damage signalling cascade, as 
detected by reduced electrophoretic mobility (phospho-XCep63 arrow). (B) Western 
blot of 293 cell lysates used in the Flag-IP assay untreated or treated with Phleomycin 
to induce DNA double strand breaks, with phospho-Ser 1981 ATM antibody, anti- ?-
H2AX and anti-Histone H2B as a loading control for ?-H2AX. Cell lysates are from 
Flag-Empty (E) or Flag-Cep63 (C63) cells. Graph shows quantification of the ?-H2AX 
bands relative to the amount of histone H2B. 
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3.3 Western blotting of Cep63 and Cep152 
The next step in confirming the interaction between Cep63 and Cep152 was to visualise 
the endogenous proteins by Western blotting.  
 
3.3.1 Cep63 antibody validation by Western blotting 
The Cep63 antibodies used in this thesis were generated in collaboration with Millipore. 
A Gateway donor vector containing the Cep63 sequence was prepared and sent to 
Millipore to generate GST-Cep63 full-length antigen for rabbit immunisation. The 
terminal bleeds of four rabbits were tested and two rabbits were identified as producing 
antibodies recognising Flag-Cep63 (47 and 49, figure 28). The resulting affinity 
purified antibodies were named Cep63 49AP and Cep63 47AP. These antibodies were 
generated using the same protocol, in two different rabbits. Antibodies 47AP and 49AP 
both specifically recognised over-expressed Flag-Cep63 by Western blotting (figure 28) 
and the endogenous protein by immunofluorescence (figures 34 and 35). A rabbit 
polyclonal Cep63 antibody was also purchased from Proteintech Group Inc. (designated 
Cep63 PTG in this thesis). The Cep63 PTG antibody recognised exogenous over-
expressed Cep63 by Western blot and the endogenous protein by immunofluorescence 
(not shown).  
 
All Cep63 antibodies were tested for Western blotting using whole cell lysates of cells 
untreated or transfected with Cep63 specific siRNAs. None of the bands detected by 
these antibodies, in whole cell lysate, appeared to be reduced or absent in RNAi treated 
cell lysates (one example is shown in figure 28b, Cep63 49AP). Cep63 RNAi did, 
however, reduce levels of GFP-Flag-Cep63 in a stable HeLa cell line (figure 28c). 
Cep63 RNAi validation was also carried out by detecting mRNA level and by 
immunofluorescence (section 3.4). Cep63 49AP and 47AP were able to recognise 
Cep63: throughout the immunisation process the serum recognised Flag-Cep63 whereas 
the pre-immune serum did not (figure 28a).  
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Figure 28 Cep63 antibody testing by Western blot 
(A) Pre-immune (pre), third bleed (test) and final bleed (final) serum from two rabbits 
immunised with GST-Cep63 (rabbit no. 47 and 49) was tested by Western blot of whole 
cell extracts from 293 cells stably expressing Flag-Empty vector (E) or Flag-Cep63 
(C63). Molecular weight markers are indicated in kDa. (B) Western blot of cell lysates 
from HeLa cells transfected with control or Cep63 specific siRNAs (63-1, 63-2), 100 
and 50 μg of cell lysates were loaded. (C) Western blot analysis of HeLa cells stably 
expressing GFP-Flag-Cep63 treated with control or Cep63 RNAi (63-1 and 63-2). Anti-
GFP and Flag antibodies were used to detect tagged Cep63 levels and ?-tubulin was 
visualised as a loading control. 
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Cep63 RNA is alternatively spliced to give rise to 4 different variants that have been 
detected in expression profiles. There are 4 predicted protein isoforms a – d, which are 
81, 63, 58 and 56 kDa in size. The isoform cloned and used for exogenous protein 
studies throughout this thesis is isoform b, 63 kDa. This was the protein identified in the 
mass spectrometry screen carried out by Andersen et al. (Andersen et al., 2003), and 
was the only full length coding sequence available from the IMAGE consortium. 
However it would be expected to see 4 Cep63 specific bands by Western blot. 
 
Since the 49AP and 47AP antibodies specifically recognise over-expressed Cep63 by 
Western blot and endogenous Cep63 by immunofluorescence (figures 28 and 35), it was 
reasoned that they did not detect Cep63 specific bands in whole cell lysate due to very 
low expression of Cep63. To overcome this problem, experiments were carried out to 
enrich Cep63 (section 3.3.3). 
 
3.3.2 Cep152 antibody validation by Western blot 
A commercial Cep152 antibody (rabbit polyclonal, Bethyl Labs no. 479) that was 
generated using an N-terminal peptide, amino acids 50-100, as an antigen was tested for 
specificity using RNAi to deplete Cep152 before analysing cell lysates by Western blot 
(figure 29). Two anti-Cep152 reacting bands migrating between the 150 and 250 kDa 
protein marker on 7.5% SDS-PAGE gels were eliminated upon transfection with 
Cep152 siRNAs, which indicated that the Cep152 479 antibody was indeed specific to 
Cep152. Flag-Cep152 migrated to the same position as the larger endogenous protein 
(figure 29) and both Flag-Cep152 and YFP-Cep152 exogenous tagged proteins were 
also recognised by Cep152 479. Importantly, anti-Cep152 479 recognised a band of the 
same size in Flag-Cep63 Flag IP eluate (figure 30) and purified centrosome fractions 
(figure 31c). Another Cep152 antibody, Cep152 9AP also recognised two bands of the 
same size on Western blots of purified centrosomes (figure 31). It is possible that the 
faster migrating band represents an alternate splice variant that results in a smaller 
protein isoform. 
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The Bethyl Cep152 antibody was not available at the time Cep152 was identified as a 
Cep63 interacting protein. Consequently, rabbit polyclonal antibodies directed against 
N-terminal (amino acids 18-31) and C-terminal (amino acids1600-1617) Cep152 
peptides were generated. The serum was affinity purified using both peptides and the 
resulting antibody, named Cep152 9AP, was able to detect full length, N-terminal and 
C-terminal halves of exogenously expressed Cep152 (figure 26a). Cep152 9AP was also 
able to recognise the endogenous protein in whole cell lysate and purified centrosomes 
(figure 31). However, no specific signal was detected when using this antibody for 
immunofluorescence (not shown), which indicated that the antibody either had low 
affinity for Cep152 or that it was only able to recognise the denatured form of the 
protein. 
 
 
Figure 29 Cep152 antibody testing by Western blot 
(A) Western blot of 293 cell lysates from cells transfected with control (C) or two 
different Cep152 siRNAs (152-1, 152-2) with anti-Cep152 479 antibody (Bethyl Labs). 
(B) Western blots of cell lysates from stable 293 Flag-Empty, Flag-Cep152 or YFP-
Cep152 cell lines with anti-Cep152 479, shown for comparison. Cep152 479 recognises 
a band that migrates at the same position as Flag-Cep152 and which disappears upon 
Cep152 RNAi. 
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3.3.3 Cep63 enrichment for Western blotting 
Using the 293 Flag-Cep63 and Flag-Cep152 cell lines, a Flag IP was performed 
followed by Western blot of the eluates using Cep63 and Cep152 antibodies in order to 
detect the endogenous proteins (figure 30). This experiment formed an important part of 
validating the Cep63 antibody. 
 
Firstly, Cep152 could be seen in input samples from all cell lines and in eluates from 
Flag-Cep152 clonal and transiently transfected cells (this is Flag-Cep152, which runs at 
around the same molecular weight as endogenous Cep152 on the 7.5% gel used here). 
Endogenous Cep152 was clearly present in the Flag-Cep63 eluate (figure 30a, last lane), 
showing that Flag-Cep63 was able to specifically interact with endogenous Cep152. 
Flag-Empty eluates did not contain any Cep152 (second lane). Flag-Cep152 IPs, from 
clonal cells and from cells transiently over-expressing the protein, contained anti-Cep63 
reacting bands that were absent from input cell lysate samples and from the Flag-Empty 
eluate (blue lines 1-4, figure 30). Band 1 indicates a band greater than 75 kDa that was 
present only in Flag-Cep152 eluates and could be Cep63 isoform a, which is predicted 
to be 81 kDa. The middle band 2, indicates a doublet, the upper of which migrated to 
the same position as Flag-Cep63. This doublet was not apparent in whole cell lysates or 
the Flag-Empty eluate, indicating that it could be Cep63 isoform b at 63 kDa. The lower 
doublet could be isoforms 3 and 4; it was present in Flag-Cep152 eluates, but not Flag-
Empty eluates.   
 
In summary, this experiment showed that Flag-Cep63 interacts with endogenous 
Cep152 and that Flag-Cep152 interacts with four anti-Cep63 reacting bands, which 
likely represent endogenous Cep63. 
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Figure 30 Flag-Cep63 interacts with endogenous Cep152 and Flag-Cep152 
interacts with anti-Cep63 reacting proteins 
Flag IPs were carried out using cell lysates from 293 stable cell lines expressing Flag-
Empty, Flag-Cep152 or Flag-Cep63; or from 293 cells transiently over-expressing Flag-
Cep152. Input (I) and eluate (E) samples were analysed by Western blotting with anti-
Cep152 (479, Bethyl) and anti-Cep63 (49AP, Millipore) antibodies. Input samples are 
100 μg cell lysate and IPs were carried out using 5 mg cell lysate. Proteins were 
separated on a 7.5% SDS-PAGE gel. Blue lines (1-4) indicate potential endogenous 
Cep63 bands, which are present in Flag-Cep152 eluate and the centrosome sample.  
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In order to enrich Cep63 by an alternative method, centrosomes were purified from a 
human lymphoblastoma cell line, KE37 according to the protocol described by Bornens 
et al. (Bornens et al., 1987). Specific details of the purification procedure can be found 
in 2.4.6. Fractions were examined by immunofluorescence and Western blot with 
antibodies against known centrosome proteins, ?-tubulin and Centrin 3, as well as the 
Cep63 49AP antibody (figure 31). Purified centrosomes assayed by 
immunofluorescence stained positive for Cep63 (figure 31a), which indicated that the 
protein should be enriched in these fractions. Analysis of fractions by SDS-PAGE on a 
15% gel showed that ?-tubulin and Centrin 3, both known centrosome components, 
were present and Western blotting with Cep63 49AP antibodies revealed some anti-
Cep63 interacting bands that were not apparent in the whole cell lysate (figure 31b). 
Fractions were then subjected to SDS-PAGE on a 7.5% gel in order to obtain better 
separation between the bands. Western blotting with Cep63 49AP (figure 31c), 47AP 
and Cep63 PTG antibodies (figure 31d) revealed the presence of 4 anti-Cep63 
interacting bands. The same pattern of bands was seen with 3 different antibodies and 
these bands were absent (bands 1 and 2), or not abundant in whole cell lysate. The 
bands are labelled 1-4 in figure 31d. Band 1 migrated to a position that could be 
expected for Cep63 isoform a, 81 kDa. Band 2 migrated as a doublet, which could be 
isoform b, 63 kDa. Bands 3 and 4 could be isoforms c and d, which would presumably 
migrate close together due to the small difference in molecular weight (56 and 58 kDa).  
 
Cep63 bands in a centrosome enriched sample and Flag-Cep152 eluate were compared 
directly, using a 10% SDS-PAGE gel and Western blotting (figure 31e). The same 
bands were present in the centrosome sample as in Flag-Cep152 eluate. Although these 
observations do not formally confirm that the identified bands were Cep63 there were 
few feasible options for further validation. RNAi of Cep63 led to no change in the 
pattern of bands in whole cell lysate (figure 28) and RNAi and subsequent centrosome 
purification would provide a way to verify that these bands are in fact Cep63, but this 
was not a viable option since the purification protocol requires 2 x 108 cells, for which 
an extremely large amount of siRNA and transfection reagent would be required. This 
purification could perhaps be scaled down for analysis of RNAi treated cells. 
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Alternatively, the generation of cell lines with stable expression of short hairpin RNAs 
(sh-RNAs) for stable knockdown of Cep63 could be used for large-scale experiments. 
 
Figure 31 Centrosome purification from KE37 human cells 
(A) Immunofluorescence of centrosomes from fraction 5 of the sucrose gradient using 
?-tubulin (green) and anti-Cep63 49AP (red) antibodies. DAPI staining highlights that 
the centrosomes are not completely pure as DNA fragments are present in the fraction. 
Arrows indicate the two centrosomes enlarged in the right-hand panels. (B) KE37 
whole cell lysate (WCL) and fractions 5-7 were analysed on a 15% SDS-PAGE gel and 
Western blotting with anti-Cep63 49AP, ?-tubulin and Centrin 3 antibodies. Arrows 
indicate Cep63 reacting bands that are not apparent in the WCL. Fractions 5 and 6 were 
separated on a 7.5% SDS-PAGE gel and Western blotting was carried out with anti-
Cep63 49AP and anti-Cep152 479 (top panel, C) and anti-Cep63 47AP and PTG 
antibodies (D). (E) Western blot comparing Flag IP inputs (whole cell lysates) and 
eluates from Flag-Empty (E) or Flag-Cep152 (C152) 293 cells; two amounts of 
centrosome fraction 5 (Cen.); and Flag-Cep63 293 whole cell lysate. Anti-Cep152 
Western blot (top panel) confirmed that Flag-Cep152 was present in the Flag-Cep152 
eluate. Cep152 endogenous protein was also seen in centrosome fractions. Blue lines 
labelled 1-4 highlight the anti-Cep63 reacting bands present both in centrosome 
fractions and in Flag-Cep152 Flag IP eluate. Protein standard markers are indicated on 
the left of Western blots, sizes indicated are kDa. 
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3.4 Cep63 immunofluorescence and RNAi validation 
 
Since endogenous Cep63 protein could not be detected by Western blotting of whole 
cell lysates, validation of Cep63 RNAi was performed by detecting Cep63 transcript 
levels by reverse transcriptase-polymerase chain reaction (RT-PCR) on purified RNA 
from untreated or Cep63 depleted cells using Cep63 primers (figure 32b and 33).  
 
As previously mentioned, there are four predicted expressed splice variants of Cep63 
(National Center for Biotechnology Information, NCBI). Since we could not predict 
which splice variants may be important in our assays it was important to ensure that all 
isoforms of the protein could be depleted. Three Cep63 siRNAs that were directed 
against exons included in all predicted Cep63 splice variants were used (figure 32a). For 
RT-PCR analysis four sets of primers were designed; two sets were designed to amplify 
regions that were identical in all variants (Cep63-2 and -5, figure 32) and two that were 
designed to differentiate variant 1 (Cep63-4) and variants 3 and 4 from 1 and 2 (Cep63-
6). Variant 1 could be detected specifically using the primers Cep63-4 (482 bp product, 
figure 32b). These primer pairs did not allow differentiation between variants 1 and 2 or 
between 3 and 4. Variants 1 and/or 2 were present (1493 bp product Cep63-2; 347 bp 
product Cep63-6) and variants 3 and/or 4 were present (209 bp product Cep63-6). 
Importantly, all of these products were greatly reduced in cells treated with either of the 
Cep63 targeting siRNAs, 62-1 or 63-2, relative to control siRNA treated cells (figures 
32b and 33). GAPDH specific primers were used as a control for the amount of RNA in 
each reaction and the PCR reaction itself (G1). Since this analysis was carried out, 
another group analysed Cep63 transcripts by quantitative PCR (qPCR) using primers 
that could identify the 4 variants specifically (Loffler et al., 2011). This study 
demonstrated that all variants are expressed in two different human cell lines, BJ and 
U2OS. Specifically, they identified variant 3 as the most abundant, followed in order by 
2, 4 then 1 (Loffler et al., 2011). 
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Future RT-PCR analyses were carried out using primers Cep63-2 and -5 since they 
allowed visualisation of all transcripts. The RNAi experiment in figure 32b was carried 
out in HeLa Kyoto cells following 2 transfections with 20 nM siRNA carried out 24 
hours apart. Cells were collected 4 days after the initial transfection. The same protocol 
was then carried out in U2OS cells (figure 33). The siRNAs depleted Cep63 in both 
U2OS and HeLa K cells with equal efficacy; in both experiments siRNA 63-2 appeared 
to be more effective, although this technique is not absolutely quantitative. 
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Figure 32 Cep63 splice variants and Cep63 RNAi 
(A) Schematic showing the 4 published Cep63 splice variants and the position of the 3 
siRNAs I used (black squares 63-1, 63-2, 63-3) and the 4 sets of primers used for RT-
PCR (coloured arrows). (B) RT-PCR reactions carried out on RNA purified from HeLa 
K cells transfected with control (C) or Cep63 specific siRNAs (63-1, 63-2). Primers 
used are indicated below each panel. GAPDH-G1 primers were used as a control. RT-
PCR products were separated by electrophoresis on a 1% agarose gel containing 
ethidium bromide to allow visualisation of DNA by UV illumination. 1 kb and 123 bp 
markers are indicated on the left and right of panels, respectively. Arrows indicate the 
estimated size of PCR products based on comparison with markers and the predicted 
product sizes. Purple box indicates variant specificity of the primer pairs. 
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Figure 33 Cep63 RNAi depletes Cep63 mRNA 
RT-PCR reactions carried out on RNA purified from HeLa K or U2OS cells transfected 
with control (C) or Cep63 specific siRNAs (63-1, 63-2), using primers Cep63-2, -5, or 
GAPDH-G1 as a control. RT-PCR products were separated by electrophoresis on a 1% 
agarose gel containing ethidium bromide to allow visualisation of DNA by UV 
illumination.  
 
Cep63 antibodies were examined for their ability to stain endogenous Cep63 by 
immunofluorescence of fixed cells. Analysis of Cep63 47 and 49 pre-immune, third 
bleed, and final bleed serum by immunofluorescence is shown in figure 34. Pre-immune 
serum from both rabbits detected the centrosome (figure 34). However, after the 
immunisation program was complete, serum from both rabbits recognised the 
centrosome with much higher affinity and the staining covered a smaller and more 
defined region of the centrosome. Furthermore, Cep63 47 and 49 affinity purified 
antibodies (AP) also stained the same region of the centrosome, whereas other non-
centrosomal cytoplasmic staining was lost. 
 
In order to confirm that the purified antibody was reacting to Cep63 specifically and not 
alternate or additional centrosome proteins, immunofluorescence was performed with 
cells transfected with Cep63 siRNAs. Cep63 RNAi either eliminated or decreased 
Cep63 immunofluorescence at the centrosome confirming that Cep63 49AP was 
specific to Cep63 (figure 35). This is also shown and quantified in figure 49, chapter 4. 
These experiments also confirmed that it was possible to deplete Cep63 protein using 
Cep63 siRNAs. Throughout RNAi trials with Cep63 siRNAs and subsequent analysis 
with Cep63 immunofluorescence it became clear that it was necessary to carry out 
RNAi for a period of at least 4 days in order to obtain cells with no visible Cep63 
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staining. After 24 hours of knockdown all centrosomes still contained Cep63. From 72 
hours, some centrosomes were depleted of Cep63, but cells often contained one Cep63 
positive and one Cep63 negative centrosome. Therefore, all experiments were carried 
out using 2 transfections with 50 nM siRNA, 24 hours apart with subsequent cell 
harvest three days after the second transfection. Longer periods of knockdown lead to 
greatly reduced cell numbers.  
 
Cep63 49AP localisation to the centrosome is dependent on Cep63. Furthermore, GFP 
and Flag tagged exogenous Cep63 proteins localise to the centrosome in 293 (figures 17 
and 18), U2OS, and HeLa cells (figure 20). Cep63 49AP antibody exclusively stained 
the centrosome in the same region as that occupied by tagged Cep63 (figure 36). Cep63 
antibody staining was present at the centrosome throughout the cell cycle; G1, G2 and 
mitotic examples are shown in figure 36. Cep63 appeared to adopt a bi-lobed shape, 
which was most apparent in mitotic cells, bottom panel figure 36. In other cells the 
shape was either bi-lobed or ring-doughnut shaped (top and middle panels). 
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Figure 34 Cep63 antibody testing by immunofluorescence 
HeLa cells were fixed and stained with pre-immune, final bleed (immune), and affinity 
purified Cep63 antibodies from rabbits 47 (A) and 49 (B) (green) and DAPI to visualise 
DNA. Images are maximum projections of z-stacks without deconvolution. The 
brightness was increased in the lower panels of the pre-immune pictures in order to 
illustrate the diffuse low-level staining seen in the centrosome region in these samples. 
Inserts show 5x enlargements of the boxed regions in each image. Pre-immune serum 
from both rabbits recognised centrosomal epitopes, but Cep63 immunisation resulted in 
the production of antibodies that recognised a very defined region of the centrosome, 
with much higher efficiency. 
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Figure 35 Cep63 immunofluorescence reduction after Cep63 RNAi 
U2OS cells transfected with control siRNA (left) or Cep63 siRNA (63-2, right). Cells 
were stained with anti-Cep63 49AP (green) and ?-tubulin (red) antibodies and DAPI. 
Cep63 staining is reduced in cells treated with Cep63 siRNAs. Images are maximum 
projections of z-sections without deconvolution. Scale bar 15 μm. 
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Figure 36 Centrosomal localisation of endogenous  and exogenous Cep63 
Left hand panels show HeLa K cells stained with anti-Cep63 49AP (green) and Centrin 
3 (red) antibodies and DAPI to visualise DNA. Right hand panels show HeLa K GFP-
Cep63 cells stained with Centrin 3 antibody (red) and DAPI; green shows direct GFP 
fluorescence. Small panels show three times enlargement of the boxed regions 
(centrosomes). Diagrams illustrate the Cep63 (green) and Centrin 3 (pink) staining with 
respect to the predicted centriole position (grey boxes). Images are maximum 
projections of deconvolved z-sections. Scale bars are 5 μm (left panels) and 15 μm 
(right panels). 
Chapter 3. Results 1 
155 
3.5 Cep152 immunofluorescence 
The anti-Cep152 rabbit polyclonal antibody from Bethyl Laboratories (no. 479) was 
used to study Cep152 localisation. This antibody recognised a band on Western blots of 
whole cell lysates, which was reduced or absent in Cep152 RNAi treated cells, 
indicating its specificity for Cep152 (figure 29). Cep152 479 antibody stained the 
centrosome in HeLa cells (figure 37a). Importantly, the signal was reduced or 
completely absent in centrosomes of cells treated with Cep152 siRNA-1, which 
indicated that the antibody was specific for Cep152. Furthermore, immunofluorescence 
in U2OS cells resulted in the same staining pattern, which was also abolished upon in 
cells transfected with two different Cep152 siRNAs (152-3 and 152-4, figure 37b). 
From these data, it was clear that anti-Cep152 479 recognised endogenous Cep152 by 
Western blotting of whole cell lysates and by immunofluorescence.  
 
Cep152 localised to the PCM, as observed by colocalisation with ?-tubulin (figure 37). 
Specifically, it co-localised precisely with GFP-Cep63 (figure 21d) and appeared to take 
on a bi-lobed shape like Cep63, which was easiest to visualise in mitotic cells (figure 
38). Cep152 localised adjacent to, but not overlapping with, Centrin 3, which fits with 
published data showing its localisation to the PCM at the proximal end of centrioles 
(Cizmecioglu et al., 2010). Cep152 showed the same localisation pattern relative to 
Centrin as Cep63 did. Anti-Cep152 479 antibody also stained the cytoplasm in a 
manner that resembled microtubule staining (figures 37 and 38). However, upon 
depletion of Cep152 by RNAi, this staining remained, while centrosomal staining was 
abolished, and was therefore assumed to be non-specific. 
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Figure 37 Visualisation of endogenous Cep152 by immunofluorescence 
(A) HeLa cells transfected with control or Cep152 (152-1) siRNAs were stained with 
anti-Cep152 479 (red) and ?-tubulin (green) antibodies and DAPI (blue). Inserts show 3 
times enlargements of the boxed regions. Scale bar 15 μm. (B) U2OS cells transfected 
with control or Cep152 (152-3 and 152-4) siRNAs were stained with anti-Cep152 479 
(green) and ?-tubulin (red) antibodies and DAPI (blue). Inserts show 3 times 
enlargements of the boxed regions. Scale bar 10 μm. Images are maximum projections 
of deconvolved z-sections. Cep152 staining colocalises with ?-tubulin and is greatly 
reduced after Cep152 RNAi with different Cep152 siRNAs.  
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Figure 38 Cep152 localises to the PCM at the proximal end of centrioles 
HeLa cells were stained with anti-Cep152 479 (green) and Centrin 3 (red) antibodies 
and DAPI (blue). Lower panels show 3 times enlargements of centrosomes marked by 
white boxes. Images are maximum projections of deconvolved z-sections. Diagram 
emphasises that Cep152 shows a bi-lobed appearance at the proximal end of centrioles, 
as seen previously for Cep63. Bi-lobed shape is most obvious in the right two panels, 
and Cep152 takes on the shape of a ring doughnut in the G2 cell shown (second panel). 
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3.6 Cep63 localisation during centrosome duplication 
The Cep63 49AP antibody was used to study localisation of Cep63 throughout the cell 
cycle and, specifically, the kinetics of its recruitment to the new centriole during 
centriole duplication. Initially a U2OS cell line expressing a GFP-tagged exogenous 
copy of Centrin 1 was used; a kind gift from Stefan Duensing (University of Pittsburgh 
Cancer Institute) with permission from Michel Bornens (CNRS – Institut Curie). 
Centrin localises to the distal lumen of centrioles (Paoletti et al., 1996) and Cep63 
localised adjacent to GFP-centrin 1 foci (figure 39a). This analysis confirmed previous 
experiments examining Cep63 and Centrin 3 immunofluorescence in HeLa cells (figure 
36). In both experiments Cep63 immunofluorescence adopted a bi-lobed shape, which 
likely corresponds to the pericentriolar material (PCM) surrounding the outer centriole 
wall of the proximal end of the mother centriole, which organises PCM. Upon centriole 
disengagement in G1, Cep63 localised adjacent to each of the separated centrin foci, 
which is expected for a PCM protein as a daughter centriole is licensed to organise 
PCM upon passing through mitosis and upon disengaging from the mother centriole 
(simplified diagrams, figure 39). The same was observed when examining Cep63 co-
staining with Centrin 2 and ?-tubulin to mark the distal ends of centrioles and the PCM, 
respectively (figure 39b). Cep152 localises to the PCM at the outer wall of the proximal 
end of centrioles (Cizmecioglu et al., 2010).  Thus it is possible to infer that Cep63 also 
localised to the PCM surrounding the proximal ends of centrioles.   
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Figure 39 Cep63 localises to the PCM surrounding the proximal end of centrioles 
(A) U2OS cells expressing GFP-Centrin 1 cells stained with anti-Cep63 49AP antibody 
(red) and DAPI. Green is direct GFP fluorescence. Scale bar 5 μm. (B) U2OS cells were 
stained with Centrin 2 (red), Cep63 (green) and ?-tubulin (blue) antibodies. Scale bar 1 
μm. Diagrams indicate the predicted position of the centrioles (grey boxes) relative to 
Centrin and Cep63. All images are maximum projections of deconvolved z-sections. 
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In order to define the localisation of Cep63 further, Cep63 and Sas-6 (hSas-6) 
immunofluorescence was compared (figure 40).  Sas-6 forms a cartwheel structure at 
the onset of procentriole formation and marks the proximal end of the newly formed 
centriole (Strnad et al., 2007) (Kitagawa et al., 2011). To test the specificity of the Sas-6 
antibody, HeLa K cells were synchronised by double thymidine block then released for 
9 to 12 hours to capture images of cells from metaphase through telophase to G1. Sas-6 
protein is degraded at mitotic exit via the APC/C (Strnad et al., 2007). One Sas-6 focus 
per centrosome was observed throughout the cell cycle, which then disappeared during 
telophase, as expected (figure 40a). When centrioles disengaged during G1, Cep63 foci 
moved apart (figure 40b, middle panel). At this stage, Sas-6 staining was very weak, but 
not completely absent as in telophase cells. When Sas-6 was fully recruited, as observed 
by maximal fluorescence, Cep63 foci adopted a bi-lobed appearance again (figure 40a 
bottom panel). Triple staining with Centrin 2, Cep63 and Sas-6 antibodies showed that 
Cep63 is more proximal than Sas-6, which, in addition to the fact that it covers a larger 
area, indicated that Cep63 was indeed localised to the PCM surrounding the proximal 
end of the mother centriole in the pair of engaged centrioles, rather than being part of 
the centriole tube (figure 40c). In addition, Cep63 appears at the procentriole at or just 
before the time of full Sas-6 recruitment to the centrosome in G1. Sas-6 represents the 
earliest structural protein at the new procentriole, before centriole microtubule 
formation.  
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Figure 40 Cep63 localisation relative to pro-centriole component Sas-6 
(A) HeLa K cells stained with Sas-6 (red), Cep63 (green) antibodies and DAPI (blue). 
Black and white pictures of the red and green channels are inverted for clarity. Sas-6 
staining disappears after the metaphase to anaphase transition. Scale bar 5 μm. (B) 
Centrosomes from HeLa K cells stained as in (A). Examples are shown from cells in 
different stages of the centrosome duplication cycle (as indicated). (C) Centrosomes 
from a mitotic HeLa K cell stained with Centrin-2 (red), Cep63 (green) and Sas-6 (blue) 
antibodies. Diagram indicates positions of the proteins with respect to centrioles (grey 
boxes). All images are maximum projections of deconvolved z-sections. 
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3.7 Chapter 3 conclusions 
Exogenous tagged Cep63 localises to the centrosome throughout the cell cycle and 
interacts with the essential centriole duplication factor Cep152. This study is the first 
demonstration of the interaction between Cep63 and Cep152. The Cep63-Cep152 
interaction is also conserved in Xenopus laevis and it remains intact in the presence of 
DNA damage signalling. In this chapter I have also described the testing and validation 
of new Cep63 antibodies and the validation of a Cep152 commercial antibody. Cep63 
rabbit polyclonal antibodies specifically recognise exogenous over-expressed Cep63 by 
Western blot, but they are not able to detect endogenous Cep63 by Western blot of 
whole cell lysates, likely due to a low abundance of endogenous Cep63 in whole cell 
lysates. However, Cep63 antibodies do specifically recognise endogenous Cep63 by 
immunofluorescence. Cep152 antibody (479 Bethyl) specifically recognises 
endogenous Cep152 by Western blot and immunofluorescence. The generation of 
another Cep152 antibody (9AP) was also carried out and this antibody was able to 
detect exogenous over-expressed Cep152 by Western blot and endogenous Cep152 on 
Western blots of centrosome enriched fractions, but it was not suitable for 
immunofluorescence. 
 
Transfection of Cep63 siRNAs led to a decrease in Cep63 mRNA and protein levels, 
observed by RT-PCR and immunofluorescence, respectively. Cep152 siRNAs were 
proved efficient by Western blot and immunofluorescence analyses of transfected cells. 
 
Immunofluorescence and direct fluorescence studies of Cep63 and Cep152 show that 
the two proteins localise to a specific region of the PCM surrounding the outer wall of 
the mother centriole at the proximal end such that fluorescent foci take on a bi-lobed or 
doughnut shaped appearance. This is the region in which daughter procentrioles are 
formed. 
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Chapter 4. Cep63 regulates centriole duplication 
RNA interference (RNAi) using short-interfering RNAs (siRNAs) targeting Cep63 were 
employed to address the role of Cep63 in centriole duplication and cell cycle regulation 
in human cells. Cep63 interacts with the essential centriole duplication factor Cep152. 
So it follows that Cep63 may be involved in the same process. This chapter describes 
the involvement of Cep63 in centriole duplication and the study of the Cep63-Cep152 
interaction and its function. 
 
Cell cycle analysis of Cep63 cells treated with RNAi is detailed in section 4.5. These 
experiments pointed towards a role for Cep63 in the early stages of mitosis, RNAi 
mediated expression silencing of Cep63 resulted in the accumulation of cells in pro-
metaphase to metaphase and a reduction of anaphase and telophase cells. However, the 
observed phenotype was not rescued upon expression of exogenous siRNA resistant 
Cep63. Attention was thus focused on the role of Cep63 in the centriole duplication 
cycle as detailed in the following sections. 
 
4.1 Inhibition of centrosome reduplication by Cep63 RNAi 
The requirement for Cep63 in centriole duplication was tested, initially, by carrying out 
centriole reduplication assays in the absence or presence of Cep63 siRNAs. Centriole 
duplication is regulated such that a new centriole can be formed only at the site of the 
original mother centriole and only once per cell cycle as discussed in 1.3 and reviewed 
in (Nigg, 2007). However, in some cell types including the human osteosarcoma cell 
line, U2OS, the regulation of centriole duplication can be uncoupled from the cell cycle 
(Balczon et al., 1995, Meraldi et al., 1999) .When these cells are incubated in the 
presence of a DNA replication stalling agent such as hydroxyurea (HU) or aphidicolin 
(Aph) for 2 to 3 days, centrioles go through multiple rounds of duplication and 
disengagement and multiple centrosomes form. This process will henceforth be referred 
to as centrosome reduplication. 
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The process of centrosome reduplication was followed in U2OS cells treated with 
control, Cep63 or Cep152 RNAi (figure 41). Two siRNA transfections were carried out 
24 hours apart and a replication-stalling drug, HU or aphidicolin, was added at the time 
of the second transfection. Cells were collected for immunofluorescence after 48 or 72-
hour drug incubations as indicated. Centrosomes were quantified by counting ?-tubulin 
foci by immunofluorescence: the percentage of cells with more than 2 centrosomes was 
scored. 
 
Treatment of U2OS cells with 1.9 μg/ml aphidicolin causes centrosome re-duplication 
(Warnke et al., 2004). These conditions were used to carry out the first experiments in 
which 16% of cells showed centrosome reduplication after 48 hours and 35% after 72 
hours incubation (figure 41). As expected, Cep152 RNAi reduced the number of cells 
with reduplicated centrosomes to 3% at 48 hours and 8% at 72 hours. Interestingly, 
Cep63 RNAi also reduced the number of cells with more than 2 centrosomes to 4% at 
48 hours and 7% at 72 hours. 
Chapter 4. Results 2 
165 
 
Figure 41 Cep63 or Cep152 RNAi prevents centrosome reduplication 
U20S cells were transfected with control, 152-1 (Cep152) or 63-2 (Cep63) siRNAs and 
incubated for 48 hours (B) or 72 hours (A and C) with 1.9 μg/ml aphidicolin. Cells were 
stained with ?-tubulin antibody (green) and DAPI (blue) (A) and cells with greater than 
2 ?-tubulin foci were scored (B and C). (B) One experiment shown; n >200 cells per 
sample. (C) 3 experiments n>150 cells per sample. Mean and standard deviation shown. 
Images are maximum projections of deconvolved z-sections. 
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Similar experiments were performed using hydroxyurea (HU) rather than aphidicolin. 
Incubation for 72 hours in 2 mM or 4 mM HU caused centrosome reduplication in 
U2OS cells transfected with control siRNAs. Reduplication was reduced by Cep63 or 
Cep152 RNAi (figure 42). 
 
These experiments demonstrate that Cep63 RNAi inhibited centrosome reduplication 
when U2OS cells are arrested with replication stalling drugs to a similar extent as 
Cep152 RNAi. In order to confirm that it was the absence of Cep63 that was preventing 
centrosome reduplication in conditions of replication inhibition, I carried out Cep63 
RNAi treatment using two different Cep63 siRNAs separately (63-1 and 63-2) in the 
presence or absence of siRNA resistant GFP-Cep63 (figure 43). U2OS cells stably 
expressing siRNA resistant GFP-Cep63 that was resistant to siRNA 63-2, but not 63-1 
were generated. The experiment was carried out in parallel with GFP-Empty or GFP-
Cep63 siRNA resistant (W) U2OS cell lines. Both Cep63 siRNAs led to a reduction in 
centrosome reduplication in cells treated with aphidicolin, relative to control siRNA 
(figure 43). Cep63 siRNA 63-1 depleted levels of GFP-Cep63 W and endogenous 
Cep63 but, siRNA 63-2 was not able to deplete GFP-Cep63 W although it depleted 
endogenous Cep63 (figure 43a). In the presence of GFP-Cep63 W, siRNA 63-2 did not 
cause a decrease in centrosome reduplication, indicating that Cep63 is specifically 
required for centrosome reduplication.  
 
Interestingly, new ?-tubulin foci were able to form in the absence of detectable Cep63: 
arrows in figure 43d point to ?-tubulin foci with no visible Cep63 staining. In these cells 
there were low levels of Cep63 at one or two of the centrosomes, presumably the 
centrosome containing the grandmother centriole. This observation lead to the 
hypothesis that Cep63 is not required for formation of new centrioles in that it is not a 
structural component, but it is required for the regulation of centriole duplication. 
Altogether, these data lead to the conclusion that Cep63 plays a role in centrosome 
duplication, perhaps in partnership with its interacting partner Cep152.  
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Figure 42 Cep63 or Cep152 RNAi prevents centrosome reduplication in response 
to HU-induced cell cycle arrest 
U20S cells were transfected with control, 152-1 (Cep152) or 63-2 (Cep63) siRNAs and 
incubated for 72 hours with 2 mM (B) or 4 mM HU (A and C). (A) Cells were stained 
with ?-tubulin antibody (green) and DAPI (blue), lower panels show enlargements of 
the boxed areas. (B) & (C) cells with greater than 2 ?-tubulin foci were scored. One 
experiment shown: n >200 cells per sample. Images are maximum projections of 
deconvolved z-sections. 
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Figure 43 RNAi resistant GFP-Cep63 rescues centrosome duplication in Cep63 
RNAi treated cells 
U2OS cell lines expressing GFP-Empty or siRNA 63-2 resistant GFP-Cep63 (Cep63 
W) were transfected with control or Cep63 siRNAs (63-1, 63-2) and incubated with 1.9 
μg/ml aphidicolin for 72 hours. (A) Cells were stained with anti- ?-tubulin (red) and 
Cep63 (green, left panel) antibodies. GFP-Cep63 W was visualised by direct GFP 
fluorescence (A, right panel).  (B) Western blot of cell lysates from GFP-Cep63 W cells 
treated with control (C) or Cep63 RNAi (63-1, 63-2). GFP-Cep63 W was visualised by 
blotting with anti-GFP antibody. ?-tubulin was blotted as a loading control. (C) Cells 
with greater than 2 ?-tubulin foci were scored. Three experiments were carried out with 
n> 150 cells per sample: mean and standard deviation are shown. (D) Some cells with 
depleted Cep63 are able to duplicate their centrosomes: arrows point to ?-tubulin foci 
with no detectable Cep63 staining. Images are maximum projections of deconvolved z-
sections. 
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Overexpression of Plk4 causes centriole over-duplication and overexpression of Plk2 
can promote centrosome reduplication, reviewed in 1.3 (Warnke et al., 2004, Chang et 
al., 2010, Krause and Hoffmann, 2010, Habedanck et al., 2005, Kleylein-Sohn et al., 
2007). Plk2 or Plk4 were over-expressed in Cep63 depleted cells in order to determine 
if Cep63 was involved in either one of these pathways specifically. 
 
Initially, Cep63 expression was silenced using RNAi in U2OS cells expressing a HA-
tagged exogenous copy of Plk2 regulated by the Tet-off system. U2OS HA-Plk2 Tet-off 
cells were a kind gift from Ingrid Hoffmann (German Cancer Research Center, DKFZ). 
U2OS cells were maintained in the presence of doxycycline. Three days prior to the 
first siRNA transfection, media was refreshed with doxycycline free medium to induce 
HA-Plk2 expression (figure 44a).  Aphidicolin was added on the day of the second 
siRNA transfection; cells were collected 72 hours later and centrin foci were counted. 
HA-Plk2 overexpression in the presence of aphidicolin lead to 60% of cells containing 
over-duplicated centrioles (greater than 4 centrin foci, figure 44c). Cep63 RNAi 
prevented centriole reduplication, which indicated that it might function in the Plk2 
pathway. However, since aphidicolin arrest-induced centriole reduplication is not solely 
Plk2 dependent, it was not possible to conclude at this stage. Further experiments would 
be required to examine centriole number in Cep63 depleted cells with or without Plk2 
overexpression, with or without aphidicolin incubation, although overexpression of 
Plk2 in asynchronous cells causes only a mild centriole reduplication phenotype 
(Warnke et al., 2004).  
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Figure 44 Plk2 and aphidicolin induced centriole reduplication is prevented by 
Cep63 RNAi 
(A) Western blot of U2OS HA-Plk2 Tet off cells after the indicated number of days 
grown without tetracycline. HA-Plk2 was detected with anti-HA antibody. (B) Sample 
images of U2OS HA-Plk2 cells after HA-Plk2 induction, incubation with aphidicolin 
and transfection with control or Cep63 siRNAs. Cells were stained with anti-Cep63 
49AP (red), anti-Centrin (20H5, green) antibodies and DAPI. Small panels show 2 
times enlargement of the boxed areas. Scale bar 5 μm. (C) Cells with greater than 4 
Centrin foci were scored, n> 150 cells. (D) Western blot of cell lysates from cells used 
in (B) and (C). HA-Plk2 is still being expressed at the end of the experiment in both 
samples. Images are maximum projections of deconvolved z-sections. 
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A Myc-Plk4 construct kindly donated by Ingrid Hoffmann (DKFZ) was used for Plk4-
induced centriole reduplication. U2OS GFP-Centrin 1 cells (from Stefan Duensing) 
were subjected to Cep63 or Cep152 RNAi followed by transfection with the Myc-Plk4 
construct and cells were collected after 48 hours. Due to cell death and a low number of 
cells with Myc-Plk4 positive centrosomes, a very low number of cells was available for 
analysis, but this preliminary experiment showed that Cep63 and Cep152 RNAi both 
reduced centriole over-duplication driven by Plk4 over-expression (figure 45). Cep152 
has been shown to be involved in the Plk4 dependent centriole duplication pathway 
(Cizmecioglu et al., 2010, Hatch et al., 2010b) and it is interesting to speculate that 
Cep63 might also be a player in this pathway via interaction with Cep152. In U2OS 
cells overexpressing Myc-Plk4, Cep63 co-localised with the anti-Myc 
immunofluorescence (figure 45d). Colocalisation with Plk4 has already been shown for 
Cep152. In fact, Cep152 localisation to the centrosome is required for efficient 
localisation of Plk4 to the centrosome (Cizmecioglu et al., 2010). It would be interesting 
to see if Cep63 is also required for the centrosome localisation of Plk4, unfortunately 
due to time constraints this has not yet been investigated. 
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Figure 45 Plk4 induced centriole duplication is prevented by Cep63 or Cep152 
RNAi 
(A) Example images of U2OS cells transfected with Myc-Plk4 and control, Cep63 (63-
2) or Cep152 (152-1) siRNAs. Cells were stained with anti-Myc 9E10 antibody and 
GFP-Centrin1 was visualised by direct fluorescence. (B) Cells with greater than 4 
centrin foci were scored; n>15 cells. (C) Images from U2OS cells over-expressing Myc-
Plk4; stained with anti-Cep63 49AP and anti-Myc 9E10 antibodies. Cep63 and Plk4 co-
localised. Images are maximum projections of deconvolved z-sections. 
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4.2 Cep63 is required for efficient centriole duplication 
RNAi experiments carried out in conditions that force centriole reduplication clearly 
showed that Cep63 and Cep152 are important in this process.  To ascertain whether 
Cep63 might be involved in centriole homeostasis in unperturbed cells, centrioles were 
counted in asynchronous cells after Cep63 RNAi. 
 
Knockdown of Cep63 or Cep152 by RNAi over 4 days in U2OS cells resulted in 
decreased centriole numbers relative to untreated cells (figure 46a and b). Centriole 
number was determined by staining with a Centrin 2 antibody and only mitotic cells 
were counted in order to eliminate cell cycle dependent variation in centriole number: 
all mitotic cells should contain 4 centrin foci. Mitotic cells were identified by DAPI 
staining and observation of mitotic chromosome condensation. Duplicate experiments 
scoring mitotic cells with centrin 2 staining showed that Cep63 RNAi samples 
contained significantly more cells with fewer than 4 centrioles (p<0.05) and 
significantly fewer cells with 4 centrioles (p<0.01, figure 46d).  In most control cells, 
centrioles are duplicated before the onset of mitosis so that each mitotic cell contains 
two pairs of engaged centrioles, one pair in each centrosome; at each spindle pole. 
Cep63 RNAi samples contained cells with fewer than 4 centrin foci, which suggested 
that centrioles were not being duplicated in time for entry into mitosis. Figure 46a and c 
show examples of Cep63 depleted cells that contain single centrin foci at one spindle 
pole, or both. This pattern of centrin foci arrangement indicated that centrioles were 
able to disengage at the end of mitosis of the previous cell cycle and that either one or 
both of the centrioles were unable to duplicate. Centrosome separation at the beginning 
of mitosis appeared to be unaffected since cells were observed with well separated 
centrosomes, regardless of the number of centrioles they contained. 
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Figure 46 Centriole loss with Cep63 or Cep152 RNAi 
(A) U2OS cells were fixed after 4 days of RNAi with control, Cep63 (63-2) or Cep152 
(152-1) siRNAs and stained with anti-Centrin 2 antibody (red) and DAPI (blue). (B) 
Mitotic cells were scored for Centrin 2 foci number; n >100. (C) U2OS cells were fixed 
after 4 days of RNAi with control or Cep63 (63-2) siRNAs and stained with anti-
Centrin 2 (red) and Cep63 49AP (green) antibodies and DAPI (blue). (D) Mitotic cells 
were scored for Centrin 2 foci number. Average from 2 experiments shown; n>60. 
Mean and standard deviation shown. * Significant difference with p<0.05; ** p<0.01; 
ns p>0.05. Images are maximum projections of z-sections with no deconvolution. Scale 
bars 5 μm. 
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In order to verify these results, an alternative method for scoring centriole number that 
does not rely on specific antibody staining was employed. U2OS GFP-Centrin 1 cells 
were used and GFP foci were counted by direct fluorescence (figure 47). Experiments 
in these cells showed the same pattern: Cep63 RNAi led to a decrease in centrin foci 
number. All cells were included in the analysis, then mitotic and interphase cells were 
separated into two data sets (figure 47b). As seen in experiments with Centrin 2 
staining: Cep63 RNAi in U2OS GFP-Centrin 1 cells caused an increase in mitotic cells 
with 3 or fewer centrioles and a decrease in cells with 4 centrioles (figure 47b, left 
panel). Analysis of interphase cells showed that Cep63 RNAi increased the proportion 
of cells containing 2 or fewer centrioles and decreased the incidence of cells with 4 
centrioles. Although a decrease in cells with 4 centrioles and concomitant increase in 
cells with 2 centrioles could be explained by a cell cycle defect resulting in an increase 
in G1 cells this was not the case for Cep63 RNAi: FACS analysis of DNA content of 
Cep63 RNAi treated U2OS did not show an increase in G1, but rather an increase in 
G2/M (section 4.5, figure 53). Also, data collected from mitotic cells clearly showed 
that reduced centriole numbers were due to a problem in centriole duplication rather 
than cell cycle arrest.  
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Figure 47 Centriole loss in GFP-Centrin 1 U2OS cells after Cep63 RNAi 
(A) RNAi was carried out for 4 days in U2OS GFP-Centrin 1 cells using control or 
Cep63 specific (63-2) siRNAs. Cells were fixed for immunofluorescence with anti-
Cep63 (red) anti-GFP (green) antibodies and DAPI (blue). Small panels show 3 times 
enlargements of the indicated boxed areas. Scale bar 5 μm. (B) GFP-Centrin 1 foci 
number was scored in mitotic cells, n>35. (C) GFP-Centrin 1 foci number was scored in 
interphase cells, n>75. Images are maximum projections of z-sections without 
deconvolution. 
Chapter 4. Results 2 
177 
4.3 Cep63 RNAi leads to formation of extra ?-tubulin foci in 
mitosis – preliminary data 
Cep63 depletion by RNAi caused an increase in mitotic cells with fewer centrioles, but 
when these cells were stained with ?-tubulin to visualise spindle poles, I noticed that 
many mitotic cells contained extra ?-tubulin foci (figure 48). Cells with extra ?-tubulin 
foci had foci not only at the major spindle poles, but also scattered throughout the cell. 
Most of these foci were not as large as the foci at spindle poles. Since the number of 
mitotic cells containing greater than 4 centrioles did not increase upon Cep63 RNAi, 
these extra ?-tubulin foci were probably devoid of centrioles. As observed for centriole 
number, this phenotype was present in only a small population of Cep63 depleted cells. 
The majority of mitotic cells contained 2 ?-tubulin foci; a small percentage contained 
only one and between 4 and 28% contained greater than 2 ?-tubulin foci (figure 48b and 
c). When 4 experiments were plotted together, the difference between the number of 
control and Cep63 RNAi cells with greater than 2 ?-tubulin foci was not significant 
(figure 48c). The same was true for the increased number of Cep63 RNAi treated 
mitotic cells with only one ?-tubulin focus.  
 
These experiments were carried out with RNAi over 4 days, as described in 2.6.3. 
However, after 6 days of RNAi, both phenotypes became more pronounced: there were 
more cells with only one ?-tubulin focus in mitosis and more cells with extra smaller ?-
tubulin foci in mitosis (figure 48a and b). The 6-day RNAi experiment must be repeated 
to confirm this interesting observation. This preliminary data suggests that there might 
be a role for Cep63 in maintenance of the mitotic spindle poles, either directly or 
indirectly by ensuring the correct complement of centrosomes are present. It is 
important to note that there were a small population of control cells that have multiple 
?-tubulin foci in mitosis, which was lower or sometimes very similar to the proportion 
of Cep63 RNAi cells, depending on the individual experiment. This initial finding is 
potentially very interesting with respect to the Xenopus Cep63 work carried out 
previously: upon depletion of XCep63, the incidence of bipolar spindles is decreased in 
Xenopus CSF extracts supplemented with sperm nuclei (Smith et al., 2009). 
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Figure 48 Extra ?-tubulin foci in mitosis in Cep63 RNAi treated cells 
(A) U2OS cells were treated with control or Cep63 (63-2) RNAi over 6 days, and then 
cells were fixed and stained with anti-Cep63 (green) and ?-tubulin (red) antibodies and 
DAPI (blue). Three examples of mitotic cells are shown for each sample. Scale bar 10 
μm. (B) Mitotic cells from this experiment were scored for the number of ?-tubulin foci, 
n>80, one experiment only. (C) Data from B was combined with 3 more experiments 
carried out with RNAi over 4 days. Graph shows the percentage of mitotic cells with 1, 
2 or greater than 2 ?-tubulin foci. The mean and standard deviation are shown for each 
category. The difference between the means for control and Cep63 RNAi samples was 
not significant for any category. 
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4.4  Cep63 and Cep152 centrosome localisation is 
interdependent 
Since Cep63 and Cep152 are interacting partners, as described in chapter 3, I decided to 
follow the localisation of each partner after RNAi of the other. U2OS cells were treated 
with RNAi over 4 days with 2 different Cep63 siRNAs (63-2 and 63-3) or two different 
Cep152 siRNAs (152-3 and 152-4) then cells were collected for immunofluorescence 
and stained with anti-Cep63 49AP and ?-tubulin, or anti-Cep152 479 and ?-tubulin 
antibodies. Images of approximately 30 cells per sample were collected and the 
fluorescence intensity of Cep63 or Cep152 at the centrosome was measured relative to 
the fluorescence intensity of ?-tubulin with local background subtraction (figure 49). 
 
Cep63 RNAi led to a decrease in both Cep63 and Cep152 fluorescence at the 
centrosome. Conversely, Cep152 RNAi resulted in decreased Cep152 and Cep63 
fluorescence at the centrosome (figure 49). This experiment was repeated in triplicate 
and the mean difference between the control sample and each RNAi sample was 
significantly different in each experiment (figure 49d and e). Importantly, Cep63 RNAi 
did not deplete the overall level of Cep152 protein as determined by Western blot 
(figure 49b). As endogenous Cep63 could not be visualised by Western blot of whole 
cell lysate, Western blot of U20S GFP-Cep63 cells treated with Cep152 siRNA, or 
Cep63 siRNA was carried out. Exogenous GFP-Cep63 protein levels were unaffected 
by Cep152 RNAi, but localisation to the centrosome was inhibited to a similar level as 
with Cep63 RNAi (figure 50).  
 
In conclusion, Cep63 and Cep152 require each other for efficient localisation to the 
centrosome. Perhaps they bind to each other when translated in the cytoplasm and are 
incorporated into the PCM together. Therefore when one is depleted, the incorporation 
of the other to the PCM is inhibited.  
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Figure 49 Cep63 and Cep152 centrosome localisation is interdependent 
(A) Centrosomes from U2OS cells transfected with control, Cep63 (63-2, 63-3) or Cep152 
(152-3, 152-4) siRNA and stained with anti-Cep63 (green) and ?-tubulin (red) or anti-Cep152 
(green) and ?-tubulin (red) antibodies, as indicated. (B) Western blot of cell lysates with anti-
Cep152 antibody. Sas-6 and ?-tubulin Western blots are shown as loading controls. Cep63 
RNAi did not affect Cep152 protein levels. (C) Fluorescence intensity measurements of Cep63 
(left panel) or Cep152 (right panel) relative to ?-tubulin fluorescence for the experiment shown 
in A and B. Bars show the mean and standard deviation for each sample. *** Indicates a 
significant difference between samples; p< 0.0001. (D) Cep63 (left) and Cep152 (right) 
fluorescence measurements, relative to ?-tubulin, for three experiments. N > 25 measurements 
in each experiment. Mean and standard deviations are shown. 
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Figure 50 GFP-Cep63 centrosome localisation is dependent on Cep152 
(A) Western blot of cell lysates from U2OS GFP-Cep63 cells transfected with control, 
Cep63 (63-3) or Cep152 (152-3) siRNAs. ?-tubulin Western blot is shown as a loading 
control. (B) Graph shows fluorescence intensity measurements of GFP-Cep63 relative 
to ?-tubulin. Cep152 RNAi did not affect GFP-Cep63 protein level (A), but affected its 
localisation to the centrosome (B). 
 
In order to investigate the function of the Cep63-Cep152 interaction further, Cep63 
truncation proteins were generated. Cep63 was divided into three sections, N-terminus, 
SMC-like domain, and C-terminus. The SMC-like domain was predicted by searching 
the Conserved Domain Database using the NCBI interface (Marchler-Bauer et al., 
2011). The region of Cep63 isoform b between amino acids 136 and 424 was predicted 
to be structurally similar to the SMC (structural maintenance of chromosomes) protein 
family. Recombinant proteins consisting of each domain (N, SMC or C); fusions N-
SMC or SMC-C; and full length Cep63 were generated (figure 51c). 
 
Initially, recombinant MBP-Cep63 truncation proteins were generated, which were 
bound to amylose resin then incubated with cell lysate from 293 cells over-expressing 
Flag-Cep152. Eluates from the amylose resin were analysed by Western blotting with 
anti-Cep152 antibody: Flag-Cep152 was present in eluates from full length (6) and C-
terminal (3) MBP-Cep63 proteins (figure 51a). This experiment indicated that the C-
terminal third of Cep63 was required for Cep152 binding since no Flag-Cep152 was 
observed in eluates from N-terminal (1), SMC (2) or N-SMC (4) MBP-Cep63 proteins. 
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However, there was also no detectable Flag-Cep152 in the eluate from MBP-Cep63 5, 
which contained SMC and C-terminal domains and therefore should have been able to 
bind Cep152. Upon further analysis, it appeared that although an equal amount of MBP-
Cep63 5 was used in the experiment (Coomassie stained gel, figure 51a), this protein 
did not bind efficiently to amylose resin used for the pull down assay (Ponceau stained 
membrane, figure 51a). The experiment was repeated and the same problem occurred, 
which suggested that the MBP-tag in this protein was perhaps not sufficiently exposed 
to allow amylose resin binding. 
 
Consequently, binding experiments were repeated using a different system. Flag-Cep63 
truncation proteins (1 to 6) were stably expressed in 293 cells and anti-Flag IPs were 
carried out in cell lysates from these cell lines. Eluates were then analysed by Western 
blotting with anti-Cep152 antibody (figure 51b). Cell lysates were blotted for Cep152 to 
ensure that Cep152 protein level did not vary between Flag-Cep63 truncation cell lines. 
Cep152 was observed in eluates from Flag-Cep63 3 (C-terminal third), 5 (SMC – C-
term) and 6 (full length) Flag IPs, which confirmed the MBP-Cep63 experiments: 
Cep63 C-terminus is necessary and sufficient for Cep152 binding. The presence of the 
Flag-Cep63 truncation proteins in cell lysates was confirmed by Western blot of whole 
cell lysates for all proteins except the N-terminal and C-terminal fragments (1 and 3). 
Flag-Cep63 N- and C-terminal fragments were not detectable in whole cell lysate, likely 
due to low expression level. Flag-Cep63 N-term was detected on the Western blot of 
Flag-IP eluates, but Flag-Cep63 C-term was not. The only evidence that Flag-Cep63 C-
term was expressed was that Cep152 was present in the Flag IP from those cell lines. 
Flag IPs from 2 clones for each of Flag-Cep63 N-term and C-term truncations were 
performed due to the inability to robustly confirm the presence of the protein. Neither 
Flag-Cep63 N-term clone was able to bind Cep152 and both Flag-Cep63 C-term clones 
were able to pull down Cep152 in the Flag IP. 
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Figure 51 Cep63 C-terminal region interacts with Cep152 
(A) MBP-Cep63 truncation proteins 1 to 6 and MBP alone were bound to amylose resin 
and incubated with Flag-Cep152 293 cell lysate. Input MBP proteins are shown on the 
Coomassie stained gel (left) and the MBP proteins present in the eluate are shown on 
the Ponceau stained membrane (middle). Eluates were also analysed by Western 
blotting with anti-Cep152 antibody (right). Flag-Cep152 was present in the eluate from 
MBP-Cep63 full length (6) and C-terminal domain (3). (B) 293 Flag-Cep63 truncation 
stable clones were used for a Flag IP experiment and the eluates were analysed by 
Western blotting for Cep152 (right, upper). Input cell lysates were analysed by Western 
blotting for Cep152 (left, upper) or Flag to visualise Cep63 truncation proteins (left, 
lower). Flag-Cep63 truncation 1 could only be observed in the Flag IP eluate (right, 
lower). Flag-Cep63 truncation 3 could not be visualised at all. 1a, 1b, 3a and 3b are 
different clones of the 293 stable cell lines, which were used in parallel in this 
experiment. (C) Diagram illustrates the regions of Cep63 contained in each Cep63 
truncation protein, 1 to 6. 
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Next, YFP-Cep63 truncation proteins were expressed in U2OS cells in order to observe 
their localisation and their effect on Cep152 localisation (figure 52). The only protein to 
show robust localisation to the centrosome was full length Cep63 (full length), but there 
were also cells expressing YFP-Cep63 1 and 4 that showed YFP localisation at the 
centrosome (figure 52a and c). In comparison, there were no cells with detectable YFP 
at the centrosome in cells expressing Cep63 truncations 2, 3 or 5, or YFP alone. Since 
the experiment was carried out by transient transfection of the YFP-Cep63 vectors, the 
small number of examples of Cep63 1 and 4 localisation to the centrosome could have 
been due to low incidence of cells that were expressing the protein. Alternatively, 
localisation of these truncation proteins (1 and 4) may be reduced compared to the full-
length protein, because the full length of the protein is required for efficient localisation. 
This hypothesis marries with the conclusion that Cep152 was required for proper 
localisation of Cep63 to the centrosome since the C-terminus of Cep63 was required for 
Cep152 binding. Without the C-terminus, and therefore without Cep152 binding, Cep63 
localisation to the centrosome may be reduced. 
 
To follow Cep152 localisation to the centrosome ?-tubulin immunofluorescence was 
used to locate the position of the centrosome (blue, figure 52a) in combination with 
Cep152 immunofluorescence (red, figure 52a). Interestingly, in cells over-expressing 
YFP-Cep63 3 or 5 (truncations containing the Cep152-binding C-terminal domain), 
Cep152 fluorescence was significantly reduced at the centrosome (figure 52a and c). 
Cep152 fluorescence was measured at the position of ?-tubulin foci, relative to ?-tubulin 
fluorescence. The level of Cep152 fluorescence in YFP-Cep63 1, 2, 4 or 6 cells was not 
significantly different from YFP-empty control cells (figure 52a and c). The expression 
of all of the YFP-Cep63 truncation proteins was confirmed by Western blotting of 
whole cell lysates with anti-GFP antibody (figure 52d). This experiment was repeated 
and the same pattern was found. Mean differences from YFP-Empty control cells for 
the two experiments are shown in figure 52e.  
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Figure 52 Cep152 is depleted from the centrosome upon overexpression of Cep63 
C-terminal region 
(A) Images of centrosomes from U2OS cells over-expressing YFP-Cep63 truncation 
proteins (1-5), full length Cep63 (6) or YFP only (E). Cells were stained with anti-
Cep152 (red) and ?-tubulin (blue) antibodies and YFP was detected by direct 
fluorescence. (B) Schematic showing the domains present in Cep63 truncation proteins. 
(C) Fluorescence measurements of Cep152 (left) or YFP (right) relative to ?-tubulin 
fluorescence. Bars show mean and SEM. *** indicates a significant difference from 
control (E) p<0.01. ns: not significant. (D) Western blot of whole cell lysates from 
U2OS cells used in (A) and (C) with anti-GFP antibody. (E) Mean differences from 
control (YFP-Empty) of Cep152 fluorescence measurements from two experiments. 
Cep152 fluorescence was lower in all experimental samples compared with control, but 
the greatest differences were seen with Cep63 3 and 5 truncations. Mean and standard 
deviation are shown. 
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These data fit with the Cep152 literature: a C-terminal region of Cep152 (amino acids 
1045-1290) is necessary and sufficient for its centrosome localisation (Hatch et al., 
2010b, Cizmecioglu et al., 2010). In support of this, data presented here show that the 
C-terminal half of Cep152 interacted with Cep63 (figure 26). Localisation of 
endogenous Cep152 relied upon binding to full length Cep63 with both the N-terminal 
centrosome localisation domain and the C-terminal Cep152 binding domain. 
Overexpression of the C-terminal Cep152-binding domain of Cep63, which was not 
able to localise to the centrosome, resulted in depletion of Cep152 from the centrosome. 
 
In conclusion, Cep63 is required for localisation of Cep152 to the centrosome since 
RNAi of Cep63 resulted in reduced levels of Cep152 at the centrosome while total 
protein levels remained constant. Furthermore, overexpression of the C-terminal 
domain of Cep63, which bound Cep152, but could not localise to the centrosome, acted 
in a dominant negative fashion such that Cep152 was depleted from centrosomes. 
However, the situation does not seem to be as simple as Cep63 being required for 
Cep152 localisation to the centrosome, perhaps acting as a chaperone or scaffold 
protein to bridge between Cep152 and another centrosome component, because Cep152 
was also required for Cep63 localisation to the centrosome.  
 
These data support the following hypothesis: Cep63 and Cep152 bind and form a 
complex upon translation in the cytoplasm. The Cep63-Cep152 complex forms an 
interface that is required for centrosome localisation, but each protein alone does not get 
efficiently incorporated into the PCM. The protein, or protein complex at the 
centrosome, to which Cep63-Cep152 binds is unknown. Cep152 RNAi leads to 
centriole loss due to its requirement for Plk4 and CPAP localisation to the centrosome 
(Cizmecioglu et al., 2010). Cep63 RNAi also led to centriole loss, most likely due to its 
requirement for efficient Cep152 localisation. Thus, if the hypothesis that Cep63 and 
Cep152 need to be bound to each other in order to localise to the centrosome is correct, 
it follows that Cep63 would also be required for efficient localisation of Plk4 and 
CPAP, which would explain how Cep63 is involved in centriole duplication. However, 
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this is purely speculative as a thorough investigation of Plk4 or CPAP localisation in 
Cep63 RNAi treated cells is yet to be completed. 
 
4.5 Cep63 in mitosis – preliminary data 
Studies using Cep63 RNAi led to the interesting observation of an increase in mitotic 
index in U2OS cells. FACS analysis of the cell population after RNAi showed this 
quantitatively (figure 53). Propidium iodide (PI) staining was used to score cells based 
on DNA content, which showed that Cep63 RNAi led to an increase in the G2/M 
population (figure 53a).  In order to differentiate between G2 and mitotic cells, FACS 
analysis of cells stained with PI and anti-phospho-histone H3 serine 10 antibody, which 
specifically stains mitotic chromatin, was performed (P-H3, figure 53b). This analysis 
showed that the number of mitotic cells increased, which indicated that there was a 
delay or block during mitosis when Cep63 was depleted. The mean averages from 3 
experiments were not significantly different, which was due to the large variation in the 
increase of mitotic index seen between experiments. The mitotic index for control cells 
was 1.11%, 1.17% and 1.59% for the three experiments and for Cep63 RNAi samples 
the mitotic index was 7.15%, 2.42% and 4.25%. There was always an increase in 
mitotic index in Cep63 RNAi treated cells, but the extent of the increase varied, perhaps 
due to the cell density used in each experiment and efficiency of transfection. The 
increase in mitotic index with Cep63 siRNA 63-1 was modest in comparison with that 
seen with 63-2, so further experiments were carried out using 63-2 since 
immunofluorescence showed that knockdown of Cep63 was much more efficient with 
63-2 compared to 63-1 (not shown). 
 
These data were extremely interesting since it resembled the XCep63 depletion 
phenotype. When XCep63 is depleted from Xenopus CSF extracts, centrosome-
dependent mitotic spindle assembly is disrupted, such that fewer bipolar spindles form 
and the presence of disordered and aggregated spindle structures increases (Smith et al., 
2009). U2OS cells treated with Cep63 RNAi were analysed by immunofluorescence to 
quantify the proportion of cells in different mitotic stages to see if there was a general 
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delay in mitosis or a delay in one particular stage (figure 54a).  Cep63 RNAi led to an 
increase in cells in prophase to metaphase, but a decrease of cells in anaphase or 
telophase. This indicated that cells were delayed in mitosis due to activation of the 
spindle assembly checkpoint (SAC).  
 
In order to find out if Cep63 RNAi induced mitotic delay was SAC dependent, cells 
were treated with Cep63 RNAi in combination with Mad2 RNAi, which abolishes SAC 
signalling, reviewed in chapter 1.1.3 and (Musacchio and Salmon, 2007). A decrease in 
mitotic index in Cep63 RNAi cells with a defective SAC was observed (Mad2 RNAi, 
figure 54b), which indicated that the increased mitotic index upon Cep63 RNAi was 
SAC-dependent. Mad2 RNAi alone caused a decrease in mitotic index compared to the 
control, as expected. This experiment was repeated twice and the same pattern was 
observed, a representative profile is shown. 
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Figure 53 FACS analysis of U2OS cells after Cep63 RNAi 
(A) U2OS cells were treated with control or Cep63 RNAi (63-1 and 63-2) for 4 days 
then fixed and stained with propidium iodide for FACS analysis of DNA content. (B) 
Percentage of cells with G2 DNA content from 4 experiments with control or Cep63 
(63-2) RNAi. * Indicates that the means are significantly different p<0.05. (C) Mitotic 
index, as determined by the percentage of phospho-histone H3 positive cells, from 3 
experiments with control or Cep63 (63-2) RNAi in U2OS cells. The means are not 
significantly different. Both histograms show the mean and standard deviation. 
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Figure 54 Increase in mitotic index after Cep63 RNAi is dependent on the SAC 
(A) Mitotic stages were counted by microscopy in cells treated with control or Cep63 
(63-2) RNAi. The average and standard deviation of 3 experiments is shown. N> 50 
mitotic cells for each experiment. The differences in pro-metaphase cells and anaphase 
to telophase cells were significant, p<0.01 (**). (B) FACS analysis showing DNA 
content and mitotic index (% phospho-histone H3 positive cells) of U2OS cells treated 
with control, Cep63 (63-2), Mad2, or Cep63 and Mad2 RNAi. 
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Live cell imaging of U2OS cells treated with Cep63 RNAi was performed to see 
directly what happens when these cells enter mitosis (figure 55). The time from 
prophase, marked by cells rounding up, to anaphase onset was scored. Whereas all cells 
treated with control RNAi were able to complete the metaphase to anaphase transition 
within 60 minutes from prophase, the majority of Cep63 RNAi treated cells took 60 
minutes or longer to satisfy the spindle assembly checkpoint and enter anaphase (figure 
55b). The same experiment was also carried out with Cep152 RNAi, for which only a 
modest increase in prophase to anaphase timing was observed in comparison to the 
control. The majority of Cep152 RNAi treated cells were also able to complete the 
metaphase to anaphase transition within 60 minutes of the cells rounding up (figure 
55b). Whereas 31% of control and Cep152 RNAi cells were able to proceed from 
prophase to anaphase in 30 minutes or less, only 1% of Cep63 RNAi cells were able to 
do the same. Furthermore, there was an increase in cells dying after rounding up in 
Cep63 RNAi samples. These cells may have been dying in mitosis due to prolonged 
SAC activation and the inability to proceed with cell division. However, this could also 
have been cell cycle independent cell death. There was no way to differentiate between 
these alternatives in this experiment. However, transfection with 63-2 siRNA also 
caused cell death in reduplication assays where the cell cycle was arrested for 3 days 
(not shown). This observation indicated that the cell death seen during time-lapse 
experiments was not exclusively due to problems in mitosis.  
 
Analysis of prophase to anaphase timing showed that although the range of times for 
Cep63 RNAi cells was varied, the mean times for control and Cep63 RNAi were 
significantly different p<0.0001 (figure 55c). A possible reason for the variation in 
timing in Cep63 RNAi cells could be the extent of knockdown of Cep63 in different 
cells. The difference in the average time between control and Cep152 RNAi was not 
significant. 
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Figure 55 Live cell imaging of Cep63 RNAi treated U2OS cells 
(A) Examples of U2OS cells going through mitosis, or dying (3rd row) after RNAi with 
control, Cep63 (63-2) or Cep152 (152-1) siRNAs. Blue arrowhead indicates cells 
rounding up, when timing was started. Red arrowhead points to cells showing the first 
indication of anaphase, when timing was stopped. Pictures were taken at 5 minute 
intervals. Orange arrows indicate the cell being recorded. (B) Cells were scored 
depending on their prophase to anaphase time; whether they died; or whether they did 
not divide at all. N>48. (C) Time of prophase to anaphase (blue to red arrowheads) was 
recorded. N>40. The difference between the mean times of control and Cep63 RNAi 
treated cells was significantly different (***) p<0.0001. The difference between Cep152 
and control was not significant. 
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Cep63 RNAi using siRNA 63-2 led to a significant increase in the length of mitosis, in 
particular, prometaphase and metaphase, and therefore caused an increase in mitotic 
index. This increase was reversed when the SAC was inactivated by depletion of Mad2 
by RNAi, which indicated that the delay in mitosis was due to the inability of Cep63 
RNAi treated cells to satisfy the SAC.  
 
Cep63 RNAi using siRNA 63-2 caused a large increase in mitotic index, whereas 
siRNA 63-1 only caused a slight increase (figure 53a). RNAi with 63-1 was not as 
efficient at depleting Cep63 from the centrosome, as observed by immunofluorescence 
(not shown), which offered an explanation for the difference in phenotype. However, 
experiments to verify whether the mitotic index phenotype was indeed due to the lack of 
Cep63, rather than an off-target effect of siRNA 63-2 suggested that off target effects 
may indeed be responsible for this phenotype (figure 56). Control RNAi or Cep63 
RNAi in U2OS cell lines stably expressing GFP alone or GFP-Cep63 W, which is the 
wobble mutant of Cep63 that is resistant to siRNA 63-2 were performed. RNAi with 
63-2 caused an increase in mitotic index in both GFP-Empty and GFP-Cep63 W cell 
lines, which indicated that it was causing a mitotic delay independent of Cep63 status. 
GFP-Cep63 W was resistant to siRNA 63-2 (figure 56b).  
 
Therefore the increase in mitotic index could have been due to either an off-target effect 
of the siRNA or due to the depletion of the other Cep63 isoforms. All four predicted 
isoforms of Cep63 are expressed in U2OS cells (figure 32)(Loffler et al., 2011) and all 
four transcript variants are targeted by siRNA 63-2 (figure 33). GFP-Cep63 W encodes 
isoform b and therefore only isoform b would have been present in the 63-2 treated 
GFP-Cep63 W cells, compared to all four isoforms (plus GFP-Cep63 W) in the control 
cells. This GFP-Cep63 W construct was able to rescue the centrosome reduplication 
phenotype, but it was not able to rescue the mitotic index phenotype. RNAi experiments 
in cells expressing siRNA resistant forms of all four different isoforms must be 
performed in order to reach a final conclusion. 
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Figure 56 Cep63 RNAi induced mitotic delay is not rescued by siRNA resistant 
Cep63 
(A) FACS analysis of DNA content (PI, x-axis) and phospho-histone H3 staining (P-
H3, y-axis). U2OS cell lines stably expressing GFP only (GFP-Empty) or GFP-Cep63 
resistant to siRNA 63-2  (GFP-Cep63 W) were transfected with control or 63-2 siRNAs 
and collected after 4 days. The percentages of phospho-histone H3 positive mitotic cells 
are indicated in the left hand panels and the percentages of cells with G2 DNA content 
are indicated in the right panels. (B) Western blot of U2OS GFP-Cep63 W cells after 
control or 63-2 RNAi with anti-Cep152, GFP antibodies with ?-tubulin as a loading 
control. Cep152 is not depleted by Cep63 RNAi and GFP-Cep63 W is resistant to 
Cep63 siRNA 63-2. 
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4.6 Phosphorylation of Cep63 – preliminary data 
Xenopus laevis Cep63, XCep63, is a target of ATM/ATR kinase signalling in response 
to DNA damage in egg extract (Smith et al., 2009). XCep63 is phosphorylated on serine 
560, which is part of a novel ATM consensus site consisting of the consecutive amino 
acids; SLE. The canonical ATM consensus site is either SQ or TQ, with the serine or 
threonine being phosphorylated (Sancar et al., 2004). Cep63 is conserved amongst 
vertebrates, but serine 560 is not. However, there are many other SQ, TQ and SLE 
sequences that could be potential ATM/ATR targets for phosphorylation (figure 57).  
 
Since XCep63 is phosphorylated in response to DNA damage, experiments were carried 
out to see if the same was true for the human protein. First of all, a Flag IP from Flag-
Cep63 293 cells untreated or incubated with Phleomycin for two hours to induce DNA 
damage was undertaken (figure 27, section 3.2.1). The eluate was separated by SDS-
PAGE and the gel was cut into slices for mass spectrometry analysis by LC-MS. There 
was only 16% peptide coverage for Cep63, which was not sufficient for this 
experiment. Although 5 of the 11 putative ATM/ATR phospho sites were covered 
within the peptides identified (black lines, figure 57), no phosphorylation was detected. 
In order to improve the protein coverage with this technique it will be necessary to 
increase the amount of protein used for mass spectrometry analysis. Identification of the 
phosphorylated residues by mass spectrometry could indicate the kinase responsible if 
the phosphorylated residue is part of a known consensus sequence, and it would allow 
verification that it is Cep63 that is phosphorylated and not the Flag tag. 
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Figure 57 Multiple alignment of Cep63 protein sequences 
Human Cep63 (isoform b) was aligned with mouse, chicken and Xenopus (top to 
bottom) Cep63 protein sequences using ClustalW alignment tool. Serine 560, which is 
phosphorylated by ATM in X. laevis. is indicated by a yellow arrowhead. Putative ATM 
target sequences (SQE or TQE) are indicated by orange stars and putative SLE target 
sites by yellow stars. Black lines indicate peptides of the human protein that were 
identified by mass spectrometry analysis of Flag-Cep63. 
Chapter 4. Results 2 
197 
Since XCep63 undergoes an electrophoretic mobility shift upon phosphorylation by 
ATM/ATR in egg extract (figure 27)(Smith et al., 2009), experiments were performed 
to examine whether human Cep63 might also be phosphorylated in egg extract. MBP-
XCep63 and MBP-Cep63 (human) were incubated in egg extract with or without short 
linear double strand DNA fragments to activate ATM (pA/pT, figure 58). Although 
XCep63 showed decreased mobility (upward shift) after incubation in extracts with 
pA/pT on a 10% SDS-PAGE gel and a 10% SDS-PAGE gel containing Phos-tag™ 
reagent, the human MBP-Cep63 did not (figure 58a). Phos-tag™ acrylamide 
specifically binds phosphate groups and therefore specifically slows the migration of 
phospho-proteins through SDS-PAGE gels. Using these conditions for the Phos-tag gel 
(40 μM Phos-tag, 40 μM MnCl2), phospho-MBP-XCep63 did not show any slower 
migration than on the 10% SDS-PAGE gel. MBP-hCep63 had the same mobility with 
or without DNA damage checkpoint activation in the absence or presence of Phos-tag, 
which indicated that human Cep63 was not phosphorylated by DNA damage kinases in 
Xenopus egg extracts. However, this did not rule out the possibility of Cep63 being 
phosphorylated, as the reaction may be species specific, such that Xenopus ATM might 
not be able to bind and phosphorylate Cep63, as it does to XCep63. 
 
In order to determine whether Cep63 was phosphorylated in human cells, cell lysates 
from YFP-Cep63 293 stable cell line were analysed by Western blotting after treatment 
of the cells with 10 Gy ?-irradiation (IR, figure 58b). Cells were irradiated then 
collected at time points up to 2 hours in the presence or absence of phosphatase 
inhibitors. No mobility shift was observed for YFP-Cep63 after DNA damage treatment 
when samples were analysed on a 10% SDS-PAGE gel. However, not all phospho-
proteins show reduced mobility in SDS-PAGE electrophoresis. 
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Figure 58 MBP-hCep63 and MBP-XCep63 incubation with Xenopus egg extracts 
+/- DNA damage 
(A) MBP, MBP-XCep63 or MBP-hCep63 (human Cep63) were incubated in Xenopus 
laevis CSF extract in the absence or presence of short double stranded DNA 
oligonucleotides (pA/pT). Extracts were treated with phosphatase inhibitors (PI) or 
lambda phosphatase (?) and separated on a 10% SDS-PAGE gel (upper panels) or a 
10% gel containing Phos-tag reagent (lower panels). Western blotting was carried out 
with anti-MBP antibody. (B) 293 YFP-Cep63 cells were treated with gamma-irradiation 
(IR) and collected at the indicated times in the absence or presence of phosphatase 
inhibitors (+ phosphatase inhib.). Cell lysates were analysed on a 10% SDS-PAGE gel 
and Western blotting with anti-GFP antibody (rabbit).  
?
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Since there was no evident mobility shift of exogenous Cep63 on standard SDS-PAGE 
gels after cells were treated with ?-IR, samples were then analysed using SDS-PAGE 
gels containing Phos-tag acrylamide. Flag-Cep63 293 cells were treated with UV (10 
Jm-2) or ?-IR (10 Gy) followed by incubation for one hour before collection (figure 59). 
Additionally, cells arrested in mitosis by 16-hour incubation with nocodazole (100 
ng/ml) or arrested in mitosis then irradiated with 10 Gy ?-IR were also analysed. Cell 
lysates were separated by SDS-PAGE on a 10% gel plus Phos-tag and Western blotting 
was carried out with anti-Flag antibody. Interestingly, Flag-Cep63 migrated as a doublet 
in cells treated with nocodazole (figure 59a), which indicated that a proportion of Flag-
Cep63 was phosphorylated in this condition. The bands on this gel did not migrate in a 
straight line, which was due to EDTA in the lysis buffer, which chelates the manganese 
ions required for Phos-tag reagent to bind to phosphate groups. Therefore, future Phos-
tag analysis was carried out using eluates from Flag IPs from Flag-Cep63 containing 
cell lysates. Anti-Flag beads were washed with PBS, then protein was eluted with 
Laemmli loading buffer to avoid the presence of salt and EDTA in samples. Also, the 
concentration of Phos-tag and MnCl2 was lowered from 40 to 20 μM. This combination 
resulted in the Flag-Cep63 band shift after nocodazole to become more evident (figure 
59b).  
 
Analysis of the same Flag-Cep63 eluate on a Phos-tag gel and a standard gel without 
Phos-tag showed that Flag-Cep63 appeared as two bands in a Phos-tag dependent 
manner (figure 59b). In the absence of Phos-tag, Flag-Cep63 migrated as a single band, 
which indicated that the upper band observed upon Phos-tag SDS-PAGE was a 
phosphorylated version of Flag-Cep63. Interestingly, the upper Flag-Cep63 band was 
only a small proportion of total Flag-Cep63, indicating that only a subset of Flag-Cep63 
was phosphorylated. The upper Flag-Cep63 band was proportionally greater in 
nocodazole treated cells, but it was also apparent in untreated asynchronous cells. 
 
In order to conclude whether the upper Flag-Cep63 band was due to phosphorylation, 
Flag-IP of Flag-Cep63 was carried out from lysates of 293 cells arrested in mitosis by 
different methods (figure 59c) and each sample was compared before and after 
Chapter 4. Results 2 
200 
treatment with ?-phosphatase. ?-phosphatase removed the upper band of Flag-Cep63 
from all samples, which confirmed that this band was a phosphorylated form of Flag-
Cep63. Cells were arrested in mitosis by incubation with nocodazole; nocodazole 
release into medium containing MG132 proteasome inhibitor to prevent anaphase onset; 
or S-Trityl-L-Cysteine, which inhibits Eg5, a kinesin motor protein required for proper 
mitotic spindle assembly and therefore arrests cells in mitosis because they cannot form 
a spindle and satisfy the spindle assembly checkpoint (Skoufias et al., 2006). In this 
experiment phospho-Flag-Cep63 was also present in the untreated, asynchronous cells, 
although the proportion of the phosphorylated protein increased in cells that were 
arrested in mitosis. However, it is unlikely that this is a phosphorylation event that 
occurs during all mitoses, because only a small proportion of Flag-Cep63 was 
phosphorylated when all cells were arrested in mitosis. Perhaps this phosphorylation 
occurs in only a subset of mitotic cells where ATM and/or ATR is active. Alternatively, 
perhaps the phosphorylated proportion of Flag-Cep63 represents the portion of the 
protein that is present at a particular location, for example the centrosome, or 
cytoplasm. 
 
In order to try and determine the kinase responsible for phosphorylation of Flag-Cep63, 
analysis of Flag-Cep63 293 cell lysates from cells treated with UV (UV was seen to 
cause an increase in phospho-Flag-Cep63 in a previous experiment) in the absence or 
presence of different specific inhibitors of DNA damage signalling proteins was carried 
out (figure 59d). UCN01, a Chk1 inhibitor (Graves et al., 2000); am ATM specific 
inhibitor (Jazayeri et al., 2006); an ATR specific inhibitor; and an ATM/ATR dual 
inhibitor, both from Oscar Fernandez-Capetillo (Toledo et al., 2011) were used. 
Although the phospho-Flag-Cep63 band was present after UV, the proportion was not 
visibly different from untreated cells, which indicated that the modification might not 
have been DNA damage dependent. Furthermore, the proportion of phospho-Flag-
Cep63 remained unchanged in cells treated with UV in the presence of each of the DNA 
damage kinase inhibitors.  
?
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Figure 59 Flag-Cep63 DNA damage independent phosphorylation 
(A) Flag-Cep63 293 cells were untreated (Un), incubated for 16 hours in 100 ng/ml nocodazole 
(N), treated with 10 Jm-2 UV (UV), treated with 10 Gy ?-irradiation (IR) or treated with ?-
irradiation after 16 hour incubation with nocodazole. Cell lysates were analysed by SDS-PAGE 
on a 10% gel containing 40 μM Phos-tag reagent followed by Western blotting with anti-Flag 
M2 antibody. (B) Flag-Cep63 293 cells were untreated (-) or incubated for 16 hours in 
nocodazole (+). Cell lysates were analysed by SDS-PAGE on a 7.5% Phos-tag gel (left panel). 
Flag IPs were carried out using the same cell lysates and eluates were analysed on a 7.5% Phos-
tag gel (middle) or on a 10% standard SDS-PAGE gel (right). Western blotting was carried out 
with anti-Flag M2 antibody. (C) Flag-Cep63 293 cells were untreated (Un); incubated with 
nocodazole for 16 hours (N); incubated with nocodazole for 16 hours then release in the 
presence of MG132 for 2 hours (NM); or incubated with S-trityl-L-Cysteine for 16 hours. Flag-
Cep63 was isolated by Flag-IP from cell lysates and was analysed before and after treatment 
with ? phosphatase (+?) on a 7.5% Phos-tag gel followed by Western blotting with anti-Cep63 
49AP. (D) Flag-Cep63 293 cells were treated with 10 Jm-2 UV (UV) in the absence or presence 
of specific inhibitors of DNA damage signalling proteins (Chk1, ATM, ATM/ATR dual 
inhibitor and ATR). Flag-Cep63 was isolated by Flag-IP from cell lysates and analysed on a 
7.5% Phos-tag gel followed by Western blotting with anti-Cep63 49AP. Flag-Empty cell lysate 
was used as a negative control for the identification of Flag-Cep63 specific bands (B-D). 7.5% 
Phos-tag gels contained 20 μM Phos-tag (B-D). 
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In conclusion to these preliminary experiments: a small proportion of Flag-Cep63 was 
phosphorylated in asynchronous 293 Flag-Cep63 cells, which increased slightly upon 
synchronisation of the cells in mitosis, but was still less than 50% of the total protein. 
The phospho-Flag-Cep63 band was still present after incubation of cells with different 
specific inhibitors of DNA damage signalling proteins and there was little increase in 
the proportion of phospho-Flag-Cep63 relative to the total amount in cells treated with 
UV. Many more experiments need to be carried out in order to determine the kinase 
responsible for this phosphorylation; the cause of the phosphorylation and ultimately, its 
function. However, this preliminary data is interesting as it leads to the hypothesis that 
Cep63 might be regulated by phosphorylation, perhaps by cell cycle dependent kinases, 
kinases involved in centriole duplication or perhaps DNA damage signalling kinases. 
 
4.7 Chapter 4 conclusions 
Cep63, and its binding partner Cep152, play a role in the positive regulation of centriole 
duplication. Cep63 depletion by RNAi led to inhibition of centrosome reduplication, 
which occurs in U2OS cells arrested with DNA replication stalling agents. Cep63 
depletion leads to inefficient centriole duplication such that around 50% of cells enter 
mitosis with fewer than four centrioles, but Cep63 appears not to be absolutely required 
for centriole duplication. 
 
Cep63 likely regulates centriole duplication via modulation of its interacting partner 
Cep152. Cep63 interacts with and recruits Cep152 to the centrosome. Conversely, 
Cep63 also depends on Cep152 for centrosomal localisation, although Cep63 N-
terminal fragments that cannot interact with Cep152 are able to localise to the 
centrosome with reduced efficiency. Studies detailed in this chapter led to the 
conclusion that Cep63 is required for efficient and timely centriole duplication, but that 
it is not required for efficient bipolar spindle assembly and mitotic progression. 
Furthermore, a proportion of exogenous Cep63 is phosphorylated when expressed in 
human cells. The kinase(s) responsible for this modification(s) has not yet been 
identified.  
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Chapter 5. Cep63 gene-trap mouse embryonic 
fibroblasts 
Centrosomes have multiple functions some of which are more important in some cell 
types than others. For example, centrosomes act as the principle microtubule organising 
centre (MTOC) in dividing cells, but differentiated cells, neuronal, epithelial and 
muscle cells for example, also use other cellular structures for the nucleation of 
microtubules (Keating and Borisy, 1999). Furthermore, centrosomes are not required to 
organise spindle assembly in certain cell types: oocytes are one example (Doubilet and 
McKim, 2007). However, in some cell types, particularly in neural stem and progenitor 
cells during mammalian embryonic brain development, centrosomes have important 
functions in positioning of the mitotic spindle (Farkas and Huttner, 2008). Cell division 
plane positioning regulates the switch of cell fate between proliferation and 
differentiation, as described in 1.2.4.  The switch from proliferation to differentiation of 
neuroepithelial cells (NE) during embryonic development is a key determinant of brain 
size. Before the onset of neurogenesis, NE cells divide symmetrically, which generates 
two NE progenitors. At the onset of neurogenesis, NE cell division becomes 
asymmetric and one daughter becomes a differentiated neuron, while the other retains 
proliferative potential. This topic is complex and many more factors than the 
centrosome are involved: the subject is reviewed in (Farkas and Huttner, 2008). The 
important point to emphasise here is that while some centrosome proteins may play a 
minor role in one particular cell type, they may play a more crucial role in another cell 
type or at a particular stage of development. As such, an animal model for Cep63 may 
shed more light on the function of the protein by illuminating a particular cell type, 
organ or developmental stage in which the protein is required. 
 
Additionally, there is growing evidence that centrosome proteins are important during 
embryonic brain development as several centrosome components have been linked to 
primary microcephaly, as described in 1.2.4. Interestingly, mutations in Cep152 have 
recently been identified as the cause of microcephaly in several patients (Guernsey et 
al., 2010, Kalay et al., 2011). 
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The generation of Cep63 null embryos would also allow analysis of cells in culture that 
are devoid of Cep63 without relying on RNAi mediated depletion of the protein, which 
may not be complete and can sometimes result in off-target effects. We collaborated 
with Dr Travis Stracker from the Institute for Research in Biomedicine (IRB) in 
Barcelona for the generation of Cep63 deficient mice and mouse embryonic fibroblast 
cell lines. At the time of writing these efforts have yielded one Cep63 homozygous 
mutant cell line and a wild type littermate control cell line. Thus all experiments 
detailed in this chapter are carried out with cells derived from one embryo (plus the 
wild type control) only. All data will need to be validated by repeating experiments in 
other Cep63 mutant cell lines. 
 
5.1 Checking the Cep63 gene-trap mouse ES cells 
Mouse embryonic stem (ES) cells with a gene-trap cassette inserted in the Cep63 gene 
(one allele) were purchased from the EUCOMM consortium (European Conditional 
Mouse Mutagenesis Programme). Although the targeting construct used was intended to 
enable a Flp and Cre recombinase mediated conditional mutation in the gene, the 3’ Lox 
P site was lost during the targeting process and thus the cassette in Cep63 could not be 
excised (see diagram, figure 60). Thus, the ES cells could not be used to generate a 
conditional knockout mouse. The ES cells were cultured and, after freezing down an 
early passage for blastocyst injection, genomic DNA was extracted to check for the 
insertion of the cassette by PCR (figure 60). Four of the 6 PCR reactions were positive, 
which confirmed that the construct was in the expected position: between the first and 
second exon of the Cep63 gene. A Southern blot of restriction enzyme digested 
genomic DNA from the ES cells was carried out to check for potential mistargeting 
events. A radioactive probe was generated using the ?-galactosidase and neomycin 
resistance gene sequence as a template, which are present in the cassette. The Southern 
blot contained one band of expected size for each of the three digest experiments carried 
out (figure 61) and no other bands were seen, which indicated that the cassette was 
inserted only in one position in the genome: the Cep63 gene. As a control for probe 
specificity, genomic DNA from mouse ES cells that did not contain the cassette was 
subjected to the same analysis; no non-specific bands were seen. 
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Figure 60 Cep63 gene-trap mouse embryonic stem cells 
Genomic DNA from mouse embryonic stem (ES) cells containing a Cep63 gene-trap 
(from EUCOMM) was analysed by PCR. Primer sequences present in the Cep63 gene 
surrounding the expected cassette position (1 – 6) were used with primers specific for 
sequences present in the gene-trap cassette (B32 and GT2). The diagram illustrates the 
composition of the gene-trap cassette and the position of the primers used (not to scale). 
Lower panel: PCR products were analysed on a 1% agarose gel containing ethidium 
bromide and DNA was visualised by UV trans-illumination. PCR reactions in lanes 4, 5 
and 7 generated no specific products. Reactions in lanes 1, 2, 3 and 5 generated 
products of the predicted size. A 1 kb DNA ladder was used for comparison of DNA 
fragment size (right hand lane). 
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Figure 61 Southern blot of Cep63 gene-trap mouse ES cell genomic DNA 
The diagram illustrates the position of the gene-trap cassette relative to exons 1 and 2 of 
the cep63 gene and the position of restriction sites of three selected restriction enzymes 
(DraI, NcoI and ApaI) within the cassette and the surrounding gene. Lower panel: the 
indicated restriction digests were carried out on genomic DNA from wild type ES cells 
as a negative control (C) or ES cells with the Cep63 gene-trap (G). The resulting DNA 
fragments were separated on a 0.7% agarose gel without ethidium bromide and 
transferred onto a nitrocellulose membrane for subsequent Southern blotting with a 32P-
?dATP labelled probe generated using the ?-geo cassette DNA as a template. 
Radioactive signals were detected using autoradiography film. Distance of the bands 
from the well in the gel and the corresponding approximate molecular sizes are 
indicated on the right. 
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Since both the PCR and Southern blot indicated that the gene-trap cassette was present 
in the expected position and not in any off-target location, the ES cells were injected 
into blastocysts in order to generate chimeric mice for breeding. All mouse work was 
carried out in Dr Stacker’s lab at the IRB. This includes injection, breeding, genotyping 
and generation of mouse embryonic fibroblasts (MEFs). 
 
5.2 Mouse embryonic fibroblast (MEF) cell lines 
Genotyping of 6 embryos from one litter indicated that one was homozygous for the 
Cep63 gene-trap (number 2, figure 62) and one was heterozygous (number 6), the rest 
were wild type homozygotes. Genotyping was carried out using primers for the intron 
between Cep63 exons 1 and 2 and also the B32 reverse primer, which anneals to a site 
in the gene-trap. Reactions carried out with primer pairs that anneal to the Cep63 gene 
showed that the expected product (for the wild type gene) was present in all embryos 
except number 2 (figure 62). This was true for both reactions carried out using primer 
pairs to detect the wild type allele. Absence of a product at this size indicated that the 
gene-trap must have been inserted in both alleles in this embryo (2). The presence of the 
gene-trap results in the primer pairs being separated such that the PCR reaction cannot 
be completed in the extension time used for the reactions. Embryo number 6 was 
positive for the presence of the cassette (B32 primer) and the wild type allele and was 
therefore heterozygous for the gene-trap Cep63 allele (figure 62). 
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Figure 62 Genotyping embryos from Cep63 gene-trap heterozygote breeding 
Figure provided by Dr Travis Stracker. PCR was carried out with genomic DNA from 
embryos 1, 2, 3 and 6. Reactions with a gene-trap specific primer (middle panel) 
indicated that embryos 2 and 6 contained the gene-trap cassette. PCR reactions using 
primers specific for the region of Cep63 flanking the cassette (middle panel, right hand 
lanes and bottom panel) indicated that embryo 6 also contained a wild type allele 
(heterozygous), whereas embryo 2 did not. Diagram indicates the position of the 
primers used in the bottom panel, with respect to Cep63 exons and the gene-trap 
cassette. 
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Embryos 1 (wt/wt), 2 (gt/gt) and 6 (wt/gt) were used to generate MEF cell lines. Initial 
culturing of the MEFs was also carried out by Dr Stracker. A 3T3 assay was carried out, 
which involved the passage of 300,000 cells into a 60 mm tissue culture plate, every 3 
days. During this time, cells numbers were recorded (figure 63a). Growth rates between 
the cell lines were comparable during early passages and FACS analyses of the cells 
showed that cell cycle distribution was comparable between cell lines (figure 63b). 
 
Intriguingly, cell line 2 (gt/gt) immortalised at a much earlier passage than wild type 
cell line 1 (figure 63a) and also in a much shorter time than previously observed in the 
lab for any other cell line. The cell lines entered a crisis period at around the same time, 
where the cells start to become senescent; around passage 7, 18 days (figure 63a). 
However, cell line 2 (gt/gt) bypassed senescence and spontaneously immortalised 
around passage 10, day 25. Cells started to form tightly packed colonies at this time, 
showing that they were overcoming contact inhibition. In comparison, the cell line 1 
(wt/wt) did not begin cell doubling again until after passage 20. The Cep63 gene-trap 
cell line (2) also spontaneously immortalised when cells were left at confluence at 
passage 6, for 2.5 weeks with regular media changes, whereas the wild type cell line 
took around 3 weeks to undergo spontaneous immortalisation under the same 
conditions.  
 
This phenotype was extremely interesting as it could be an indication that Cep63 is 
involved in the maintenance of genome stability. Inactivation of Cep63 could lead to 
cell division aberrations, possibly through its role in centriole duplication, and provide a 
background with high genome instability, thus creating an environment suitable for 
mutations to occur at a high rate and allow loss of growth inhibition. However, this 
phenotype could be due to differential loss of tumour suppressor functions, for example. 
Further investigation is required in order to conclude on this topic. Analysis of 
additional MEF cell lines will be required and expression of exogenous Cep63 in the 
gene-trap homozygous MEFs will provide a way to validate this data and conclude 
whether the difference observed here is specifically due to lack of Cep63. 
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Figure 63 Cep63 MEF growth curve and cell cycle analysis 
(A) Provided by Dr Stracker: Growth curve of Cep63 wild type 1 (WT +/+), gene-trap 2 
(GT/GT) and heterozygous 6 (+/GT) cell lines. Cells were counted in triplicate every 3 
days. Cell number (y axis) is plotted on a logarithmic scale. (B) Cell cycle stage 
analysis carried out by FACS of propidium iodide stained fixed cells in order to 
measure DNA content. FACS analyses carried out in duplicate. Graph shows the mean 
and standard deviation. 
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Immunofluorescence analysis of wild type (1) and gene-trap (2) cell lines from the 
fourth passage was carried out to determine the Cep63 protein status (figure 64). Anti-
Cep63 49AP antibody stained the centrosome specifically in wild type cells, but not 
gene-trap homozygous cells. Co-staining was carried out with ?-tubulin to determine the 
position of centrosomes. Cells in all stages of the cell cycle were analysed and no 
Cep63 was detected at the centrosome in any of the Cep63 gene-trap 2 cells (figure 64). 
Anti-Cep63 49AP antibody recognised the N-terminal, middle (SMC-like domain) and 
C-terminal thirds of the human Cep63 protein. Although the specificity for the entire 
length of the mouse Cep63 protein has not been tested, the absence of any Cep63 
staining in gene-trap cells led us to a tentative conclusion that there were no Cep63 
proteins produced in these cells. Certainly, there was no detectable Cep63 at the 
centrosome, and no staining was observed elsewhere in the cell. 
 
Absence of Cep63, full length or truncated or alternatively spliced transcripts, was 
further verified by reverse transcriptase-PCR (RT-PCR) analysis of mRNA from the 
cell lines using primer pairs covering the length of the Cep63 coding region. No PCR 
products were observed in the Cep63 gene-trap cell line 2 (figure 65), which indicated 
that there were no Cep63 transcripts present. 
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Figure 64 Cep63 gene-trap MEFs lack Cep63 immunofluorescence at the 
centrosome 
Cells from the fourth passage of the Cep63 gt/gt (2) or +/+ (1) cell lines were fixed and 
stained with anti-Cep63 (green) and ?-tubulin (red) antibodies and DAPI (blue). Cells in 
interphase, prophase, metaphase and telophase/G1 are shown. Small panels show 3 
times enlargements of the boxed areas. Scale bar 10 μm. Images are maximum 
projections of deconvolved z-sections. 
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Figure 65 RT-PCR analysis of mRNA from Cep63 gene-trap cell lines 
Figure provided by Dr Stracker. RT-PCR analysis of mRNA from MEF cell lines: wild 
type (+/+) and gene-trap (trap/trap) with primers spanning different regions of the 
Cep63 coding sequence, as indicated at the bottom of each panel. Cep63 specific 
primers only produced a product in wild type MEFs. No products were detected in 
Cep63 gene-trap MEFs. Control reactions (unrelated gene) showed that input mRNA 
levels were the same for each cell line and that the preparation was proficient for RT-
PCR. 
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5.3 Centriole and centrosome analyses in primary MEFs 
Cep63 gene-trap cell lines were analysed further by immunofluorescence in order to 
determine their centrosome and centriole status. Cep63 RNAi in the human cell line 
U2OS caused a loss of centrioles, such that over half of mitotic cells contained fewer 
than the usual 4 centrioles (56% versus 5% in control treated cells, figure 46). This 
phenotype was stochastic, such that some cells lacking Cep63 were able to duplicate 
their centrioles in time for the entry into mitosis, while others were not. However, since 
RNAi did not completely remove Cep63 from these cells, the stochastic nature of the 
phenotype may have been due to the RNAi technique rather than the function of Cep63 
in centriole duplication. Analysis of Cep63 gene-trap MEFs with no detectable Cep63 
removed this layer of ambiguity. 
 
Firstly, centrosomes were counted by scoring ?-tubulin foci in all cells in wild type (1, 
wt/wt) and gene-trap (2, gt/gt) cells from the fourth passage (figure 66). Since FACS 
analysis showed that these cell lines have very similar cell cycle profiles, it was possible 
to compare centrosome counts from all cells and deduce that any difference seen would 
be due to centrosome duplication differences, rather than cell cycle differences. There 
was clearly a greater number of cells with only one centrosome in cell line 2 (gt/gt), 
which indicated that there might be a problem with centrosome duplication in these 
cells (figure 66a). Whereas the number of cells in G1 was roughly equal in wild type 
and gene-trap cell lines (57% and 53% respectively), the number of cells with only one 
centrosome was quite different (7% and 21% respectively). 
 
Interestingly, the number of cells with more than 2 ?-tubulin foci was similar between 
wild type and gene-trap cell lines. The maximum number of ?-tubulin foci throughout 
the cell cycle should be 2, in theory, since ?-tubulin is a centrosome marker. Thus, 
Cep63 gene-trap cells can accumulate extra centrosomes, just as wild type cells can. 
This observation, and the fact that 56% (compared to 67% in wild type) of cells contain 
2 centrosomes, indicated that centrosomes without Cep63 were able to duplicate, 
although duplication efficiency was perturbed.
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Figure 66 Inefficient centrosome duplication in Cep63 gene-trap MEFs, but 
normal mitotic progression 
(A) Wild type cell line 1 (1 wt/wt) and gene-trap cell line 2 (2 gt/gt) cells from passage 
4 were fixed and stained with ?-tubulin antibody. The number of ?-tubulin foci was 
recorded, n = 250. Graphs show ?-tubulin number in cells from all cell cycle stages 
(left) or interphase cells only (right). (B) Cell lines 1 and 2 were fixed and stained with 
?-tubulin and phospho-histone H3 antibodies to mark centrosomes and mitotic cells, 
respectively, and DAPI to stain DNA. All phospho-H3 positive cells were counted and 
categorised into mitotic stages depending on the shape of mitotic chromosomes; n > 160 
phospho-H3 positive cells. (C) Cell lines 1 and 2 were fixed and stained with ?-tubulin 
and pericentrin antibodies to mark microtubules and centrosomes, respectively and 
DAPI to visualise DNA. Cells with mitotic spindles were counted and categorised 
depending on the shape of the spindle and the mitotic chromosomes; n > 65 cells with 
mitotic spindles. 
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Analysis of mitotic progression demonstrated that Cep63 gene-trap cells were able to 
progress through all stages of mitosis with similar kinetics to wild type cells (figure 66). 
If there was a block or delay in any stage of the cell cycle, FACS analysis of DNA 
content would have shown an increase in that cell cycle stage. Since cell cycle analysis 
by flow cytometry showed that wild type and gene-trap cell lines have a similar profile, 
this indicated that Cep63 deficiency did not cause a delay or block in any cell cycle 
phase, including mitosis. However, to analyse this in more detail, the different stages of 
mitosis were examined in order to identify any potential mitotic processes, e.g. spindle 
assembly that may be slowed down in Cep63 deficient gene-trap cells. This was not the 
case as analysis of all mitotic cells, identified by positive phospho-histone H3 Serine 10 
staining, showed that the proportion of cells in each mitotic stage was similar between 
cell lines (figure 66b).  
 
Analysis with ?-tubulin immunofluorescence showed that Cep63 deficient cells were 
able to progress through mitosis and form a proper mitotic spindle (figure 66c). 
However, the Cep63 gene-trap cell line did show a small percentage of cells with 
monopolar spindles, with just one centrosome at the pole: 5% of mitotic cells compared 
with zero in the wild type cell line (figure 66c). Since there was an increase in cells with 
one centrosome as indicated by ?-tubulin staining and no increase in the proportion of 
G1 cells (figure 66a and 63b), it follows that some cells contain only one centrosome 
despite having progressed through S phase.  
 
Further to the ?-tubulin counts in asynchronous cells, ?-tubulin foci in mitotic cells 
(identified by phospho-histone H3 staining) were examined (figure 67). All stages of 
mitosis were included in the analysis: ?-tubulin counts were carried out using the cells 
represented in figure 67b. As expected from the ?-tubulin counts in asynchronous cells 
(figure 66a), the Cep63 gene-trap cell line contained cells with only one ?-tubulin focus 
(15% compared to 2% in wild type). Despite this, cells were able to progress through all 
stages of mitosis (figure 67b), perhaps by forming a second, acentrosomal spindle pole. 
Both wild type and gene-trap cell lines contained cells with diffuse ?-tubulin foci or 
extra, smaller ?-tubulin foci in addition to the larger foci at spindle poles. However, 
Chapter 5. Results 3 
217 
examples of these were more common in Cep63 gene-trap cell line 2 (figure 67b). Since 
?-tubulin stains the centrosome and the spindle pole, it was not possible to tell whether 
the cells with diffuse ?-tubulin foci contained centrosomes or not. In order to determine 
the centrosome status of these cells, centrin immunofluorescence was carried out to 
mark the distal end of centrioles and therefore indicate the position of the centrosomes. 
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Figure 67 Extra mitotic ?-tubulin foci in Cep63 gene-trap MEFs  
 (A) Wild type (1 wt/wt) and Cep63 gene-trap (2 gt/gt) cell lines were fixed and stained 
with ?-tubulin and phospho-histone H3 antibodies to mark centrosomes and mitotic 
cells, respectively, and DAPI to stain DNA. All phospho-H3 positive cells were 
analysed. Images show examples of ?-tubulin foci appearance in wild type and gene-
trap cells. Images are maximum projections of deconvolved z-sections. Scale bar 10 
μm. (B) Quantification of the categories of ?-tubulin focus illustrated in A; n >160. 
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Immunofluorescence with ?-tubulin and Centrin 2 antibodies was performed to identify 
centrosomes and centrioles respectively (figure 68). Centrin 2 staining was variable in 
wild type cells, such that some mitotic cells contained 4 very clear centrin foci with 
little background, while others contained high levels of Centrin 2 staining in multiple 
foci all over the cell. Centrin 2 immunofluorescence was also variable between different 
samples from the same cell line. So, for each sample, cells were counted from a single 
coverslip all of which were stained at the same time. Centrin 2 analysis of mitotic cells 
indicated that Cep63 gene-trap cells contained fewer than the expected 4 centrioles: 
45% of gene-trap cells contained less than 4 centrioles compared to 17% of wild type 
cells. There was a high number of wild type cells with 3 centrioles (17%), which might 
have been due to there only being 3 centrioles, or due to staining limitations of Centrin 
2 immunofluorescence. However, while numbers of cells with only 3 centrioles was 
similar in wild type and gene-trap cell lines, cells with less than 3 centrioles were only 
detected in the gene-trap cell line (30% compared to zero in wild type, figure 68b). 
Therefore, lack of Cep63 led to inefficiency of centriole duplication in these cultured 
primary MEFs. While Cep63 must have a role in centriole duplication, it is not required 
because 47% of Cep63 gene-trap cells are able to duplicate their centrioles and 
centrosomes in time for entry into mitosis (compared with 83% in wild type). 
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Figure 68 Centriole duplication defect in Cep63 gene-trap MEFs 
Wild type (1 wt/wt) and Cep63 gene-trap (2 gt/gt) cell lines were fixed and stained with 
?-tubulin (green) and Centrin 2 (red) antibodies to mark centrosomes and centrioles, 
respectively, and DAPI to stain DNA. Mitotic cells were scored for centrin foci number. 
(A) Images show examples of cells with different numbers of centrin foci in wild type 
and gene-trap cells. The number of centrin foci is indicated in the small panels, which 
are 3 times enlargements of the boxed regions. Scale bars are 5 μm. Images are 
maximum projections of z-sections without deconvolution. (B) Quantification of cells 
illustrated in A; n >30 mitotic cells. 
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Dr Jens Luders (IRB, Barcelona) carried out additional counts using ?-tubulin and a 
different centrin antibody that was a gift to his lab (figure 69). All cells were counted, 
regardless of cell cycle stage and, in concurrence with my analysis; Cep63 gene-trap 
cells had fewer centrioles. As daughter cells are born, they should contain two 
centrioles (two centrin foci), then during centriole duplication in G1 and through S 
phase, 2 new centrioles are formed. Therefore cells should contain either 2 or 4 
centrioles. There are fewer Cep63 gene-trap cells with 4 centrioles (12%) compared to 
wild type (32%) and a concomitant increase in cells containing less than 2 centrioles 
(19% compared to 2% in wild type cells). The number of cells containing 3 centrioles 
was very similar between the two cell lines, but the arrangement of these centrioles 
differed, i.e. whether there was a pair of centrin foci plus a single one (2+1) or whether 
there were three single foci (1+1+1) (figure 69b). 
 
Data presented in categories of ?-tubulin and centrin foci arrangement showed that there 
was a decrease in ‘normal’ arrangements (blue arrows, figure 69b). Normal ?-tubulin 
and centrin arrangements include 1 ?-tubulin to 2 centrin foci in early G1; 2:2 just 
before new centrioles are formed; then 2:4 through G2 and mitosis when cells have 
fully duplicated centrioles and centrosomes, as illustrated in figure 69c. The ?-tubulin 
and centrin arrangements were heterogeneous in both cell lines, possibly due to some 
centrioles not being detected by centrin immunofluorescence and the presence of non-
specific background staining. However, the Cep63 gene-trap cell line clearly showed 
more examples of abnormal arrangements including increased incidence of cells with 
one centrin foci per ?-tubulin focus (76% compared to 56% in wild type).  
 
Interestingly, this analysis also showed that Cep63 gene-trap cells show a higher 
incidence of abnormal ?-tubulin foci number, as seen previously (figure 66-68). Cells 
should contain one or two ?-tubulin foci depending on cell cycle stage, yet Cep63 gene-
trap cells contained cells with no ?-tubulin focus (4% compared to zero in wild type 
cells) and cells with greater than 2 ?-tubulin foci (20% compared to 12% in wt). Also, 
there were more Cep63 gt cells with only one ?-tubulin focus (17% compared to 4% in 
wt).  
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These data support the conclusion that primary MEFs lacking Cep63 were unable to 
duplicate centrioles in an efficient and timely manner such that some cells enter mitosis 
with fewer than 4 centrioles and a proportion of these, with only one centrosome. 
Despite the lack of centrioles and, in some cases, centrosomes, Cep63 deficient cells 
were able to progress through all stages of mitosis with no detectable delay. Perhaps the 
diffuse ?-tubulin foci observed in some mitotic cells were due to the lack of a 
centrosome at the spindle pole, which would lead to less efficient microtubule 
focussing. Further to this, Cep63 gene-trap cells displayed heterogeneity in ?-tubulin 
foci number. Importantly, as illustrated in figure 69b, the extra ?-tubulin foci observed 
in Cep63 gene-trap cells were not entire centrosomes as the majority only contained one 
centrin focus. Electron microscopy analysis of Cep63 deficient MEFs would clarify the 
centriole status of these extra ?-tubulin foci. 
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Figure 69 Cep63 gene-trap MEFs show heterogeneity in centriole and centrosome 
number  
Centrin and ?-tubulin arrangement was analysed in wild type (1 wt/wt) and Cep63 gene-
trap (2 gt/gt) by Dr Jens Luders (IRB, Barcelona). All cells were counted in an 
asynchronous population, n >110. (A) Graph shows the total number of centrin foci per 
cell. (B) Graph shows ?-tubulin and centrin ratio arrangement in the cell 2 indicated 2 
foci together, whereas 1+1 indicates two separated foci. Bars marked with blue arrows 
show ‘normal’ centrosome arrangements that would be expected throughout the cell 
cycle. (C) Diagram shows centrin and ?-tubulin arrangement throughout the centrosome 
duplication cycle. Each of these configurations is marked with a blue arrow in B.  
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5.4 Functional DNA damage checkpoint in Cep63 gene-trap 
cells 
As described previously, Xenopus laevis Cep63 is an ATM/ATR kinase target, which is 
phosphorylated upon DNA damage induction in Xenopus egg extract. Due to the 
possible implication of the mouse Cep63 orthologue also being involved in DNA 
damage checkpoint signalling, the competence of Cep63 gene-trap cells to initiate a 
DNA damage checkpoint induced cell cycle arrest was tested. When asynchronous cell 
cultures are subjected to DNA damage treatments they initiate a DNA damage 
signalling cascade via ATM or ATR DNA damage signalling kinases and the cell cycle 
is halted at the G1/S phase transition, during S phase or in G2. Entry into mitosis is 
prevented in the presence of DNA damage signalling and therefore, the mitotic index of 
asynchronous cell cultures subjected to DNA damage treatments is lower than untreated 
cultures. If cells are deficient in a checkpoint signalling protein, the cell cycle will not 
be halted and the mitotic index will remain unchanged after DNA damage treatment. 
This is true for ATM and ATR deficient cells and for deficiencies in other proteins 
downstream of these kinases (Griffith et al., 2008). 
 
UV irradiation primarily induces an ATR kinase signalling response. ?-irradiation 
predominantly causes double strand DNA breaks and activates ATM dependent 
signalling. Therefore, cells defective in ATR signalling show a G2/M checkpoint 
response after ?-irradiation, but not after UV and vice versa for cells defective in ATM 
signalling (Griffith et al., 2008). The G2/M checkpoint was assayed by counting 
phospho-histone H3 positive (mitotic) cells by FACS before and after UV or ?-
irradiation treatment. Dr Stacker carried out these experiments. Cep63 gene-trap cells 
showed efficient ATM and ATR-dependent checkpoint signalling (figure 70). The 
G2/M checkpoint was activated in Cep63 gene-trap cells, as in wild type cells, after 
both UV and ?-irradiation, as determined by a decrease in mitotic index (figure 70a). 
Importantly, mitotic index in untreated cells was very similar between wild type and 
gene-trap cells, which further confirmed that these cells had no problems with the 
timing of mitosis. 
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DNA damage signalling proficiency was assayed by immunofluorescence with 
antibodies that detect activated DNA damage signalling proteins (figure 70b). Histone 
variant H2AX is a target of the DNA damage signalling pathways and its 
phosphorylated form (?H2AX) can be detected by immunofluorescence with an 
antibody that specifically recognises the phosphorylated form of the protein. H2AX is 
phosphorylated by ATM and ATR checkpoint kinases on regions of chromatin 
surrounding the DNA lesion (Rogakou et al., 1998, Stiff et al., 2004). First of all, ?-
H2AX immunofluorescence showed that there was no activation of DNA damage 
signalling cascades in untreated cells, but as in wild type, Cep63 gene-trap cells were 
able to respond to DNA damage in the form of hydroxyurea (HU) treatment, as 
determined by detection of ?-H2AX foci in the nucleus. 53BP1 is another marker of 
DNA damage, which is also recruited to the site of the DNA lesion (Huyen et al., 2004). 
Using an anti-53BP1 antibody, HU induced 53BP1 foci were observed in Cep63 gene-
trap and wild type cells (not shown). In conclusion, Cep63 gene-trap cells showed no 
deficiency in DNA damage checkpoint signalling and subsequent cell cycle arrest. 
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Figure 70 DNA damage checkpoint signalling in Cep63 gene-trap MEFs 
(A) Experiment carried out by Dr Stacker. Cells were untreated (mock) or irradiated 
with 5 Jm-2 UV or 5 Gy ?-irradiation then incubated for 1 hour before collection and 
analysis of mitotic index by FACS of phospho-histone H3 positive cells. The y-axis 
shows % of mitotic cells. Wild type (1 wt/wt), Cep63 gene-trap homozygous (2 gt/gt) 
and heterozygous (6 wt/gt) MEFs were used. Experiments were carried out in triplicate; 
error bars show the standard deviation. (B) MEFs were treated with 4 mM HU for 1 
hour then fixed for immunofluorescence with anti-?-H2AX. Blue (DAPI) and green (?-
H2AX) channels are shown in black and white and inverted. Cells were co-stained with 
DAPI to visualise DNA. Images show one section without deconvolution. Scale bar 10 
μm. 
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5.5 Centriole analysis of Cep63 gene-trap 3T3 transformed 
MEFs 
 
Centriole analysis in primary MEFs was limited by the number of primary cells 
available and their limited growth capacity. These experiments were continued by 
analysing the resulting MEFs after spontaneous immortalisation by the 3T3 protocol.  
 
Cep63 protein levels were examined by immunofluorescence in case there was any kind 
of mutation in the Cep63 gene-trap cells that allowed Cep63 to be expressed either in 
part or in full. Cep63 localised to the centrosome throughout the cell cycle in wild type 
cells, but there was no detectable Cep63 in the Cep63 gene-trap (gt) 3T3 cells (3T3-2, 
figure 71). 
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Figure 71 Cep63 immunofluorescence in transformed MEF cell lines 
Wild type (3T3-1 wt/wt) and Cep63 gene-trap (3T3-2 gt/gt) immortalised MEFs were 
fixed and stained with anti-Cep63 49AP (green) and ?-tubulin (red) antibodies and 
DAPI to visualise DNA. Cells in G1, G2 and mitosis are shown (left to right). Small 
panels show enlargements of the boxed regions (centrosomes). Images are maximum 
projections of deconvolved z-sections. Scale bar 10 μm. 3T3-2 Cep63 gt/gt cells show 
no Cep63 staining at the centrosome. 
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Next, centriole number in the transformed MEFs cells was analysed using a Centrin 3 
antibody to mark centrioles and a pericentrin antibody to mark centrosomes and spindle 
poles. Only mitotic cells were scored in order to make a direct comparison of centriole 
number from all cells and to reduce centrin staining ambiguity seen in interphase cells. 
Centrin staining was much clearer in mitotic cells compared to interphase because 
interphase nuclei stained very strongly with centrin antibodies, but upon nuclear 
envelope breakdown the staining was less intense.  
 
As observed in the analysis of mitotic primary MEFs (figure 68), Cep63 gene-trap 
transformed MEFs (3T3-2) entered mitosis with fewer than the expected 4 centrioles 
(figure 72). There were fewer gene-trap cells with 4 centrioles (3T3-2) than wild type 
(3T3-1): only 45% of 3T3-2 cells in mitosis contained 4 centrioles, compared with 75% 
of 3T3-1 (figure 72b). There was a concomitant increase in cells with less than 4 
centrioles, which contained a range of centriole numbers and arrangements (figure 72c). 
Overall, there was an increase in cells with one unpaired centrin focus per spindle pole 
(24% of gt 3T3-2 compared to 10% of wt 3T3-1) and cells with no centrin foci at the 
spindle pole (26% of gt 3T3-2, 12% of wt 3T3-1, figure 72d). Although wild type 3T3-1 
cells did contain some spindle poles with only one detectable centrin focus, the opposite 
spindle pole in these cells contained a pair of centrin foci (figure 72c). Mitotic cells with 
fewer than 3 centrioles were much more common in 3T3-2 cell samples with 30% of 
cells with less than 3 centrioles compared to 5% of wild type 3T3-1 cells. 
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Figure 72 Reduced centriole numbers in Cep63 gene-trap 3T3 MEFs 
(A) Wild type (3T3-1) and Cep63 gene-trap (3T3-2) transformed cells were incubated for 7 
hours with 100 ng/μl nocodazole to arrest cells in mitosis, then released into medium containing 
10 μg/ml MG132 to prevent mitotic exit for 1 hour. Cells were fixed and stained with anti-
Centrin 3 (red) and pericentrin (green) antibodies and DAPI (blue). Images are maximum 
projections of deconvolved z-sections. Right hand panels show 3 times enlargements of the 
boxed regions and the number of Centrin 3 foci is indicated below. Scale bar 5 μm. (B) Total 
number of Centrin 3 foci per cell. (C) Mitotic cells were categorised depending on Centrin 3 
arrangement. (D) Number of paired, single or no Centrin 3 foci per spindle pole. N = 100 
mitotic cells. 
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Following the RNAi studies and YFP-Cep63 truncation protein overexpression in 
human cell lines (chapter 4), which showed that the localisation of one of the Cep63-
Cep152 binding partners to the centrosome was reduced in the absence of the other, an 
analysis of Cep152 localisation to the centrosome in transformed MEF cell lines was 
conducted. 
 
It was not possible to visualise endogenous mouse Cep152 by immunofluorescence or 
Western blot, as the antibody used to detect the human protein gave no signal by either 
method. This antibody was raised against a peptide from the human protein and was 
probably unable to recognise the mouse orthologue. Consequently, transformed MEF 
cell lines were transfected with the human GFP-Cep152 expression vector used for 
previous experiments in human cell lines (figure 73a). Experiments with GFP-Cep63 
transfection were carried out simultaneously, for comparison (73b). After 48 hours, 
cells were collected and stained with ?-tubulin antibody for identification of the 
centrosome by immunofluorescence; and centrosomes were scored for the presence of 
GFP fluorescence. Importantly, all three cell lines used were able to express GFP-
Cep152 and GFP-Cep63. Cell line SP-2 was an additional transformed cell line 
generated from embryo 2 (gt/gt) primary MEFs by spontaneous transformation of cells 
left at confluence for 2.5 weeks. At the time of this experiment the wild type (1) MEFs 
had not yet transformed by this method. GFP-Cep152 localised to the centrosome in 
wild type cells, but none was detected at centrosomes in Cep63 gene-trap cells (3T3-2, 
SP-2, figure 73a). Interestingly, all three cell lines were able to incorporate GFP-Cep63 
into their centrosomes, although Cep63 gene-trap cell lines (3T3-2 and SP-2) showed 
reduced efficiency. Perhaps this was due to wild type centrosomes already containing 
some Cep63, and consequently some Cep152, which would make localisation of new 
GFP-Cep63 more efficient, according to previous data from human cell RNAi 
experiments Cep152 also mediates the centrosomal localisation of Cep63 (figure 49). 
This data provides additional support to RNAi experiments, which showed the inter-
dependency of Cep63 and Cep152 for their centrosome localisation. 
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Figure 73 Cep63 is required for GFP-Cep152 incorporation into centrosomes  
(A) Transformed MEF cell lines (3T3-1 (wt/wt), 3T3-2 (gt/gt) and SP-2 (gt/gt)) were 
transfected with human GFP-Cep152 and immunofluorescence was carried out with ?-
tubulin antibody (red) to mark centrosomes and DAPI (blue). GFP-Cep152 was 
detected by direct fluorescence (green). Western blot of whole cell lysates with anti-
GFP antibody showed that GFP-Cep152 was expressed in all cell lines, the ?-tubulin 
Western blot indicates the amount of cell lysate loaded. Graph shows the percentage of 
cells with GFP fluorescence at the centrosome. (B) The same experiment was carried 
out using GFP-Cep63. Small panels show 3 times enlargement of the GFP signal at 
centrosomes indicated by boxes in the rgb image. Images are maximum projections of 
deconvolved z-sections. N = 100 cells per sample. Scale bars 5 μm. 
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5.6 Chapter 5 conclusions 
In conclusion to the work carried out using Cep63 gene-trap MEFs: Cep63 is involved 
in the regulation of centriole duplication, but is not absolutely required for duplication 
to occur. Cep63 gene-trap cells did not show any Cep63 protein expression, as 
determined by immunofluorescence of cells and RT-PCR analysis of mRNA. These 
Cep63-deficient cells were able to grow at the same rate as a wild type littermate control 
cell line. The Cep63 gt/gt studied here showed premature spontaneous immortalisation 
under two different growth conditions, which is indicative of genome instability. 
However, this phenotype could be due to differential loss of tumour suppressor 
functions rather than directly due to loss of Cep63. This remains to be fully 
investigated. Cep63 deficient and wild type MEFs cells showed very similar cell cycle 
progression. Furthermore, Cep63 deficient cells were able to elicit a DNA damage 
signalling response and cell cycle arrest to the same extent as wild type cells in response 
to DNA damage.  
 
Analysis of centriole and centrosome number showed that Cep63 deficiency resulted in 
reduced centriole number and aberrant centrosome number, as determined by centrin 
and ?-tubulin staining, respectively. Approximately half of the Cep63 deficient MEFs 
entered mitosis with fewer than 4 centrioles and half were able to duplicate their 
centrioles in time for mitotic entry. A smaller proportion of these cells entered mitosis 
with only one or two detectable centrioles. The stochastic nature of this phenotype led 
to the conclusion that Cep63 is not absolutely required for centriole duplication, but it is 
required for fully efficient duplication that is tightly coordinated with the cell cycle to 
ensure faithful inheritance of 2 centrioles per daughter cell. Data presented in this 
chapter are in accordance with data presented in chapter 4. Both studies in Cep63 
deficient MEFs and Cep63 depleted human cell lines showed that Cep63 has a role in 
centriole duplication, perhaps via Cep152 binding and recruitment to the centrosome. 
 
Further to the analysis of cellular behaviour, the Cep63 gt/gt embryo number 2 showed 
defects in the head upon collection for MEF generation at embryonic day 14.5. Another 
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litter of Cep63 gene-trap embryos has recently been collected and one of two 
homozygous gene-trap homozygotes also had a structural defect in the head area, which 
is reminiscent of exencephaly, a defect in neural tube closure leading to growth of 
neural tissue outside of the skull (figure 74). This intriguing phenotype is discussed 
further in chapter 6. 
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Figure 74 Cep63 gene-trap embryos, litter 2. 
This litter of embryos was collected at embryonic day 14.5, pictures were provided by 
Dr Stracker. One of the gene-trap homozygotes shows a structural defect of the head 
(bottom left). Heterozygote controls are shown, there were no wild type embryos in this 
litter. Pictures from litter 1 were not available.
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Chapter 6. Discussion 
The aim of this study was to determine the function of human Cep63. This thesis 
provides evidence for the following: 
• Cep63 localises to the PCM throughout the cell cycle. 
• Characterisation of Cep63 directed antibody, which specifically stains Cep63 by 
immunofluorescence. 
• The interaction between Cep63 and Cep152. 
• Cep63 is required for efficient centriole duplication. 
• Cep63 and Cep152 centrosomal localisation is inter-dependent.  
• The role of Cep63 in centriole duplication is conserved in mice. 
 
6.1 Cep63 in centriole duplication 
Cep63 interacts with Cep152, a PCM component required for centriole duplication due 
to its role in recruiting CPAP and facilitating the recruitment of Plk4 to the centrosome. 
Cep63 colocalises precisely with both Cep152 and Plk4, to the PCM surrounding the 
proximal end of the centriole wall, which is the area where daughter centriole formation 
is initiated. Without Cep63, Cep152 fails to localise to the centrosome and centriole 
duplication does not occur efficiently. Although Cep63 deficient cells were able to 
duplicate their centrioles, around half of the population entered mitosis with less than 4 
centrioles, and a smaller proportion with only one centrosome. As Cep63 is required for 
localisation of Cep152 to the centrosome, Cep152 is also required for efficient 
localisation of Cep63 to the centrosome. Thus, it is likely that the two proteins, Cep63 
and Cep152, interact with each other upon translation in the cytoplasm and move to the 
centrosome together where the interface of the combined protein complex is important 
for stable maintenance of both proteins in the PCM. The role of Cep63 in centriole 
duplication is therefore likely to be mediated through its interaction with Cep152 and, in 
turn, Cep152-mediated recruitment of Plk4 and CPAP (figure 75).  
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However, Cep152 is absolutely required for centriole duplication whereas Cep63 
deficient cells show a stochastic phenotype. The root of this difference in phenotypes is 
likely due to alternative recruitment of Plk4 and CPAP to the centrosome, via Cep63 
independent recruitment of Cep152 to the PCM. The Cep63-Cep152 interaction is 
clearly required for efficient recruitment of Cep152 to the centrosome, but perhaps 
Cep152 localisation to the centrosome can occur via both Cep63-dependent and Cep63-
independent pathways. Precise centrosomal levels of Plk4 and CPAP are required for 
centriole duplication: too much of either lead to centriole reduplication or increase in 
centriole length, respectively (Kleylein-Sohn et al., 2007, Kohlmaier et al., 2009, 
Schmidt et al., 2009). Conversely, depletion of either Plk4 or CPAP, or their 
recruitment factor, Cep152, leads to inhibition of centriole duplication (Habedanck et 
al., 2005, Tang et al., 2009, Hatch et al., 2010a, Cizmecioglu et al., 2010). Cep63 
depletion impairs Cep152 localisation to the centrosome and thus the critical threshold 
level of these essential duplication components may not always be reached. Perhaps 
centrosome recruitment of these proteins is slower in the absence of Cep63 and 
consequently cells that spend longer in G1 and S phase may be able to reach the critical 
level in time for duplication of both centrioles before entry into mitosis, whereas cells 
that progress more quickly will contain one or both centrioles that do not accumulate 
enough Plk4 and CPAP in order to duplicate. One could imagine that in cells where one 
centriole is able to duplicate, but not the other, it would be the grandmother centriole 
(the mother in the previous cell cycle) that would be able to duplicate due to it having 
more PCM at an earlier stage in the cell cycle.  
 
Although evidence points to a regulatory role for Cep63 in centriole duplication as 
described above, an additional role for Cep63 in centriole duplication is not ruled out. 
Interestingly, Loffler and colleagues have recently shown that the N-terminal 209 amino 
acids were sufficient to drive centrosome reduplication (Loffler et al., 2011), which 
confirms that Cep63 is a positive regulator of centrosome duplication and shows that it 
may have an additional role in centriole duplication other than recruitment of Cep152 to 
the centrosome, as this region is not able to bind Cep152. Perhaps Cep63 acts as a 
scaffold component of the PCM and regulates the binding of several centriole 
duplication factors, including Cep152. It is a possibility that Cep152 functions alone in 
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the recruitment and maintenance of CPAP and Plk4 at the centrosome, but the Cep152-
Cep63 complex is important for other regulatory processes. If this was the situation, 
centriole duplication would not be possible in Cep152 depleted cells due to loss of 
centrosomal Plk4 and CPAP, and loss of Cep63 would impinge on the regulation of 
centriole duplication via an unknown pathway, but CPAP and Plk4 recruitment would 
not be affected and centriole duplication would still be able to occur, albeit at reduced 
efficiency. 
 
In order to test these hypotheses it will be important to assess the ability of Plk4 and 
CPAP to localise to the centrosome in the absence of Cep63. Furthermore, generation of 
a non-rabbit Cep63 or Cep152 specific antibody could be used to simultaneously 
monitor Cep63 and Cep152 levels at the same centrosome. Additionally, an antibody 
that recognises the mouse Cep152 orthologue will be important for studying 
endogenous Cep152 in Cep63 gene-trap MEFs. Detailed analysis with a series of 
different centriole antibodies will shed light on the duplication defect in Cep63 depleted 
cells. Is Sas-6 recruited to form the cartwheel structure; are proteins of the central tube 
recruited; is CPAP recruited? This type of analysis would help determine the point at 
which Cep63 plays a regulatory role in centriole duplication. From evidence described 
so far, the prediction for Cep63 would be that it works with Cep152 to recruit Plk4 and 
CPAP and is therefore required for initiation of procentriole formation, beginning with 
recruitment of Sas-6, and at a later stage in centriole elongation (recruitment of CPAP). 
Thus the expected observed phenotype would be that centrosomes in G2/M Cep63 
deficient cells that have only one centrin focus have only one centriole and no visible 
procentriole (Sas-6 negative). Correlative EM to visualise centriole structure in cells 
depleted of Cep63 would also be useful for determining the stage at which duplication 
is prevented. 
 
The work presented in this thesis adds another player to the field of centriole 
duplication. Cep63 has not previously been described as a regulator of centriole 
duplication and the evidence that it provides an additional layer of regulation in 
vertebrates, where Cep63 orthologues are present, may lead to further understanding of 
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the evolutionary changes in the regulation of this process. Despite the conservation of 
centriole structure, there is quite some variety in centriole protein sequence (Carvalho-
Santos et al., 2010). Sas-6, Cep135 and CPAP comprise a universally conserved module 
that defines centriole architecture. However, other proteins essential for regulation of 
centriole duplication are not well conserved including Plk4, for which there is an 
orthologue in flies, but not in worms, as determined by sequence or structural similarity 
(Carvalho-Santos et al., 2010). Furthermore, although Plk4 is conserved between 
humans and flies there is a functional difference between the orthologues reflected by 
the inability of one to cause centriole reduplication in cells from the other species 
(Carvalho-Santos et al., 2010). This example of divergence in centriole duplication 
between flies and humans may be linked to the presence of Cep63 in humans, but not 
flies. In the least, it provides evidence that although the structure of centrioles and 
regulation of centriole biogenesis are highly conserved, there are emerging differences 
in the molecular mechanisms of centriole duplication regulation. The main players may 
still have their role, but additional layers of regulation have been added. An interesting 
line of investigation will be to determine the capabilities that have been acquired by the 
addition of these regulatory controls. Study of Cep63 will further our understanding of 
the regulation of centriole duplication when compared across different vertebrate 
species and in comparison to those species lacking Cep63. Fundamental to these future 
studies will be the study of Cep63 at the level of the whole organism. Cep63 may offer 
an additional layer of regulation for centriole duplication that is important for a 
particular tissue or developmental process specific to vertebrates.  
 
A Cep63 deficient mouse would be an extremely useful model for the study of centriole 
duplication deficiencies since mice null for other essential centriole regulatory proteins 
are embryonic lethal, for example, Plk4 mutant homozygotes (Harris et al., 2011). 
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6.2 Cep63 and cell cycle control 
Loffler and colleagues propose a role for Cep63 in mitotic entry via recruitment of 
Cdk1 to the centrosome (Loffler et al., 2011). In this study, Loffler and colleagues show 
that depletion of Cep63 in U2OS cells by RNAi lead to an increase in polyploid cells 
(11% compared to 3.5% control siRNA) (Loffler et al., 2011). This phenotype was 
observed with two other siRNAs to a lesser extent (6.6% and 4.38% compared to 2.48% 
with control siRNA). The phenotype was inferred to be specific to Cep63 due to the 
repeated observations with different siRNAs targeting Cep63, but no complementation 
experiment was carried out. The authors conclude that polyploidisation occurs due to 
mitotic skipping, which is the inability of cells to enter mitosis followed by another 
round of DNA replication. Indeed, upon Cep63 RNAi centrosomal levels of Cdk1 are 
reduced (Loffler et al., 2011). Additionally, a small proportion of Cdk1 interacts with 
GFP-Cep63. Thus, Cep63 plays a role in regulation of mitotic entry at the centrosome 
by ensuring the centrosomal localisation of Cdk1. However, this phenotype was not 
observed with the three siRNAs used in this thesis, two of which successfully depleted 
Cep63 from the centrosome. One of these siRNAs caused an increase in the percentage 
of cells with 4N DNA content, but this was likely off target (described in 4.5). 
However, polyploid cells were not observed by FACS analysis. Furthermore, Cep63 
gene-trap primary MEFs did not show signs mitotic skipping or polyploidisation. It will 
be important to look carefully at the efficiency of the G2 to M transition and the 
efficiency of the G2/M checkpoint in additional Cep63 deficient MEF cell lines. 
 
Furthermore, there is a potential role for Cep63 in the DNA damage signalling pathway 
as determined by the work carried out in the Costanzo lab using Xenopus laevis Cep63 
(Smith et al., 2009). Although functions may not be fully conserved between the 
Xenopus and human Cep63 orthologues, the possibility of human Cep63 being involved 
in a DNA damage signalling pathway has not been ruled out. Certainly, Cep63 deficient 
primary MEFs are proficient in DNA damage checkpoints, but Cep63 may be important 
for the less well characterised response to DNA damage in mitosis, or perhaps a 
constitutive mitotic signalling pathway present during unperturbed mitoses, involving 
DNA damage signalling kinases such as ATM and ATR. Identification for role of 
human Cep63 in DNA damage signalling processes is yet to be demonstrated: 
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phosphorylation site identification will provide an important starting point in this 
investigation. 
 
6.3 Cep63 in genome stability 
Unusually early spontaneous immortalisation of a Cep63-deficient MEF line points to 
an important role for Cep63 in genome stability. Transformation requires several 
genetic changes to occur and is therefore promoted in genetically unstable backgrounds 
(Hanahan and Weinberg, 2000). This preliminary, but exciting, finding is an indication 
for the implication of Cep63 in cancer. Genome stability could arise in Cep63 deficient 
cells through centriole duplication defects leading to aberrant mitoses and consequent 
aneuploidy. Centrosome aberrations are observed in tumours and although there is little 
direct evidence for centrosomes in causing cancer, centrosome aberrations are found in 
early pre-malignant lesions; coincident with chromosome aberrations; and they 
correlate with poor clinical outcome (Nigg, 2002). Interestingly, the presence of 
multiple centrosomes can initiate tumourigenesis in flies: when Plk4 over-expressing 
Drosophila larval brain cells are transplanted into the abdomen of adult flies, the cells 
over-proliferate and form tumours (Basto et al., 2008). In addition to the effects of 
centrosome abnormalities on cell division, centrosomes may also play a role in cancer 
progression via microtubule organisation effects on cell shape, polarity, and motility, 
and consequently the ability of cells to metastasise (Nigg and Raff, 2009).  
 
As a protein that is involved in the regulation of centrosome duplication and cell cycle 
control, Cep63 is an interesting candidate for maintenance of genome stability. 
Although there is not yet sufficient evidence for ascribing a role for Cep63 in genome 
stability maintenance, it will be interesting to investigate this further. Firstly and most 
importantly, the effect of Cep63 deficiency on immortalisation timing needs to be 
examined in duplicate experiments with the generation of more Cep63 gene-trap MEF 
cell lines and complementation experiments with exogenous Cep63 must be carried out 
to validate any findings. Further to this, generation of Cep63 gene-trap homozygous 
mice will, amongst other things, allow the study of the effect of Cep63 deficiency on 
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cancer predisposition and cancer progression. Interestingly there is correlative evidence 
for a role for Cep63 as a tumour suppressor in humans (Buim et al., 2005).  
 
6.4 Cep63 and brain development 
The striking head defect seen in two (of three) Cep63 gene-trap homozygous mouse 
embryos is reminiscent of exencephaly. Exencephaly is a condition of neural 
overgrowth outside of the skull due to a defect in neural tube closure, which therefore 
indicates a role for Cep63 in brain development. Intriguingly, Cep63 mutation have 
recently been found in primary microcephaly in humans, although details are currently 
unpublished (Fanni Gergely, CRUK Cambridge Research Institute, personal 
communication). As described in chapter 1.2.4, the cause of microcephaly at the 
molecular and cellular level is under investigation, but no unifying theme has arisen 
from studies so far. Of the seven identified primary microcephaly genes, four are 
constitutive centrosome proteins and the other three are associated with mitotic spindle 
poles, which indicates the importance of mitotic spindle organisation in neuroepithelial 
(NE) cell divisions. Molecular and cellular roles have been described for MCPH1, 
Cdk5Rap2, Cep152, ASPM, CPAP and STIL. These proteins are all involved in 
centrosome function, whether it may be centriole duplication (Cep152, CPAP); spindle 
pole focussing (ASPM); centrosome to spindle pole attachment (Cdk5Rap2); or 
regulation of the G2/M checkpoint at the centrosome (MCPH1) (introduction 1.2.4).  
 
DNA damage signalling is also a common theme in patients with a range of 
microcephaly causing syndromes: ATR, pericentrin, MCPH1, and Cdk5Rap2 are all 
required for efficient G2/M checkpoint although phenotypes of these patients and 
patient-derived cell lines are not all overlapping. ATR and pericentrin mutations cause 
Seckel syndrome (O'Driscoll et al., 2003, Griffith et al., 2008), although most patients 
with pericentrin mutations are clinically described as MOPD II, which has many 
overlapping clinical features with Seckel syndrome (Piane et al., 2009). At a cellular 
level, ATR-Seckel and pericentrin-Seckel cell lines share the features of defective 
G2/M arrest after UV treatment; nuclear fragmentation upon prolonged hydroxyurea 
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treatment; and supernumerary centrosomes (Griffith et al., 2008). MCPH1 mutations 
also result in these cellular phenotypes (Alderton et al., 2006), yet MCPH1 patients 
have primary microcephaly without the short stature seen in Seckel syndrome. 
Furthermore, Cdk5Rap2 mutation causes primary microcephaly, and at a cellular level, 
G2/M checkpoint signalling is defective (Barr et al., 2010). Interestingly, one particular 
CPAP (CENPJ) mutation has also been observed in Seckel syndrome patients, which 
differs from other CPAP mutations that cause MCPH, although the cellular phenotypes 
have not been described (Al-Dosari et al., 2010). In addition to Seckel syndrome and 
MOPD II, microcephalic primordial dwarfism, which comprises microcephaly as well 
as severe short stature, is observed Meier-Gorlin syndrome (MGS), which is caused by 
mutations in pre-replicative complex proteins required for DNA replication licensing 
(Bicknell et al., 2011a). Interestingly, not all Meier-Gorlin syndrome mutations cause 
microcephaly, but microcephaly is associated with MGS patients with Orc1 mutations, 
which may be due to its reduced function in replication origin licensing, or in centriole 
duplication (Bicknell et al., 2011b).  
 
In summary, the clinical feature of microcephaly is caused by a wide variety of 
mutations. However, other associated clinical features and cellular phenotypes are not 
always conserved from mutation in one microcephaly gene to the next. Studies carried 
out so far highlight several cellular processes that are defective in microcephaly 
patients, mouse models, and cell culture: centrosome function in spindle assembly, 
mitotic spindle pole maintenance, centrosome duplication, and DNA damage signalling. 
Microcephaly genes and their associated clinical classifications are outlined in figure 
75. Cep63 is important for the proper regulation of centriole duplication and centriole 
number, and may also be involved in DNA damage signalling, and cell cycle regulation, 
which therefore places it as a potential microcephaly gene and indeed this is the case. 
 
Perhaps the centriole duplication defects caused by Cep63 depletion would cause 
microcephaly via knock-on effects in centrosome dependent spindle organisation. 
Although spindle organisation appears not to be affected in tissue culture cells depleted 
of Cep63, the precise regulation and positioning of the mitotic spindle in NE cells is 
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important in regulating division plane positioning and can affect the fate of the division; 
symmetric proliferative versus asymmetric neurogenic. Cep63 deficient NE cells unable 
to duplicate their centrioles would end up with asymmetric spindle poles, such that there 
may be a pair of centrioles at one pole and only one centriole at the other; or one 
centriole at one spindle pole with an acentrosomal spindle pole opposite. Thus, control 
of mitotic spindle positioning and the consequent division plane position may be 
deregulated. Spindle positioning relies on interaction of astral microtubules emanating 
from the centrosome with the cell cortex. Cep63 may have an indirect role in spindle 
positioning via regulation of centriole duplication; or alternatively it could play more 
direct role via the organisation of astral microtubules. 
 
Aside from positioning of the mitotic spindle in NE cells, Cep63 may play a role at the 
centrosome in determining symmetry of cell fate determinants orchestrated by 
centrosomes and the carriage of components by motor proteins on spindle microtubules. 
Like ASPM, it could maintain symmetry of cell division such that its absence would 
cause an increase in asymmetric cell divisions at earlier stages of developments where 
symmetric divisions are important to build the population of neural progenitors (Fish et 
al., 2006). Animals with this kind of defect would have depleted neural progenitor pools 
and the number of neurons produced would consequently be much lower. Alternatively, 
if Cep63 regulated symmetry of cell fate determinants required for cell cycle 
progression, the asymmetric divisions induced upon loss of Cep63 could generate a 
daughter cell that exits the cell cycle prematurely, while the other daughter continues to 
cycle. Indeed, this type of asymmetric cell division is a phenotype observed in several 
cancer cell lines and tumours after irradiation treatment, although the causative 
mechanisms have not yet been described (Dey-Guha et al., 2011). In this case, Cep63 
deficiency would result in a reduced number of cell divisions, which may not be evident 
in most organs where the phenotype would be masked by ongoing cell division that 
occurs through development and postnatal life. In the development of the cerebral 
cortex, on the other hand, NE cell divisions and neurogenesis is limited to a particular 
developmental window of time. In this case, a decrease in cell divisions due to 
premature cell cycle exit of a subpopulation of NE cells would lead to a decreased 
neural progenitor pool and consequently reduced neuron number. Premature cell cycle 
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exit and increased levels of apoptosis are a likely cause of microcephaly observed in 
mice with Cdk5Rap2 mutations (Buchman et al., 2010). 
 
The primary cilium may also be important in embryonic neurogenesis. As opposed to 
the motile cilia that are found in specialised epithelial cells of the respiratory tract, for 
example, most vertebrate cells can form a primary cilium, which is a non-motile array 
of 9 microtubules organised by the mother centriole. Primary cilia play important roles 
during vertebrate development via their role in sonic hedgehog (shh) signalling. Ssh 
signalling is used in many different tissues throughout development and most shh 
signalling in mice requires primary cilia, whereas shh signalling can occur in the 
absence of a primary cilium in Drosophila melanogaster (Nigg and Raff, 2009). The 
primary cilium is important for both shh and wnt signalling in the detection of 
extracellular signals in the later stages of brain development (Farkas and Huttner, 2008).  
Perhaps there is also a role for the primary cilium in embryonic development of the 
cerebral cortex and the potential for microcephaly resulting from defective centriole 
structure or function. In fact, multiple cilia, as well as multiple centrosomes, were 
observed in one mouse model of MCPH3 with truncation of Cdk5Rap2, although this 
particular model did not show microcephaly (Barrera et al., 2010). The role of Cep63 in 
primary cilium formation has not yet been studied and it will be important to investigate 
this further in human tissue culture cells and in the mouse model. 
 
Evolutionary studies of the Cep152 gene show that it is under positive selection in the 
human lineage, compared to primates and other vertebrates (Guernsey et al., 2010). The 
same is found for other MCPH genes, MCPH1 and ASPM (Kouprina et al., 2004, Evans 
et al., 2004, Ponting and Jackson, 2005). These findings, in addition to mutations in 
these genes causing microcephaly, support the conclusion that there is a causative link 
between changes in MCPH genes and the increase in brain size evident in humans 
compared to hominoid ancestors (Bond et al., 2002, Woods et al., 2005). Furthermore, 
these studies may provide an explanation for the differences seen between human 
MCPH patient phenotypes and mouse model phenotypes. For example, mouse models 
of MCPH5 (Aspm) show very slight or insignificant reductions in the size of the 
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neocortex compared to human patients with similar mutations (Pulvers et al., 2010). An 
equivalent evolutionary study of Cep63 would be extremely interesting, as it has arisen 
at a later evolutionary time point than Cep152: Cep63 is present only in vertebrates 
whereas flies have a Cep152 orthologue. Cep63 may also be under positive selection for 
a role in neuroepithelial cell divisions and neocortex expansion.  
 
It will be exciting to study Cep63 gene-trap homozygous embryos and, if possible, adult 
mice in order to determine if Cep63 deficiency does indeed cause microcephaly and to 
understand the cause of this microcephaly. Further investigation should begin with 
measuring the cerebral cortex in Cep63 gene-trap homozygous embryos and adults, 
including brain sectioning to observe cell numbers and carry out immunohistochemistry 
(ICH) of centrosome and spindle components; cell cycle stage markers; and markers of 
apoptosis. Analysis of wild type mouse neuroepithelium between embryonic day 9 to 14 
by FISH (fluorescent in situ hybridisation) or ICH will be important to determine 
whether Cep63 is expressed in neuroepithelium at the time of neurogenesis like other 
microcephaly genes. Analysis of cleavage plane orientation and symmetric versus 
asymmetric inheritance of the apical membrane in NE cell of Cep63 deficient embryos 
will also be interesting. Establishing neural cell cultures in vitro from Cep63 gene-trap 
and wild type mice would provide a useful model for determining the role of Cep63 in 
neural cell divisions. Further to the potential microcephaly phenotype, analysis of 
Cep63 deficient embryos and adults will be extremely important in identifying 
alternative developmental processes in which Cep63 is involved, as well as non 
developmental processes. A Cep63 mouse model will provide a possibility of studying 
the effects of Cep63 deficiency on genome stability. 
 
One additional hypothesis for Cep63 deficiency is that it may cause problems in 
spermatogenesis. The Drosophila melanogaster orthologue of Cep152, asterless, is 
essential for proper spindle assembly and meiotic cell division during spermatogenesis 
(Bonaccorsi et al., 1998). Furthermore, mice with a heterozygous mutation in Plk4 have 
defects in spermatogenesis (Harris et al., 2011), and mouse models of MCPH1 and 
Chapter 6. Discussion 
247 
MCPH3 (Cdk5Rap2) also cause male infertility (Liang et al., 2010, Lizarraga et al., 
2010). 
 
6.5 Conclusions  
Cep63 is a constitutive PCM component that is involved in the regulation of centriole 
duplication. In the absence of Cep63 centrioles can duplicate, but do so with reduced 
efficiency. The role of Cep63 in centriole duplication is predicted to be mediated 
through its binding partner, Cep152, which is required for centriole duplication due to 
its role in recruiting Plk4 and CPAP to the centrosome. This study is the first to 
implicate Cep63 in centriole duplication; identify and characterise the interaction 
between Cep63 and Cep152; and show the requirement for Cep63 in localisation of 
Cep152 to the centrosome. Other than the primary phenotype of a defect in centriole 
duplication, preliminary evidence from Cep63 null mouse embryos and derived cell 
lines show evidence for a potential role for Cep63 in embryonic brain development. 
 
Figure 75 depicts the hypothesis drawn from Cep63 studies described in this thesis. 
Although the situation is likely to be much more complicated than depicted, this model 
serves as a good basis for designing future experiments to understand Cep63 function at 
the molecular level more thoroughly. Further to the characterisation of the molecular 
details of the involvement of Cep63 in centriole duplication, study of Cep63 deficient 
mice will provide information on the importance and the role of Cep63 in different cell 
types and during development. The Cep63 deficient mouse model may prove a useful 
system for understanding the molecular and cellular phenotypes underlying primary 
microcephaly. 
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Figure 75 Hypothesis 
(A) Cep63 is a constitutive PCM protein that localises around the outside of the 
proximal centriole wall, which is visualised as a bi-lobed (left) or doughnut-shaped 
(right) appearance by immunofluorescence. (B) Predicted localisation of Cep63 with 
respect to mother and daughter centrioles; to be tested by immuno-electron microscopy. 
(C) Cep63 functions in promoting centriole duplication by recruiting Cep152 to the 
centrosome. Cep152, in turn, recruits CPAP and aids recruitment of Plk4 to promote 
pro-centriole formation. The dashed arrow represents a possible alternative mode of 
recruitment of Cep152 to the centrosome that could occur in the absence of Cep63. 
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Figure 76 Microcephaly genes 
MCPH1, WDR62, Cdk5Rap2, ASPM, STIL, CPAP and Cep152 mutations cause 
primary microcephaly. CPAP and Cep152 mutations have also been found in patients 
with Seckel syndrome. ATR and pericentrin (PCNT) mutations cause Seckel syndrome, 
although most patients with PCNT mutations are diagnosed with MOPD II. A subset of 
Meier-Gorlin syndrome (MGS) patients have microcephaly, these patients have Orc1 
mutations. Of the microcephaly genes whose proteins have been characterised at a 
cellular level (italics), MCPH1, Cdk5Rap2, ATR, and PCNT are required for efficient 
DNA damage signalling; CPAP, Cep152, and Orc1 are required for proper centrosome 
duplication; and Cdk5Rap2 and ASPM are required for mitotic spindle pole integrity. 
Perhaps Cep63 will also be placed in the MCPH category.
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